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Abstract 
 Small interfering RNAs (siRNAs), microRNAs (miRNAs), and piRNAs (piRNA) 
are conserved classes of small single-stranded ~21-30 nucleotide (nt) RNA guides that 
repress eukaryotic gene expression using distinct RNA Induced Silencing Complexes 
(RISCs). At its core, RISC is composed of a single-stranded small RNA guide bound to a 
member of the Argonaute protein family, which together bind and repress complementary 
target RNA. miRNAs target protein coding mRNAs—a function essential for normal 
development and broadly involved in pathways of human disease; small interfering 
RNAs (siRNA) defend against viruses, but can also be engineered to direct experimental 
or therapeutic gene silencing; piwi associated RNAs (piRNAs) protect germline genomes 
from expansion of parasitic nucleic acids such as transposons. Using the fruit fly, 
Drosophila melanogaster, as a model organism we seek to understand how small 
silencing RNAs are made and how they function. 
In Drosophila, miRNAs and siRNAs are proposed to have parallel, but separate 
biogenesis and effector machinery. miRNA duplexes are excised from imperfectly paired 
hairpin precursors by Dicer1 and loaded into Ago1; siRNA duplexes are hewn from 
perfectly paired long dsRNA by Dicer2 and loaded into Ago2. Contrary to this model we  
found one miRNA, miR-277, is made by Dicer1, but partitions between Ago1 and Ago2 
RISCs. These two RISCs are functionally distinct—Ago2 could silence a perfectly paired 
target, but not a centrally bulged target; Ago1 could silence a bulged target, but not a 
perfect target. This was surprising since both Ago1 and Ago2 have endonucleolytic 
cleavage activity necessary for perfect target cleavage in vitro. Our detailed kinetic 
studies suggested why—Ago2 is a robust multiple turnover enzyme, but Ago1 is not. 
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Along with a complementary in vitro study our data supports a duplex sorting mechanism 
in which Diced duplexes are released, and rebind to Ago1 or Ago2 loading machinery, 
regardless of which Dicer produced them. This allows structural information embedded 
in small RNA duplexes to direct small RNA loading into Ago1 and/or Ago2, resulting in 
distinct regulatory outputs.  
 Small RNA sorting also has chemical consequences for the small RNA guide. 
Although siRNAs were presumed to have the signature 2′, 3′ hydroxyl ends left by Dicer, 
we found that small RNAs loaded into Ago2 or Piwi proteins, but not Ago1, are modified 
at their 3´ ends by the RNA 2´-O-methyltransferase DmHen1. In plants Hen1 modifies 
the 3´ ends all small RNAs duplexs, protecting and stabilizing them. Implying a similar 
function in flies, piRNAs are smaller, less abundant, and their function is perturbed in 
hen1 mutants. But unlike plants, small RNAs are modified as single-strands in RISC 
rather than as duplexes. This nicely explains why the dsRNA binding domain in plant 
Hen1 was discarded in animals, and why both dsRNA derived siRNAs and ssRNA 
derived piRNAs are modified. The recent discovery that both piRNAs and siRNAs target 
transposons links terminal modification and transposon silencing, suggesting that it is 
specialized for this purpose.   
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Introduction: 
In 1969 Britten and Davidson proposed a theory to explain how multicellular 
organisms achieve tissue specific gene expression (Britten and Davidson, 1969). They 
postulated the existence of regulatory RNAs that would control batteries of genes, 
defining the gene expression program for a given cell type. They reasoned that eukaryotic 
genomes - much larger and harboring far more repetitive sequences than prokaryotic 
genomes – may contain RNAs corresponding to these repetitive sequences that could 
base pair in cis- or  trans- to homologous elements scattered throughout the genome to 
regulate sets of non-contiguous cell specific genes. “Activator” RNAs binding repetitive 
DNA proximal to a gene could displace repressive histones, allowing transcription to 
proceed. Employing occam’s razor they considered, but dismissed the possibility that 
proteins might carry out such a function.   
Because protein transcription factors had not been discovered yet, the idea of 
ribo-regulation seemed simpler. Moreover, it led directly to ideas about how genetic drift 
in repeteated sequences might alter gene expression and drive evolution. While the 
discovery of transcription factors filled the regulatory role proposed for Britten and 
Davidson’s “activator” RNAs, a new class of RNAs, collectively known as small silecing 
RNAs, appears possess many of the properties they suggested—but they perform an 
equally important role in repressing gene expression instead. Small silencing RNAs are 
often cell type specific, some derive from repetitive sequences, they broadly regulate 
gene expression utilitzing basepairing interactions to elements dispersed throughout the 
genome, and alterations in their sequences appear to play an important role in evolution 
(Bartel, 2004; Zamore and Haley, 2005; Aravin et al., 2007). Importantly, the discovery 
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of small RNAs has forced us to reconsider gene expression paradigms; ribo-regulation by 
small RNAs is now recognized as a critical point of regulation in the conversion of 
genetic information from DNA to protein. Now, 15 years after the first small RNA was 
described, it appears that few biological processes in animals and plants function 
optimally in the absence of small RNA regulation. Here we discuss the evolution of the 
small RNA field in order to frame the research presented in chapters II, III and 
Apendices. Subsequent studies will be discussed in Chapter IV.  
 
miRNAs, siRNAs, and RNAi 
 
 
miRNA Discovery 
 Victor Ambros and colleagues identified the first small RNA, a microRNA 
(miRNA) named lin-4 (Lee et al., 1993). Over 10 years of genetic studies by the Ruvkun 
and Ambros groups suggested an interaction between the lin-4 gene and the 
3′untranslated region (UTR) of another gene lin-14, which encoded a nuclear protein 
(Ambros and Horvitz, 1984; Ruvkun et al., 1989; Arasu et al., 1991; Wightman et al., 
1991). Mutation in either gene gave a “heterochronic” phenotype - a defect in the timing 
of developmental transitions in the nematode, C.elegans (Ambros and Horvitz, 1984). 
Ambros’ finding that lin-4 was not a protein, but rather a small 22 nt non-coding RNA 
with a 61 nt precursor came as a shock - but it fit perfectly with the careful genetic 
analyses implicating an interaction with the lin-14 3′UTR (Wightman et al., 1993); lin-4 
small RNA had extensive complementarity to 7 sites in the lin-14 3′UTR.  Moreover, the 
mutations in both lin-4 and lin-14 mapped precisely to the complementary regions and 
partial deletion of the sites gave a weaker phenotype than deletion of them all. lin-14 
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mRNA abundance was unaltered in all mutants, but disruption of the lin-4:lin-14 mRNA 
duplex by mutations at the 5′ end of lin-4 caused persistent production of Lin-14 protein, 
suggesting that lin-4 binding inhibits translation of lin-14 mRNA (Lee et al., 1993).  
These studies were an amazing feat of forward genetics that revealed many of the 
fundmental principles of miRNA regulation. That is, miRNAs are encoded in the 
genome, commonly in introns. They contain characteristic hairpin precursors that are 
processed to yield 22 nt RNAs. These 22 nt guides basepair with partially complementary 
target mRNA sequences in 3′UTRs and inhibit translation. 
Unfortunately, lin-4 is only conserved in worms, leading the scientific community 
(and Ambros and Ruvkun) to wonder whether lin-4 was an innovation unique to worms, 
or perhaps even unique in worms (hence the news and views title, “Deviants – or 
Emissaries?”)(Wickens and Takayama, 1994). The former seemed likely when another 
miRNA, let-7, and its target lin-41, also heterochronic C. elegans genes, were discovered 
by Ruvkun’s group 7 years later (Reinhart et al., 2000). The potenial for a more general 
role of small RNAs became clear when Pasquinelli and colleagues found that let-7 was 
conserved in both its sequence and the timing of its expression at the transition to 
adulthood in bilaterian animals (Pasquinelli et al., 2000). At this point, parallel studies of 
the RNA interference pathway converged with the budding miRNA field and the line 
between the two pathways began to blur.  
 
RNAi Discovery 
RNA interference (RNAi) phenomena were first observed in plants by two groups 
in their efforts to make a purple petunia more purple. Paradoxically, transgenic 
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introduction of the pigment synthesis genes chalcone synthase or dihydroflavonol-4-
reductase, often resulted in production of white or mottled white flowers instead (Napoli 
et al., 1990; van der Krol et al., 1990). This phenomenon of homologous transgenes 
triggering silencing of an endogenous gene was termed “Co-suppression”. Further studies 
by Baulcombe and colleagues suggested that this might be caused by transgene derived 
antisense RNA targeting the endogenous RNA; such a phenomenon might be related to a 
system to silence plant viruses (Baulcombe, 1996; Ratcliff et al., 1997; Voinnet and 
Baulcombe, 1997; Brigneti et al., 1998).     
Antisense RNA regulation of endogenous genes had also been observed in C. 
elegans. Fire and colleagues disrupted myofilament genes unc-22 and unc-54 by injecting 
oocytes with vectors expressing corresponding antisense fragments. They observed high 
levels of antisense RNA with little change in sense mRNA levels and speculated that 
either transport to the cytoplasm or translation were affected (Fire et al., 1991). Extending 
this approach Guo and Kemphues injected worm oocytes with in vitro transcribed 
antisense RNA targeting, par-1, a kinase gene important for establishing embryo polarity. 
To their surprise, their sense RNA control phenocopied par-1 with the same frequency as 
antisense RNA (Guo and Kemphues, 1995).  
In their landmark study, Fire and Mello revealed that the effect seen by Guo and 
Kemphues (RNA interference or RNAi) was likely due to unintended formation of 
dsRNA (Fire et al., 1998). Injected dsRNA was over 100-fold more potent trigger for 
silencing of unc-22 than either sense or antisense suggesting that even small amounts of 
contaminating sense or antisense RNA produced during in vitro transcription could 
produce a phenotype. Injected long dsRNAs (300-1000 nt) could silence genes 
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systemically, causing mRNA reduction even at a distance from the injection site; RNAi 
only worked if exons were targeted implying a post-transcriptional mechanism, and 
remarkably, silencing could be transmitted to progeny. This fact was especially 
intriguing—it suggested that the silencing mechanism involved amplification or a 
catalytic component, because dilution alone would not produce more than a few 
molecules per cell of dsRNA from the original injection. Fire and Mello’s Nobel Prize 
winning characterization of RNAi in worms ignited the field. The tremendous potential 
of RNAi as a reverse genetic tool and as important biology drove the field forward at a 
furious pace. 
Conservation of an RNAi response was rapidly demonstrated in a host of 
organisms, including plants, flies, trypanosomes, planaria, zebrafish embryos, hydra, and 
mouse oocytes or early embryos (Ngo et al., 1998; Kennerdell and Carthew, 1998; 
Waterhouse et al., 1998; Lohmann et al., 1999; Sánchez-Alvarado and Newmark, 1999; 
Wargelius et al., 1999; Wianny and Zernicka-Goetz, 2000; Svoboda et al., 2000). The 
finding that RNAi activity was present in Drosophila embryos led to the development of 
an important in vitro system that recapitulates RNAi – addition of long dsRNA to 
syncitial blastoderm extracts can induce specific degradation of a homologous mRNA 
(Tuschl et al., 1999). Further biochemical studies examining the fate of both the dsRNA 
and targeted mRNA showed that the dsRNA trigger is processed to 21-23 nt fragments, 
even in the absence of a target; target mRNA is also cleaved at intervals of the same size, 
suggesting that mRNA degradation in RNAi is directed by the dsRNA derived small 
RNA fragments (Zamore et al., 2000). Similarly, fly S2 cells treated with dsRNA 
produced ~25 nt RNAs that co-fractionated with an mRNA degradation activity 
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(Hammond et al., 2000). These studies along with an earlier study in plants showing that 
accumulation of 25 nt antisense RNAs correlated with transgene silencing (Hamilton and 
Baulcombe, 1999) and a later study in worms (Parrish et al., 2000) strongly suggested 
that RNAi is mediated by small RNAs 21-25 nt long that guide degradation of 
homologous mRNAs. The fractionation experiments also suggested that a small RNA 
guided nuclease resides in a high molecular weight ribonucleoprotein (RNP) complex, 
which they dubbed RNA Induced Silencing Complex (RISC).           
 
Common Features of siRNA and miRNA Biogenesis in Animals 
The discovery that RISC contains small RNA guides cleaved out of long dsRNA 
immediately suggested the action of an RNAse III enzyme, the only class of double-
stranded RNA nuclease known to produce small RNA fragments (Bass, 2000). 
Experiments using RNAi in S2 cells and recombinant proteins showed that this was the 
case – the eukaryotic RNase III enzyme responsible for this was named “Dicer” 
(Bernstein et al., 2001). Bacterial RNAse III enzymes were already known to leave 
characteristic dsRNA ends containing 5′ phosphates, 2′, 3′ hydroxyl ends with 2 nt 3′ 
overhangs (Nicholson, 1999). Concurrent, studies by the Tuschl group found that the 
small RNAs produced from dsRNA in Drosophila extracts, small interfering RNAs 
(siRNA), were sensitive to calf intestine phosphatase (indicating the presence of a 5′ or 3′ 
phosphate) and periodate oxidation followed by β-elimination (indicating that the 3′ end 
contained both a 2′ and 3′ OH groups, rather than a 3′ cyclic phosphate) (Elbashir et al., 
2001b). Although this was “data not shown” in the manuscript it was consistent with 
RNase III processing. Furthermore, synthetic small RNA duplexes with 5′ phosphates, 3′ 
hydroxyls and the characteristic RNase III-like 3′ overhangs could mediate target 
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cleavage in vitro. This allowed precise mapping of mRNA target cleavage sites, 
indicating that homologous mRNAs were cleaved in the middle of the antisense small 
RNA guides by an unidentified nuclease activity, later termed “Slicer” activity (Parker et 
al., 2004). Elucidation of siRNA’s chemistry also formed the basis for Tuschl’s major 
breakthough—that siRNAs can direct RNAi in mammalian cells, bypassing the Protein 
Kinase R (PKR) response (Elbashir et al., 2001a). The PKR response, a mammalian anti-
viral response to long dsRNA that causes global translational arrest, was the main 
impediment to RNAi in mammalian cells. Overcoming this barrier opened up a new 
approach to reverse genetics in mammals. Armed only with a gene’s mRNA sequence, 
now readily available with completed human and mouse genomes, researchers could 
perform loss of function experiments by introducing a gene specific siRNA. siRNA 
therapeutics were an obvious extension of this approach.  
The surprisingly similar size of siRNAs to small temporal RNAs (miRNAs) and 
their double-stranded hairpin origin hinted that they might be related. Are small temporal 
RNAs also made by Dicer?  The overwhelming repsonse - yes. Genetic studies in worms 
demonstrated that Dicer mutants and RNAi knockdown gave phenotypes reminiscent of 
let-7 and lin-4, caused accumulation of precursor RNAs, and worms had defective RNAi 
responses (Grishok et al., 2001; Ketting et al., 2001). Just as siRNAs were excised from 
long dsRNA in fly extracts, let-7 could be excised from an in vitro transcribed hairpin 
precursor. Endogenous let-7 had the same 5′ phosphate and 3′ hydroxyl ends as siRNAs, 
and depletion of Dicer in human cells also caused accumulation of its precursor 
(Hutvágner et al., 2001).  
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Although Dicer was originally presumed to make both cuts in miRNA maturation 
from their longer precursors, Narry Kim’s group found that a second nuclear RNAse III 
protein, Drosha, cuts long primary miRNA tanscripts (pri-miRNA) derived from 
independent pol II or III transcription units or introns (Lee et al., 2003; Han et al., 2006). 
The resulting 60-80 nt hairpin—a pre-miRNA—is then exported to the cytoplasm where 
Dicer makes a second cut to produce a small RNA duplex intermediate, consisting of the 
miR strand (which is stabilized accumulates), bound to the miR* strand (which is 
degraded). Thus a miR/miR* duplex has two RNAse III-like ends – one made in the 
nucleus by Drosha, the other made in the cytoplasm by Dicer. 
Identical in their chemistry, miRNAs could in theory be cloned, just as Tuschl’s 
lab had done for siRNAs. Indeed, cloning of endogenous small RNAs by the Ambros, 
Bartel, and Tuschl groups from C. elegans (Lau et al., 2001; Lee and Ambros, 2001), 
Drosophila embryo extracts, and human tissue culture cells (Lagos-Quintana et al., 2001) 
clearly demonstrated that, (1) miRNAs are a diverse and extensive class of genes, (2) that 
many are conserved in vertebrates and invertebrates, (3) that they are differentially 
expressed, and (4) that their signature feature in the genome is formation of hairpin 
precursor transripts. While this initial round of sequencing revealed ~90 miRNAs 
between these three species, increasing sophistication in sequencing technologies and 
bioinformatics has fueled a massive expansion of known miRNA genes; the human 
genome alone appears to contain over one thousand miRNA genes (Berezikov et al., 
2006).  
In addition to Dicer, the Mello lab identified another class of genes central to both 
the RNAi and miRNA pathways—Argonaute proteins. Argonautes are highly conserved, 
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containing two distinctive domains – Paz and Piwi. Dicer also has a Paz domain 
suggesting it may be specialized for small RNA pathways. A genetic screen in the Mello 
lab identified rde-1 as a mutant unable to perform RNAi, but viable and fertile. Rde-1 
was one of 27 Argonaute proteins in worms. Two more Argonaute mutants, alg-1 and 
alg-2 gave phenotypes similar to Dicer and the lin-4 and let-7 genes, lending additional 
support to the idea that similar mechanisms governed the RNAi and miRNA pathways 
(Grishok et al., 2001). Importantly, this was the first evidence indicating that Argonautes 
had specialized functions, dedicated to the similar but discrete RNAi and miRNA 
pathways. The importance of Argonautes in RNAi was reinforced by biochemical and 
functional studies in the Hannon lab; the fly protein Argonaute 2 co-purified with target 
degradation activity and RNAi knockdown studies in fly S2 cells crippled RNAi activity. 
Furthermore, Ago2 associated with Dicer. (Hammond et al., 2001). A human Argonaute 
protein eiF2C2 (later called Ago2) also copurified with miRNAs (Mourelatos et al., 
2002) and siRNA target cleavage activity (Hutvágner and Zamore, 2002; Martinez et al., 
2002). Remarkably, endogenous let-7 associated with Ago2 could also cleave a perfectly 
paired target, but not one resembling its bulged native target, lin-41. Thus it appeared that 
siRNAs and miRNAs utilized the same RISC in human cells, spawning the idea that the 
mode of small RNA silencing - translational repression or target cleavage - may be solely 
determined by the structure of the guide:target duplex. Supporting this view, Doench and 
Sharp found that siRNAs can also direct miRNA-like translational repression in human 
cells (Doench et al., 2003). Conversely, an siRNA sequence engineered into a miRNA-
like hairpin precursors might be used in place of synthetic siRNA for RNAi in 
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mammalian cells. Indeed, small hairpin RNAs are now routinely used for RNAi 
experiments (Paddison et al., 2002; McManus et al., 2002).  
 Initially, 22 nt miRNAs were known to be single-stranded (Lee et al., 1993), 
while their siRNA counterparts were duplexes (Elbashir et al., 2001b). The idea that 
mature siRNAs were duplexes in cleavage competent RISC diminished, as biochemical 
analyses of RISC formation in fly extracts suggested an ATP-dependent unwinding step 
in RISC assembly (Nykanen et al., 2001); single-stranded siRNAs could also cleave 
targets, albeit inefficiently (Schwarz et al., 2002; Martinez et al., 2002). Finally, two 
studies definitively showed that functional RISC contained only a single-stranded guide. 
Using biochemical and cellular assays, Schwarz and colleagues found that alterations in 
the thermodynamic stability of the siRNA ends governed which strand of the siRNA 
duplex entered RISC; the strand with the less stable 5′ end is loaded into RISC—the other 
stand is destroyed (Schwarz et al., 2003). An identical result was obtained by Khvorova 
and collegues using high-throughput screening of siRNA efficacy and in silico analysis 
(Khvorova et al., 2003). Not only did these studies guide experimentalists in future 
siRNA design—they implied the same principles might be used in vivo to make single-
stranded miRNAs from a duplex intermediate consisting of a mature miRNA and its 
imperfectly paired complement, miRNA*. After production of a miRNA/miRNA* 
duplex by Dicer, the miRNA would be retained in RISC, while the miRNA* would be 
destroyed. The 5′U bias of miRNAs (Lau et al., 2001)and examination of known 
miRNAs supported this idea; the fact that miRNAs can be made from either arm of the 
pre-miRNA hairpin also suggested a duplex intermediate (Lau et al., 2001; Lagos-
Quintana et al., 2001; Lee and Ambros, 2001). 
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 Additional protein components are required for siRNA or miRNA/miRNA* 
duplexes to be loaded into RISC. dsRNA binding proteins and appear to have a 
conserved role directing assembly small RNAs into RISC. In worms rde-4, a protein with 
two dsRNA binding domains (dsRBD), associates with Dicer and the argonaute protein 
Rde-1, and is required for RNAi (Tabara et al., 2002). There are two Rde-4 homologues 
in flies—R2D2 and Loquacious (Loqs).  R2D2 binds Dicer2 and is required for siRNAs 
to assemble into RISC (Liu et al., 2003), while Loqs binds Dicer1 and is required for 
efficient miRNA processing (Jiang et al., 2005; Saito et al., 2005; Förstemann et al., 
2005). Similarly, miRNA and siRNA RISC assembly in human cells requires the dsRBD 
proteins TRBP and PACT, which interact with Dicer (Lee et al., 2006; Chendrimada et 
al., 2005). RNA helicases seem to play conserved roles in RNAi (Dalmay et al., 2001; 
Tabara et al., 2002; Tomari et al., 2004; Meister et al., 2005; Robb and Rana, 2007; 
Ishizuka et al., 2002; Ishizuka et al., 2002). While several studies indicate that helicases 
play facilitate assembly of active RISC their precise function remains unclear (Tomari et 
al., 2004; Meister et al., 2005; Robb and Rana, 2007). Other RISC associated proteins 
that impacted RNAi efficacy include RNA binding proteins Vasa Intronic Gene (Vig), 
Fragile-X mental retardation protein (dFXR), the  helicase Dmp68, and a staphylococcal 
nuclease homologue, Tudor-SN (Caudy et al., 2002; Caudy et al., 2003).     
Despite the growing catalogue of RISC associated proteins, the identity of RISC’s 
“Slicer” remained elusive. From previous studies and increasingly rigorous biochemical 
purifications it became clear that human and fly Argonaute 2 were intimately associated 
with small RNA cleavage activity (Meister et al., 2004b; Rand et al., 2004). Definitive 
proof that Ago2 is Slicer was provided by two studies which showed that that the Piwi 
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domain of Argonautes had an RNase H-like fold (Song et al., 2004) and that mutation of 
the putative catalytic residues of a tagged version of human Ago2 protein abolished its 
nuclease activity (Liu et al., 2004). Notably, overexpressed tagged Ago1, 3, and 4, three 
close homologues that can also bind miRNAs and siRNAs, lack these catalytic residues 
and cannot cleave target mRNAs (Meister et al., 2004b; Liu et al., 2004). The crystal 
structure also revealed a groove ideally suited for small RNA guided target cleavage—
large enough for a guide-target duplex and running close to the DDH catalytic site. 
Combined with earlier structural and biochemical studies showing that the Paz domain 
binds siRNA 3′ ends (Yan et al., 2003; Lingel et al., 2003; Song et al., 2003), a clear 
picture now emerged; an Argonaute protein bound to a small RNA guide forms the 
catalytic core of RISC.  
 
Common Features of  miRNA and siRNA Silencing 
 From Ambros and Ruvkun’s original studies, miRNAs appeared to regulate their 
targets through imperfect base-pairing. The precise patterns of that basepairing have been 
rigorously scrutinized both computationally and experimentally. Because miRNAs and 
siRNAs appear to assemble into the same RISCs (at least in mammals), the rules 
governing target specificity suggest both putative targets of a miRNA, as well as potential 
unintended “off-targets” of an siRNA. A number of studies immediately suggested that 
the specificy of miRNAs was very small indeed. Eric Lai noticed that newly sequenced 
miRNAs paired perfectly to 8 base K-box motifs that had been identified genetically as 
sites of negative post-transcriptional regulation (Lai, 2002). Several groups used 
bioinfomatic approaches to look for miRNA targets in mammals, flies, and worms, 
considering both miRNA:target duplex thermodynamics and cross species conservation 
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of putative target sites that might basepair with miRNAs (Stark et al., 2003; Lewis et al., 
2003; Enright et al., 2003; Lewis et al., 2005; Brennecke et al., 2005). The results of 
these studies agreed with Lai’s observation; specificity is determined by basepairing of 
bases 2-7 at the 5′ end of a miRNA—the so-called “seed” sequence. This also agreed 
with mutational analysis of reporter target:miRNA pairing in tissue culture cells (Doench 
and Sharp, 2004). Kinetic analysis of in vitro target cleavage by Drosophila RISC also 
indicated that the “seed” region is critical for target binding, while pairing of the central 
bases of the small RNA guide are required for catalysis (Haley and Zamore, 2004). The 
tiny size of the “seed” sequence has big implications; each miRNA could regulate 
hundreds of target mRNAs - an estimated ~30% of mRNAs (Lewis et al., 2005). This 
may underestimate the true number, because only conserved sites in 3′UTRs are 
considered.  As we and others have observed, miRNAs can also regulate target sites that 
reside in coding sequences (Appendix II) (Kloosterman et al., 2004; Easow et al., 2007; 
Duursma et al., 2008).  
Because miRNAs were thought to repress translation (Lee et al., 1993; Olsen and 
Ambros, 1999) it was surprising that a transfected siRNA reduced mRNA levels of 
unintended target transcripts that contained only signatures of the siRNA seed (Jackson et 
al., 2003). This along with a study cataloguing the transcripts downregulated by miRNA-
like siRNAs (Lim et al., 2005), suggested that small RNAs could induce cleavage 
independent degradation of targeted transcripts in mammalian cells. Studies in worms, 
mice, zebrafish, and fly cells also confirmed that miRNAs could cause degradation of 
targets in addition to or instead of translational repression (Bagga et al., 2005; Giraldez et 
al., 2006; Behm-Ansmant et al., 2006; Krutzfeldt et al., 2005). Although there is some 
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evidence that the specific pattern of pairing at the central bases can influence whether a 
reporter miRNA target is degraded or repressed (Aleman et al., 2007), the biochemical 
nature of these mechanistic options remains to be determined. Likely due to the 
comparative difficulty of proteomic approaches versus mRNA expression arrays, no 
studies to date have assessed the extent of siRNA off-target effects at the translational 
level.  
In contrast to RNAi, lack of an in vitro system that recapitulates small RNA 
directed translational repression has hampered efforts to understand the mechanism of 
miRNA directed translational repression. Although the translational repression 
mechanism has been intensely scrutinized, a unified picture has not yet emerged. Early 
studies in worms suggested a post-initiation translational block (Olsen and Ambros, 
1999), as did more recent studies in human tissue culture cells (Petersen et al., 2006; 
Maroney et al., 2006). By contrast, several recent studies suggest that translational 
initiation is blocked (Pillai et al., 2005; Thermann and Hentze, 2007; Mathonnet et al., 
2007; Chendrimada et al., 2007; Kiriakidou et al., 2007). This includes two studies that 
finally recapitulate miRNA directed translational repression using fly and mouse in vitro 
systems (Thermann and Hentze, 2007; Mathonnet et al., 2007). Although the findings 
that RISC associates with eIF6, a ribosome anti-association factor (Chendrimada et al., 
2007), and that Argonaute proteins contain a conserved 7meG cap binding motif in the 
“mid” domain (Kiriakidou et al., 2007), support a pre-initiation block, a recent study in 
Drosophila cells disputes these claims; eIF6 knockdown has no effect on miRNA 
silencing, and mutation of the cap binding motif of fly Argonaute prevents miRNA 
binding all together (Eulalio et al., 2008). Complicating matters further, one study even 
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suggests that miRNAs can stimulate translation in non-proliferating cells (Vasudevan et 
al., 2007).  
Translational repression and target mRNA degradation likely occur in P-bodies, 
cytoplasmic organelles consisting of mRNP aggregates. Defined by the human auto-
antigen GW182, these foci also contain miRNAs, Argonautes, mRNAs, decapping 
enzymes, deadenylating enzymes, translational repression factors, and a host of other 
RNA processing machinery (Parker and Sheth, 2007).   Argonaute proteins can directly 
bind GW182 in humans, flies, and worms, likely inducing formation of P-bodies (Behm-
Ansmant et al., 2006; Liu et al., 2005; Ding et al., 2005). The importance of this 
interaction is suggested by experiments showing that disruption of human GW182 
relieves translational inhibition of a targeted miRNA (Liu et al., 2005), and that tethering 
of an mRNA to GW182 is sufficient for silencing in fly cells (Behm-Ansmant et al., 
2006). Because silencing by small RNAs as well as other RNA decay processes can 
proceed in the absence of visible P-bodies (Eulalio et al., 2007), appearance of P-body 
aggregates is likely a result, not a cause of silencing.  
 
miRNA and siRNA Functions in Animals 
 The dramatic developmental phenotypes seen in animals with defective small 
RNA biogenesis machinery indicate critical functions for small RNAs in development. 
Ablation of Alg-1 and 2 or Dicer in worms (Grishok et al., 2001), Ago2 or Dicer in mice 
(Bernstein et al., 2003), Dicer1, Loqs, or Ago1 in flies (Kataoka et al., 2001; Lee et al., 
2004; Park et al., 2007), and Dicer in zebrafish (Giraldez et al., 2005), all result in 
embryonic lethality. More recent studies creating tissue specific loss of Dicer in mice, 
also suggest important roles for small RNAs in the mophogenesis and homeostasis of the 
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heart, brain, limbs, lung, muscle, pancreas, and skin (Chen et al., 2008; Kim et al., 2007; 
Andl et al., 2006; Cuellar et al., 2008; Davis et al., 2008; O'Rourke et al., 2007; Lynn et 
al., 2007; Zhao et al., 2007; Harris et al., 2006; Harfe et al., 2005). So why then did 
miRNAs evade genetic detection for so long? The explanation likely comes from (1) their 
small size, (2) their complex genomic organization in polycistrons and introns, and (3) 
extensive functional redundancy. The original lin-4 heterochronic alleles were isolated at 
1/10 the frequency of protein coding genes (Ambros and Horvitz, 1984). Furthermore, in 
a recent study in which deletions were reported for 83% of known miRNA genes in C. 
elegans, loss of most individual miRNA genes caused no obvious phenotype (Miska et 
al., 2007). Functional redundancy likely explains this result, as combining deletions of 
several let-7 family members that alone had no phenotype, caused distinct phenotypes 
(Abbott et al., 2005). Similarly, another recent study in mice showed that deletion of two 
miRNA cluster paralogs miR-106a~363 or miR-106b~25 produced no obvious 
phenotype; yet combining these deletions with a third paralagous cluster, mir-17~92, 
results in embryonic lethality (Ventura et al., 2008).  
Despite the functional redundancy of many miRNA genes, several cases do now 
exist in flies and mice where disruption of a single miRNA produces a visible phenotype. 
Two genetic screen based studies in Drosophila found that defects in individual miRNAs, 
bantam or miR-14, resulted in defects in apoptosis and cell proliferation (Brennecke et 
al., 2003; Xu et al., 2003). These early studies confirmed that miRNAs play important 
roles in animals besides worms; intriguingly, as negative regulators of apoptosis and cell 
proliferation they suggested that miRNAs might be tumor suppressors. More focused 
studies using targeted deletions of muscle specific miR-1 in mice and flies demonstrated 
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its requirement for myogenesis and cardiogenesis (Zhao et al., 2007; Sokol and Ambros, 
2005; Kwon et al., 2005). Deletion of miR-9a in flies produces ectopic peripheral sensory 
neurons (Li et al., 2006), while deletion of miR-8 induces neuronal apoptosis (Karres et 
al., 2007). In both of these cases, the miRNAs and their targets appear to be conserved in 
mammals.   
 The rapidly expanding catalogue of miRNA genes coupled with the difficulty of 
obtaining genetic mutants prompted development of a new tool to study miRNA 
function—antisense oligonucleotide (ASO) inhibitors. ASOs are nuclease resistant 
oligonucleotides that bind cognate miRNAs in RISC (Hutvágner et al., 2004; Meister et 
al., 2004a). Our group developed 31 nt 2’-O-Me ASO inhibitors that block the function 
of siRNAs or miRNAs in vitro and in transfected human tissue culture cells, permitting 
miRNA loss of function studies to be conducted in human cells. ASOs can also inactivate 
miRNAs in worms—injected let-7 ASO phenocopies let-7 mutants (Hutvágner et al., 
2004). ASOs have several advantages over genetic approaches. (1) studies are rapid and 
require only the miRNA’s sequence, (2)  they can simulataneously inactivate miRNA 
paralogues differing by one or two bases, and (3) they can be used in human cultured 
cells to inactivate miRNAs.  
We found that addition of a 3′- cholesterol moiety enhances the potency and 
duration of action of our ASOs in Drosophila S2 cells, and facilitates delivery without 
the use of a lipid carrier (Appendix 2). Subsequent to our finding the Stoffel group 
reported that injection of 3′-cholesterol-modified ASOs, called “antagomirs”, into mice 
not only inactivated, but directed degradation of targeted miRNAs (Krutzfeldt et al., 
2005). Furthermore, miRNA degradation occurred in every tissue except brain. When 
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miR-122, a liver specific miRNA, was inactivated mRNAs containing miR-122 seeds in 
their 3′UTRs increased, and many mRNAs devoid of miR-122 seeds decreased—likely a 
secondary effect. These reduced mRNAs were enriched in cholesterol biosynthesis genes 
and a corresponding decrease in plasma cholesterol was observed. A similar study 
performed with 2’-Methoxy-ethyl ASOs, confirmed their result, but only showed partial 
reduction of detected miR-122 signal (Esau et al., 2006). Because our previous results 
indicated that ASOs were stoichiometric inhibitors, we were suspicious of the antagomir 
directed degradation. We found that (1) antagomirs do not direct degradation of miRNA 
in S2 cells, (2) incubation of a small RNA with excess antagomir can cause a northern 
blot artifact that prevents accurate detection of the small RNA, and (3) this artifact can be 
largely corrected by use of an LNA northern probe instead with high hybridization 
temperature, instead of a DNA probe. Our data indicates that the apparent degradation 
seen in antagomir treated mice could be caused by excess antagomir which might prevent 
detection of the targeted miRNA on Northern blot with a DNA probe (See Appendix 2).  
Regardless of the mechanism, ASO studies in flies, mice, and cultured cells have 
been an important tool to dissect miRNA function (see Appendix 2 for review). Their use 
has led to findings that individual miRNAs are involved in insulin release, cholesterol 
metabolism, hepatitis C replication, cardiac arrhythmia, apoptosis, and cell cycle 
progression (Poy et al., 2004; Krutzfeldt et al., 2005; Yang et al., 2007; Bommer et al., 
2007; Pedersen et al., 2007; Matsubara et al., 2007), just to name a few.  
To understand the function of the highly conserved let-7 family of miRNAs we 
used an ASO based approach to identify mRNA targets whose abundance is regulated by 
the human let-7 gene family (Appendix 1). Because let-7 has 8 paralogues, equivalent 
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genetic studies would be extremely demanding. We sought to identify genuine 
endogenous targets of let-7 by comparing two set of mRNAs: those that are upregulated 
when endogenous let-7 is inactivated by an ASO, and those that are down regulated when 
a let-7 siRNA is introduced into cells that do not express let-7. Our study identified a set 
of genes that included the oncogenic architectural transcription factor HMGA2 and Dicer. 
HMGA2 is the top predicted target for let-7 (Lewis et al., 2005), which contains seven 
conserved let-7 seeds in its 3′UTR. Dicer also contains four conserved let-7 sites, but 
these are in its coding sequence rather than its 3′UTR. Dicer regulation by let-7 was 
confirmed in adult mice, and inappropriate introduction of let-7 can lead to accumulation 
of pre-miRNAs in cultured cells. This suggests a novel function for let-7 as part of a 
regulatory loop for miRNA biogenesis (Appendix II).   
 Our finding that HMGA2, an oncogene, is regulated by let-7 lends further support 
to the idea that miRNAs can function as tumor suppressors. While our study was in 
revision Bartel and co-workers also showed that HMGA2 is targeted by let-7; they also 
noted that some oncogenic chromosomal translocations occur in its 3′UTR, removing let-
7 regulation (Mayr et al., 2007). Let-7 has an additional tumor suppressor function 
through its regulation of the Ras oncogene (Johnson et al., 2005).  This gene escaped our 
detection, likely because it is regulated by translational repression. miRNAs can also 
function as oncogenes (He et al., 2005), promote metastasis (Ma et al., 2007), or prevent 
metastasis (Tavazoie et al., 2008). Thus therapeutic modulation of miRNAs, by 
introduction or inhibition may offer a novel treatment.   
  
Unique Aspects of Small RNA Silencing 
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The RNAi and miRNA pathways have evolved unique features in different 
organisms. Key differences are reviewed here. 
 
Argonautes  
Worms appear to have greatly elaborated their RNAi silencing pathways—by 
contrast to S. Pombe which contains one Argonaute protein, worms contain 27; Plants 
contain 10, Humans 8, and flies 5 (Tolia and Joshua-Tor, 2007). Argonaute proteins fall 
into two major clades—Ago and Piwi. To date all Ago subclade Argonautes interact with 
small RNAs processed by a Dicer enzyme; this includes all Argonautes in plants, Ago1-4 
in humans, Ago1 and 2 in flies, Ago1 in S.Pombe, and Alg-1 and Alg-2 in worms.  Not 
all Ago proteins retain their catalytic function. For instance human Ago1, 3, and 4 lack 
catalytic activity, suggesting their small RNA guides (miRNAs), do not require it to 
function. Piwi proteins however, all seem to have catalytic residues, but they bind small 
RNAs (piwi interacting RNAs or piRNAs) that don’t require Dicer for their production 
(see piRNAs below). C.elegans also contains a third class of Argonautes that don’t fit 
into either clade. This class includes Rde-1 which binds siRNA generated by Dicer, as 
well as the Argonautes Csr-1 and Sago-1 and -2, which do not.     
 
RNA-dependent RNA Polymerases  
The presence of an RNA-dependent RNA polymerase (RdRP) seems to be a 
major determinant of how RNAi works in different organisms. Worms, S. pombe, and 
plants require RdRPs for their RNAi response, but Drosophila and mammals do not— 
RdRP genes have not been detected biochemically or computationally in insect or 
mammalian genomes (Zamore and Haley, 2005).   
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RdRPs appear to function differently in plants and worms.  In plants single-
stranded transcripts are cleaved by miRNAs or other small RNA classes, a second strand 
is synthesized by RdRPs from the 3′ end of the cleavage site, and the resulting long 
dsRNA is Diced into phased siRNAs by one of 4 plant dicers (Ramachandran and Chen, 
2008). This amplification step generates small RNAs upstream from the region originally 
targeted, a phenomenon termed “transitive RNAi”. RdRPs mediate transitive RNAi in 
worms too, confirming Fire and Mello’s prediction of an amplification step (Fire et al., 
1998). But in worms Dicer is only required for production of primary siRNAs from the 
double-stranded trigger. As expected, sense and antisense primary siRNAs have 5′ 
phosphates and 3′ hydroxyl groups and are loaded into Rde-1 (Sijen et al., 2007). 
Secondary siRNAs, however, are only antisense, they have 5′ di- or tri-phosphates 
generated by RdRPs, and are loaded into “secondary” argaonautes, Csr-1, Sago-1, and 
Sago-2 (Yigit et al., 2006; Aoki et al., 2007; Pak and Fire, 2007; Sijen et al., 2007). Csr-1 
has in vitro target cleavage activity, suggesting its silencing mechanism (Aoki et al., 
2007). Thus plant secondary siRNAs require both dicer and RdRPs for initiation and 
production, while worm secondary siRNAs require dicer for initiation targeting by 
primary siRNAs, but not production (Aoki et al., 2007).  S. pombe also has a single 
RdRP, which seems to act most similarly to those in plants; it mediates second strand 
synthesis after targeting by an Ago1 bound siRNA, elongates a nascent transcript, 
producing a long dsRNA which is then Diced, producing new siRNAs (Colmenares et al., 
2007). Perhaps this pathway accounts for the robust chromatin silencing roles mediated 
by the RNAi machinery in these organisms (Buhler and Moazed, 2007).    
 
Plant miRNAs 
 24
 Like animal miRNAs, plant miRNAs are derived from hairpin precursors and 
they silence endogenous mRNAs. Unlike animal miRNAs that bind mRNA 3′UTR 
sequences with partial complementarity to induce translational repression or slicer 
independent decay, plant miRNAs slice their targets; conserved sites to plant miRNAs 
with near perfect complementarity are easily identified in coding and 3′UTR sequences of 
mRNAs (Jones-Rhoades et al., 2006). Also, unlike animal miRNAs, plant miRNAs are 
produced by the action of a single RNAse III enzyme in the nucleus, Dicer-like-1(DCL-
1) (Kurihara and Watanabe, 2004). miRNAs are also loaded into Ago1 in the nucleus, but 
exported to the cytoplasm where they are believed to act on their targets (Park et al., 
2005; Jones-Rhoades et al., 2006).  
 Plants miRNAs also appear to be chemically distinct from miRNAs in animals; 
plant miRNAs and indeed all plant small RNAs are methylated at their 3′ ends by the 
Hen1 methyltransferase. Hen1 (Hua Enhancer 1) was discovered by Xuemei Chen in her 
characterization of a plant mutant that enhanced the reproductive organ identity defects 
seen in HUA mutants (Chen et al., 2002). Because hen1 mutants had phenotypes similar 
to carpel factory (DCL-1), a plant Dicer orthologue, they checked miRNA levels and 
found that they were greatly reduced in both mutants (Park et al., 2002). hen1 mutants 
also have impaired transgene silencing with reduced transgene siRNA accumulation and 
impaired resistance to cucumber mosaic virus (Boutet et al., 2003). A specific role was 
suggested for Hen1 when an N-terminal dsRNA binding domain and a C-terminal 
methyltransferase domain were recognized; biochemical studies showed that all plant 
small RNAs have a terminal 2’-O-Methyl modification which protects them from both an 
exonuclease and a 3′ Uridylation activity that might trigger their degradation (Yu et al., 
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2005; Li et al., 2005). 3′ end uridylation of cleaved miRNA targets is a conserved activity 
in plants and animals; it appears to trigger decapping and 5′ exonuclease activity (Shen 
and Goodman, 2004). This same activity might mediate degradation of small RNAs in 
hen1 mutants. Recombinant plant Hen1 specifically methylates small RNA duplexes with 
3′ overhangs, suggesting that in plants, both strands of a small RNA duplex get modified 
after production by Dicer (Yang et al., 2006).   
Although the methyltransferase domain of Hen1 has homologues in all species 
with an RNAi pathway (including mammals, flies, worms, and S.pombe, but not S. 
cerevisiae), no small RNA species were known to have modified 3′ ends. Chapter III 
details our studies that contradict early findings demonstrating that fly siRNAs and 
miRNAs have unmodified 3′ ends. Indeed the Drosophila Hen1 homologue (DmHen1) 
modifies the 3′ ends of siRNAs, some miRNAs, and piRNAs, by a mechanism distinct 
from that in plants. Explaining why the dsRNA binding domain is dispensible in animal 
Hen1, we found that only single-stranded small RNAs are modified after loading into 
Ago2 or Piwi in flies. 
 
Separate miRNA and RNAi Pathways in Drosophila 
 Genetic and biochemical studies in Drosophila Melanogaster have provided 
much of the mechanistic detail about general principles of small RNA silencing. In fact, 
flies have proved to be an valuable model system for understanding RNAi and miRNA 
silencing in mammals. Because both organisms lack RdRP activity, small RNA silencing 
involves multiple turnover catalytic activities of RISC (Hutvágner and Zamore, 2002; 
Haley and Zamore, 2004), rather than the combinatorial amplification and catalysis seen 
in worms and plants.  
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 While most animals have one Dicer gene, flies have two—Dicer1 and Dicer2. 
Early studies showed that recombinant Dicer1 could process long dsRNA, but to impair 
RNAi in S2 cell knockdown experiments both Dicers were knocked down simultaneously 
(Bernstein et al., 2001). Purification of the dicing activity from S2 cell extracts revealed 
that Dicer2 and its dsRNA binding domain partner, R2D2, process long dsRNA, and load 
that siRNA to Ago2 RISC (Liu et al., 2003). Elegant genetic and biochemical studies by 
the Carthew and Sontheimer groups confirmed that Dicer2 is required in vivo for RNAi, 
and that dicing of dsRNA and siRNA loading into RISC are genetically separable 
activities—mutations in Dicer2’s helicase domain (dcr2G31R) or several in its RNAseIII 
domain block RNAi triggered by dsRNA, but not siRNA. Furthermore, they assign a 
function for Dicer1 in processing of pre-miRNAs. Consistent with this, Dicer1 flies have 
eye patterning defects, while Dicer2 mutants have no obvious developmental defects.  
This along with a study by Tomari and colleagues suggest that fly Dicers assemble into 
their respective RISCs, rather than simply transferring small RNAs into a separate RISC 
(Pham et al., 2004; Lee et al., 2004; Tomari et al., 2004). The Dicer2:R2D2 complex also 
plays a critical role in directing asymmetric RISC assembly—R2D2 binds the more 
thermodynamically stable end of an siRNA duplex, defining the 3′ end of the guide 
strand (Tomari et al., 2004). The human R2D2 orthologue, TRBP, along with Dicer and 
Ago2 can mediate asymmetric small RNA loading from recombinant proteins but it is 
unknown whether the mechanism of asymmetry detection is conserved (MacRae et al., 
2008).  
Further supporting the idea that the fly miRNA and RNAi pathways are separated, 
the Siomi group found miRNA functions associated with Ago1 and confirmed Ago2’s 
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role in the RNAi pathway. Using lysates from an Ago2 deletion mutant (ago2414), they 
showed that Ago2 is required for accumulation of single-stranded siRNA and that Ago2 
is required for cleavage of targets by siRNAs, but dispensible for target cleavage by 
miRNAs. Conversely, an Ago1 mutation impaired target cleavage by miRNAs, but not 
by siRNAs. Furthermore, the miRNA bantam was reduced in Ago1, but not Ago2 
mutants and RNAi knockdown S2 cells. Similarly, Dicer1, but not Dicer2 knockdown 
increased pre-bantam levels and a physical interaction between Ago1 and Dicer1 from 
immunoprecipitations suggested coupling of pre-miRNA processing by Dicer1 to Ago1 
RISC loading, like that observed in the RNAi pathway (Okamura et al., 2004). This 
showed that miRNA loaded Ago1 RISC had catalytic activity, just like human RISC in 
human cells. The finding that Dicer1 also had its own double-stranded binding partner, 
Loquacious, also suggested the parallel nature of the RNAi and miRNA pathways in 
Drosophila (Förstemann et al., 2005; Saito et al., 2005; Jiang et al., 2005). Further studies 
demonstrated that indeed, recombinant Ago1 and Ago2 can slice perfect targets (Miyoshi 
et al., 2005). Thus each pathway has a separate Dicer, dsRNA binding protein, and slicer 
equipped Argonaute protein, ready to make their respective miRNA or siRNA guided 
RISC (Figure 1).  
 Given all the evidence suggesting separation of these pathways, we were 
surprised to find that our model somatic miRNA, miR-277, did not behave as expected. 
The existence of a sole Argonaute protein for miRNAs in flies prompted us to isolate 
Ago1 loaded miRNAs and their targets biochemically to identify fly miRNA targets. But 
when we immunodepleted S2 cell extract of Ago1, most miR-277 remained in the 
supernatant. This combined with functional data from reporter S2 cells and a parallel  
 28
Figure I-1. A Model For Drosophila Small RNA Silencing Pathways, circa 2006.  
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study done by Yuki Tomari demonstrating that small RNA duplexes partition between 
Ago1 and Ago2 based on duplex structure, proved that in flies small RNA assembly into 
RISC is not strictly coupled to the Dicer that produced them. Additionally, we found that 
loading into Ago1 or Ago2 RISC impacts target specificity—Ago1 is required to silence 
a miRNA-like bulged target and Ago2 is required to silence a perfectly paired target. 
These studies appear in Chapter II. 
 
Innate Immune Response to dsRNA in Vertebrates   
 While RNAi in Drosophila constitutes innate anti-viral response to dsRNA 
(Zambon et al. 2006, Wang et al. 2006), vertebrates appear to have additional innate anti-
viral  pathways. The existence of such pathways, as well as a more sophisticated cellular 
and humoral immune system, may patially explain why vertebrates lack dedicated the 
dedicated RNAi machinery seen in flies.  The vertebrate response to viral dsRNA is 
modulated by two classes of dsRNA sensors, 1) cell surface/endosomal receptors from 
the toll-like receptor family (TLR3) and 2) cytoplasmic sensors, including Protien Kinase 
R (PKR), or the helicase Retinoic acid inducible-1 (RIG-I) and its homologue Melanoma 
differentiation associated-5 (MDA5) (Akira et al. 2006).  These sensors bind dsRNA in 
their respective cellular compartments and activate distinct signaling cascades that 
ultimately converge to activate transcription of pro-inflamatory cytokines via the 
transcription factor NF-κB or IRF3 and/or type I interferon via IRF7 (Akira et al. 2006). 
Activation of PKR also induces a general translational inhibition to combat viral 
replication; dsRNA induces dimerization of PKR, autophosphorylation and activation, 
followed by phosphorylation of the translation initiation factor eIF-2α, which blocks 
translation (Garcia et al. 2006). PKR is activated by dsRNA > 30 nt and RIG-I is 
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activated by blunt ended dsRNA, but not RNA with 2 base 3´ overhangs (Marques et al. 
2006). Thus endogenous miRNAs or exogenous siRNAs evade the cytoplasmic dsRNA 
sensors. However, recent evidence suggests that TLR3 can respond to exogenous 
siRNAs. Although type I interferons do not seem to be induced by exogenous siRNAs, a 
TLR3 dependent non-sequence-specific anti-angiogenic effect was seen when siRNA 
were injected into mouse eyes (Kleinman et al. 2008).  Thus siRNAs may trigger a 
distinct anti-angiongenic signaling cascade through TLR3.  While endogenous miRNAs 
appear to have anti-viral functions in mammals (Lecellier et al. 2004, Pedersen et al. 
2007), it is unclear if processing of viral RNA by the vertebrate RNAi/miRNA pathway 
is important in viral defense as seen in flies. Innate immune responses mediated by 
dsRNA sensors may be sufficiently robust to defend against RNA viruses in vertebrates.  
Yet to be discovered connections between dsRNA sensors and the RNAi/miRNA 
pathway may also contribute to innate viral immunity. 
     
piRNAs 
 Transposons are “selfish” virus-like elements present in eukaryotic genomes, 
capable of replicating and re-inserting. Their expansion has clearly had a major impact on 
genome evolution; ~22% of fly, ~40% of human and 80% of maize genomes consist of 
transposon derived sequence (Kapitonov and Jurka, 2003; Lander et al., 2001; Flavell et 
al., 1974). While the bulk of this genomic scaffolding contains benign transposon relics, 
genomic defense systems to silence active mutagenic transposons are required to 
maintain genomic integrity in eukaryotes. 
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The first implication that RNAi phenomenae might keep transposons in place 
came from two studies in worms: the Mello group found that some RNAi deficient (Rde) 
mutants mobilized transposons in the germline(Tabara et al., 1999); conversely, the 
Plaskerk group found that some mutants with germline transposon mobilization were 
RNAi deficient(Ketting et al., 1999). The fact that rde-1 and rde-4, were otherwise 
normal suggested that there might not be a simple connection. Although the Argonaute 
protein rde-1 had no overt phenotype besides its RNAi deficiency, a Drosophila 
homologue, sting (now known as Aubergine, a piwi protein) failed to silence Stellate, a 
protein that forms crystals in testes if homologous repetitive loci on the Y chromosome 
are absent(Schmidt et al., 1999). Corresponding small RNAs were later detected, but 
differed in size—they were 25-27 nt long instead of the 21-23 nt Dicer products 
previously described. Intriguingly, a mutant in the helicase Spindle-E that affected 
Stellate silencing also affected long terminal reapeat (LTR) retrotransposon 
silencing(Aravin et al., 2001). Small RNAs cloned from Drosophila embryos revealed 
hundreds of larger 23-27 nt RNAs corresponding to transposons and repetitive elements 
in heterochromatin, termed repeat associated siRNAs (rasiRNAs). rasiRNA are enriched 
in germline tissues and early embryos, correlating with expression of the Drosophila piwi 
proteins, Piwi, Aubergine, and Ago3(Aravin et al., 2003; Williams and Rubin, 2002).  
 The conundrum posed by rasiRNAs’ large size was explained when Vagin and 
colleagues found that rasiRNAs constitute a distinct germline specific silencing pathway 
to silence transposons and repetitive sequences, that does not require Dicer(Vagin et al., 
2006). Along with other groups studying mammalian piwi proteins, they confirmed that 
rasiRNAs are piwi associated RNAs (piRNAs), they are derived from discrete loci, 
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predominantly from long single-stranded transcripts rather than double-stranded 
precursors, transposons are de-silenced in piwi mutants, but not miRNA or RNAi 
pathway mutants, and piRNAs have modified 3′ ends—further supporting their 
independence from Dicer(Vagin et al., 2006; Girard et al., 2006; Aravin et al., 2006; Lau 
et al., 2006). The piRNA pathway is likely required for maintenance of genomic integrity 
in the germline; piRNA pathway mutants are generally sterile with embryonic axis 
specification defects, but these defects can be suppressed by mutations in the ATR/Chk2 
DNA damage signal transduction pathway. Whether the DNA damage that occurs in the 
absence of a functional piRNA pathway is a direct consequence of transposon 
mobilization has yet to be determined(Klattenhoff et al., 2007). Although several studies 
indicate that piwi proteins contain slicer activity, it is unclear whether they generally act 
at the level of transcription or post-transcriptionally(Lau et al., 2006; Saito et al., 2006). 
Transcriptional silencing at the level of chromatin or DNA modification may be the 
mechanism, as studies now indicate piRNA-dependent DNA methylation of some mouse 
transposons(Aravin et al., 2007) and both histone methylation and heterochromatin 
protein HP1 deposition on the telomeric HeT-A transposon in fly ovaries, but not somatic 
tissues (Klenov et al., 2007). However, this contradicts an earlier study that reported 
mislocalization of HP1 on fly salivary gland polytene chromosomes in Piwi, Aubergine, 
and Spindle-E mutants (Pal-Bhadra et al., 2004).     
How are piRNAs made? Two studies that cloned fly piRNAs from 
immunoprecipitates of Piwi, Aubergine, and Ago3 suggest that piRNAs make piRNAs—
at least their 5′ ends(Brennecke et al., 2007; Gunawardane et al., 2007). Piwi and 
Aubergine bound small RNAs tend to be antisense to transposons, and have a U bias at  
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Figure I-2. The “Ping-Pong” Model for piRNA Biogenesis.   
* Indicates 3′ terminal modification 
 
 
 
 
 
 
 
 
 
 
 34
their 5′ end. Ago3 bound piRNAs generally correspond to sense transposon sequences, 
and have an A bias at position 10, the nucleotide adjacent to the cleavage site. Alignment 
of the piRNA sequences revealed that almost 50% of Ago3 piRNAs had 10 nt 
complementarity to the first 10 nt of Aubergine bound piRNAs, suggesting that piwi 
proteins’ slicer activity generates the 5′ end of both sense and antisense piRNAs. This 
predicts the existence of an elegant amplification loop (the “ping-pong” model) in which 
sense transcription of transposable elements in the presence of antisense piRNAs 
produces sense piRNAs, which will in turn slice antisense transcript to produce more 
antisense piRNAs (Figure 2). The result of this model is the prediction that antisense 
transcription of a piRNA locus containing transposons could silence distant genomic 
copies in trans. Remarkably, uniquely mapping antisense piRNAs clustered in a  
transposon rich locus called flamenco that had already been shown to be critical to 
repress the transposon gypsy(Prud'homme et al., 1995; Pelisson et al., 1994). This 
suggests that antisense transcription of a piRNA locus can regulate many homologous 
genes throughout the genome, providing an adaptable innate immunity locus for 
transposon silencing. To date, this mode of piRNA silencing is conserved in flies, mice, 
zebrafish, platypus, and planaria(Vagin et al., 2006; Aravin et al., 2007; Houwing et al., 
2007; Tam et al., 2008; Murchison 2008; Palakodeti 2008). 
While “ping pong”-ing explains how the 5′ end of some piRNAs are made, many 
piRNAs, such as those associated with Drosophila Piwi, lack detectable pairing partners, 
suggesting additional biogenesis mechanisms for 5′ ends. Some details of 3′ end 
biogenesis are beginning to emerge. First, piRNA length appears to be largely determined 
by which piwi protein they bind. In flies piRNAs are on average 23, 24, or 26 nt 
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depending on whether they are bound to Ago3, Aubergine, or Piwi respectively. 
Mammals have longer piRNAs, 27 nt on average in Mili and 30 nt in Miwi. Second, 
modification of piRNA 3′ ends is conserved in flies, mammals, and zebrafish. Like small 
RNAs in plants, piRNAs are 2’-O-Methylated at their 3′ terminal base(Vagin et al., 2006; 
Houwing et al., 2007; Kirino and Mourelatos, 2007a; Ohara et al., 2007). Our group and 
the Siomi group found that the fly orthologue of Hen1 is the piRNA 
methyltransferase(Horwich et al., 2007; Saito et al., 2007). Recombinant mouse Hen1 can 
also methylate small RNA in vitro (Kirino and Mourelatos, 2007b). We hypothesize that 
piRNA length is determined by the geometry of individual piwi protein:Hen1 complexes. 
We predict that after the 5′ end of a nascent piRNA is bound to a piwi protein, that an 
unidentified 3′ exonuclease trims the single-stranded precursor until it is small enough to 
contact the Hen1 catalytic domain. Mutations in the putative nucleases, Zucchini and 
Squash, reduce piRNA production, but their precise role is not known(Pane et al., 2007).  
Although it is clear that piRNAs have a conserved role in defence against 
transposons, the abundance of non-transposon derived piRNAs suggests additional 
functions. Many of the principles that direct piRNA biogenesis and function remain to be 
determined. 
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Chapter II: 
Drosophila microRNAs Are Sorted into Functionally Distinct  
Argonaute Complexes after Production by Dicer-1 
 
Contributions: The work presented in this chapter was a collaborative effort. I 
performed experiments shown in Figures 4, S1, S3, and S4. Klaus Förstemann conducted 
experiments in Figures 2, 3, and 5. Liang-Meng Wee and Yuki Tomari did experiments 
shown in Figures 6 and S5, and Table 1. Klaus Förstemann and Phillip Zamore wrote the 
paper. 
 
Summary 
Small interfering RNAs (siRNAs) and microRNAs (miRNAs) guide distinct 
classes of RNA-induced silencing complexes (RISCs) to repress mRNA expression in 
biological processes ranging from development to antiviral defense. In Drosophila, 
separate but conceptually similar endonucleolytic pathways produce siRNAs and 
miRNAs. Here, we show that despite their distinct biogenesis, double-stranded miRNAs 
and siRNAs participate in a common sorting step that partitions them into Ago1- or 
Ago2-containing effector complexes. These distinct complexes silence their target RNAs 
by different mechanisms. miRNA-loaded Ago2-RISC mediates RNAi, but only Ago1 is 
able to repress an mRNA with central mismatches in its miRNA-binding sites. 
Conversely, Ago1 cannot mediate RNAi, because it is an inefficient nuclease whose 
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catalytic rate is limited by the dissociation of its reaction products. Thus, the two 
members of the Drosophila Ago subclade of Argonaute proteins are functionally 
specialized, but specific small RNA classes are not restricted to associate with Ago1 or 
Ago2. 
 
Introduction 
microRNAs (miRNAs) are 22 nt RNA guides that control gene expression in both 
plants and animals (Bartel, 2004; Du and Zamore, 2005). miRNAs regulate genes 
required for a wide range of cellular functions such as differentiation and development 
(Lee et al., 1993; Reinhart et al., 2000; Grishok et al., 2001; Ketting et al., 2001; 
Bernstein et al., 2003; Lee et al., 2004; Li and Carthew, 2005; Harfe et al., 2005; 
Kanellopoulou et al., 2005), metabolic homeostasis (Poy et al., 2004; Teleman et al., 
2006), and memory (Ashraf et al., 2006; Schratt et al., 2006). In animals, miRNAs 
typically reduce the stability or repress translation of the mRNAs they regulate. miRNAs 
can regulate mRNAs with which they are only partially complementary, because they 
bind their target RNAs largely through a small region at the 5′ end of the miRNA 
(positions 2–7 or 8), the “seed” (Lai, 2002; Lewis et al., 2003; Brennecke et al., 2005). 
Consequently, half or more of the protein-coding genes in Drosophila and humans are 
predicted to be regulated by miRNAs (Stark et al., 2003; Lewis et al., 2003; Rajewsky 
and Socci, 2004; Lewis et al., 2005; Krek et al., 2005). 
Animal miRNAs are produced by the sequential action of two distinct RNase III 
endonucleases. Drosha converts primary miRNAs, most of which are full-length RNA 
polymerase II transcripts, into pre-miRNAs, 70 nt RNAs that fold into a stem-loop or 
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hairpin structure. Dicer then excises the mature miRNA, bound to its miRNA* strand, 
from the pre-miRNA (Hutvágner et al., 2001; Grishok et al., 2001; Ketting et al., 2001; 
Lee et al., 2003). In Drosophila, distinct Dicer enzymes produce siRNA and miRNA. 
Dicer-1 (Dcr-1) acts with a double-stranded RNA (dsRNA)-binding protein partner, 
Loquacious (Loqs), to convert pre-miRNA to a miRNA/miRNA* duplex, whereas Dicer-
2 (Dcr-2) produces siRNA duplexes by cleaving long dsRNA (Bernstein et al., 2001; Lee 
et al., 2004; Förstemann et al., 2005; Saito et al., 2005; Jiang et al., 2005). Dcr-2 also acts 
with its dsRNA-binding partner protein, R2D2, to load an siRNA duplex into Ago2 (Liu 
et al., 2003; Tomari et al., 2004; Tomari et al., 2004; Matranga et al., 2005; Liu et al., 
2006), a function that is separable from its role in siRNA production (Pham et al., 2004; 
Lee et al., 2004). 
Both siRNAs and miRNAs act as components of RNA-induced silencing 
complexes (RISCs); the core protein component of all RISCs is a member of the 
Argonaute family of small RNA-guided RNA-binding proteins (Tabara et al., 1999; 
Hammond et al., 2001; Song et al., 2003; Liu et al., 2004; Meister et al., 2004b; Rand et 
al., 2004; Song et al., 2004; Qi et al., 2005; Rivas et al., 2005; Baumberger and 
Baulcombe, 2005). The Drosophila genome encodes five Argonaute proteins, which 
form two subclades. The Ago subclade comprises Ago1 and Ago2, which have been 
reported to bind miRNAs and siRNAs, respectively (Hammond et al., 2001; Okamura et 
al., 2004). Piwi, Aub, and Ago3 form the Piwi subclade of Argonaute proteins and bind 
repeat-associated siRNAs (rasiRNAs; also called piRNAs), which direct silencing of 
selfish genetic elements such as transposons (Saito et al., 2006; Vagin et al., 2006; 
Gunawardane et al., 2007; Brennecke et al., 2007). 
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Argonaute proteins are readily identified by their characteristic single-stranded 
RNA-binding PAZ domain (Song et al., 2003; Lingel et al., 2003; Yan et al., 2003) and 
their Piwi domain, a structural homolog of the DNA-directed RNA endonuclease, RNase 
H (Song et al., 2004). The Piwi domain is thought to bind a small RNA guide both by 
coordinating its 5′ phosphate and through contacts with the phosphate backbone, arraying 
the small RNA so as to create the seed sequence (Ma et al., 2004; Ma et al., 2005; Parker 
et al., 2004; Parker et al., 2005; Yuan et al., 2005). Only a subset of Argonaute proteins 
contain Piwi domains that retain their RNA-directed RNA endonuclease activity: e.g., 
Ago1 in plants, Ago2 in mammals, and both Ago1 and Ago2 in flies. Drosophila Ago1 
and Ago2 have been proposed to be restricted to the miRNA and siRNA pathways 
respectively (Okamura et al., 2004; Saito et al., 2005). Such restriction of each class of 
small RNA to a distinct Argonaute complex could occur because miRNAs and siRNAs 
are produced by different Dicer pathways in flies (Figure 1A). 
In this manuscript, we show that the specific pathway that produces a miRNA or 
siRNA does not predestine that small RNA to associate with a particular Argonaute 
protein (Figure 1B). Rather, we find that a miRNA produced by Dcr-1 and Loqs can 
nonetheless be loaded by Dcr-2 and R2D2 into an Ago2-containing RISC. Our data from 
both cultured Drosophila cells and adult flies suggest that small RNA production and 
small RNA loading into Argonaute protein complexes are separate steps in vivo. In the 
accompanying paper (Tomari et al., 2007), we describe the molecular basis for sorting 
small RNA duplexes, explaining why some miRNAs associate predominantly with Ago1 
while others associate mainly with Ago2. Here, we show that the sorting of miRNAs into 
Ago1- and Ago2-RISCs has unexpected consequences for the mechanism of target 
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mRNA regulation: Ago1, but not Ago2, can repress an mRNA containing multiple, 
partially complementary miRNA-binding sites in its 3′ untranslated region (UTR), 
whereas Ago2, but not Ago1, can silence an mRNA containing fully complementary 
miRNA-binding sites. The different regulatory capacities of Ago1 and Ago2 can be 
explained, in part, by our finding that while Ago2 is a robust, multiple-turnover RNA-
directed RNA endonuclease, Ago1 is not. 
 
 
Results 
miR-277 Is Produced by Dcr-1, But Loaded into Ago2 
Like all known Drosophila miRNAs, miR-277 is produced by cleavage of its 
precursor by Dcr-1 acting with Loqs, rather than Dcr-2, which generates siRNAs (Lee et 
al., 2004; Saito et al., 2005; Förstemann et al., 2005; Jiang et al., 2005). Both siRNAs and 
miRNAs are proposed to be loaded into Argonaute-containing effector complexes from 
double-stranded intermediates: guide/passenger strand duplexes for siRNAs and 
miRNA/miRNA* duplexes for miRNAs (Hutvágner and Zamore, 2002; Rand et al., 2005; 
Miyoshi et al., 2005; Matranga et al., 2005; Leuschner et al., 2006). The miR-277/miR-
277* duplex is predicted to have more double-stranded character than typical 
miRNA/miRNA* duplexes, which are interrupted by mismatches and internal loops 
(Khvorova et al., 2003; Han et al., 2006). Thus, miR-277 has a miRNA/miRNA* duplex 
that resembles an siRNA. We asked if the resemblance of the miR-277/miR-277* duplex 
to an siRNA led to its being loaded into Ago2, rather than Ago1, in Drosophila cells. 
That is, is the biogenesis of a miRNA tightly coupled to its loading into Ago1? Or are 
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miRNAs, and perhaps siRNAs, sorted into distinct Ago proteins by a step unlinked to the 
Dicer that produced them? 
To this end, we established stable lines of S2 cells expressing green fluorescent protein 
(GFP) mRNA alone, with a 3′ UTR containing one or two sites fully complementary to 
miR-277 or with four 3′ UTR sites complementary to miR-277 but bearing mismatches 
with miR-277 nucleotides 9, 10, and 11 (Figures S1–S3). Surprisingly, repression of the 
reporter bearing two fully complementary miR-277-binding sites required Ago2 but not 
Ago1 (Figure 1). Treating the S2 cells with dsRNA to deplete Ago2 by RNAi increased 
GFP expression 6-fold (Figures 2A and 2B). This agrees well with the extent of 
derepression observed with a miR-277-specific antisense oligonucleotide (ASO; 
Figure S1), suggesting that without Ago2, the reporter is no longer repressed. Moreover, 
ago1(RNAi) increased repression of this reporter. Essentially identical data were obtained 
for a reporter containing a single miR-277-binding site (Figure S3). 
Expression of the miR-277-regulated reporter also increased when the cells were 
treated with dsRNA to deplete Drosha, the enzyme that excises pre-miRNAs from their 
primary transcripts or with dsRNA to deplete Dcr-1 or Loqs, which together convert pre-
miRNA to miRNA/miRNA* duplexes (Figure 2A). RNAi directed against ago1, ago2, or 
drosha had no detectable effect on the expression of the GFP reporter lacking miR-277-
binding sites. 
We note that a control dsRNA was not inert with respect to Ago2-dependent 
silencing (i.e., RNAi), likely because it can compete with miR-277 for Ago2 loading. The 
idea that nonspecific dsRNA can compete for Ago2 and other components of the Ago2-
loading machinery is consistent with earlier reports that RNAi is a saturable (Haley and 
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Zamore, 2004). Thus, the most straightforward method to assess the significance of the 
effect of different dsRNAs on miR-277-directed repression of the perfect reporter in this 
Figure II-1. Two Models for the miRNA and siRNA Pathways in Drosophila 
(A) Small RNA biogenesis and RISC assembly are tightly coupled. miRNAs are 
exclusively loaded into Ago1 and siRNAs into Ago2.  (B) Small RNA biogenesis and 
RISC assembly are independent. After their production, small RNA duplexes are 
proposed to be actively sorted into distinct Ago proteins solely according to their 
structures. 
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Figure II-1 
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Figure II-2. Components of Both the miRNA and the RNAi Pathways Are Required 
to Silence a Reporter with Perfect Matches to miR-277 
(A) Mean GFP fluorescence (average ± standard deviation for three or four trials). 
DsRNA-triggered RNAi was used to deplete the cells of the indicated protein. 
(B) Western blotting confirmed the extent and specificity of the RNAi-mediated 
depletion for each protein. dcr-2(RNAi) reduced the abundance of both Dcr-2 and R2D2, 
as previously reported (Liu et al., 2003), but r2d2(RNAi) had no detectable effect on Dcr-
2 abundance. The three isoforms of Loqs are indicated at the right of the Loqs panel. The 
bands above and below Ago2 correspond to crossreacting proteins characteristically 
detected with this antibody. 
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Figure II-2 
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experiment is not to compare the individual specific knockdown experiments to the 
control dsRNA, but rather to compare the change in GFP expression for the unregulated 
reporter to that observed for the perfect reporter for each RNAi knockdown. Analyzed 
this way, depletion of components of the miRNA biogenesis pathway clearly has a 
significant effect on miR-277-directed repression of the reporter: dcr-1(RNAi), p < 0.005; 
drosha(RNAi), p < 0.007; loqs(RNAi), p < 0.028. 
Together with previously published results (Förstemann et al., 2005), our data 
therefore suggest that miR-277 is produced by the standard miRNA pathway, but directs 
repression of a perfectly matched GFP reporter through Ago2. 
 
Ago1 But Not Ago2 Mediates Repression of mRNAs Bearing Bulged miR-277-Binding 
Sites 
mRNAs containing miRNA-binding sites with perfect complementarity to 
specific miRNAs occur in animals, but are rare (Yekta et al., 2004; Mansfield et al., 
2004; Davis et al., 2005). Instead, most miRNAs are incompletely complementary to the 
mRNAs they repress. Typically, these miRNAs bind to multiple sites in the 3′ UTR of 
their targets. This mode of miRNA-directed repression can be recapitulated by 
engineering into the 3′ UTR of the reporter mRNA four, partially mismatched, miRNA-
binding sites, each of which forms a central bulge when paired to its cognate miRNA 
(Zeng et al., 2002; Doench et al., 2003). 
We established stable lines of S2 cells expressing a GFP mRNA bearing four such 
sites (Figure S1A). Repression of the reporter was modest, but required miR-277: 
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transfection of a miR-277-specific, but not a control, ASO caused a small but statistically 
significant (p < 0.003) increase in GFP fluorescence (Figure S1B). miR-277 is relatively 
abundant in S2 cells, which contain 2200 miR-277 molecules per cell (M.H. and P.D.Z., 
unpublished data). Nonetheless, we wondered if the free pool of endogenous Ago1-
loaded miR-277 was insufficient to repress expression of the bulged reporter. 
We increased the expression of miR-277 by engineering stable S2 lines 
expressing both the GFP reporter and a “mini” pri-miR-277 driven by the ubiquitin 
promoter. The resulting doubling of miR-277 expression caused a dramatic increase in 
the repression of the bulged GFP reporter, as evidenced by the more than 3-fold increase 
in GFP fluorescence observed when a miR-277-specific ASO was transfected into the 
cells (Figure 3A). Compared to the repression of this reporter by endogenous miR-277, 
the exogenous miR-277 increased repression of the bulged reporter by 230% (Figures 
S1A and 3A). Repression was also enhanced, but to a smaller extent, for the reporter 
bearing two perfectly complementary miR-277-binding sites. 
For both the reporter bearing perfectly complementary miR-277-binding sites and 
the reporter with four bulged miR-277-binding sites, miR-277 reduced GFP expression 
by reducing the stability of the reporter mRNA, rather than by repressing GFP 
translation. We used qRT-PCR to measure the steady-state reporter mRNA abundance 
(Figure S4A) and fluorescence-activated cell sorting (FACS) to measure GFP protein 
abundance (Figure S4B). For each stable cell line, we measured reporter mRNA and 
protein expression after transfection with a control ASO or a miR-277-specific ASO. 
Even when miR-277 was overexpressed, nearly all of the increased GFP-protein 
expression observed when miR-277 was blocked could be accounted for by a 
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corresponding increase in GFP-mRNA expression. Figure S4C reports the relative GFP-
protein expression normalized to the relative GFP-mRNA expression. In all cases, when  
Figure II-3. Only Components of the miRNA Pathway Are Required to Silence a 
Reporter Bearing Four Imperfectly Matched miR-277 Target Sites 
(A) Overexpression of miR-277 from a mini-pri-miRNA transgene increased repression 
of the miR-277-regulated perfectly matched and bulged reporters. 
(B) Mean GFP fluorescence (average ± standard deviation for three or four trials). 
DsRNA-triggered RNAi was used to deplete the cells of the indicated protein. 
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Figure II-3 
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miR-277 was inhibited, the ratio of relative protein expression to relative mRNA 
expression was close to one, indicating that most of the miR-277-directed reporter 
repression reflected mRNA destabilization rather than translational repression. However, 
for the bulged reporter, mRNA degradation might be tightly coupled to translational 
repression and therefore be a consequence, rather than a cause, of the decrease in protein  
production. 
Silencing of the bulged reporter required Ago1 but not Ago2: ago1(RNAi) 
increased reporter expression, whereas ago2(RNAi) (Figure 2B) caused a small but 
statistically significant decrease in reporter expression (p < 0.008) (Figure 3B). While 
RNAi directed against drosha, dcr-1, or loqs—all genes required for biogenesis—
increased expression of the bulged reporter, dcr-2(RNAi) and r2d2(RNAi)—both genes 
required to load small RNAs into Ago2 but not Ago1—caused a small but statistically 
significant (p < 0.001 and p < 0.003, respectively) increase in reporter silencing. These 
data suggest that (1) the Ago1 and Ago2 pathways compete for miR-277, and (2) Ago1 
and Ago2 are functionally distinct and nonredundant, with Ago2 alone mediating small 
RNA-directed silencing of perfectly complementary target mRNAs (RNAi) and Ago1 
mediating silencing of mRNAs with central mismatches in the target sites. 
 
miR-277 Accumulation Requires Ago2 
Our experiments in stable S2 reporter cell lines suggest that miR-277 is loaded 
predominantly into an Ago2-containing RISC and that Ago1 and Ago2 compete for miR-
277 in cultured Drosophila cells. Moreover, they suggest that miR-277 repressed the 
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reporter to which it was fully complementary as a component of an Ago2-RISC, but 
repressed the bulged reporter as a component of an Ago1-RISC. Supporting this view, the  
Figure II-4. Most Endogenous miR-277 Is Not Associated with Ago1 in S2 Cells 
(A) Northern analysis revealed that ago2(RNAi) reduced the steady-state abundance of 
miR-277, but not bantam, whereas ago1(RNAi) decreased the abundance of bantam, but 
not pre-bantam or miR-277.  (B) Western blotting showed that immunoprecipitation of 
Ago1 depleted nearly all Ago1, but little or no Ago2, from S2 cell cytoplasmic extract. 
(C) The majority of bantam, but not pre-bantam coimmunoprecipitated with Ago1 
(northern analysis). In contrast, the majority of endogenous and of overexpressed miR-
277 remained in the supernatant, unbound by Ago1. The asterisk marks nonspecific 
hybridization of the probe with 5S rRNA. 
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cellular concentration of miR-277 decreased when Ago2 was depleted by RNAi but not 
when Ago1 was depleted (Figure 4A). The concentration of bantam, a miRNA shown 
previously to associate with Ago1 (Okamura et al., 2004), was reduced by ago1(RNAi), 
but unaffected by ago2(RNAi). Pre-bantam RNA was unaltered by either treatment 
(Figure 4A), supporting the idea that the loss of bantam in ago1(RNAi) S2 cells reflects a  
failure to load the miRNA into its Ago1-RISC, rather than a defect in pre-miRNA 
processing, which would cause pre-bantam to accumulate. Moreover, most bantam but 
only a minority of miR-277 is physically associated with Ago1 (Figures 4B and 4C). We 
immunoprecipitated Ago1 using a monoclonal antibody bound to agarose beads. Western 
blotting with the same antibody demonstrated that the overwhelming majority of Ago1, 
but little or no Ago2, was depleted from the supernatant and recovered with the beads 
(Figure 4B). By northern blotting, more than half of bantam, but less than a third of miR-
277, was recovered with the beads (Figure 4C). 
 
In Vivo, miR-277 Is Produced by Dcr-1, Then Loaded by Dcr-2 into Ago2 
Both dcr-1(RNAi) and dcr-2(RNAi) increased GFP expression for the reporter 
mRNA bearing two fully complementary miR-277-binding sites (Figure 2A). While the 
effect of dcr-1 dsRNA was anticipated, current models for the miRNA pathway in 
Drosophila do not predict a role for Dcr-2 in miRNA function. Moreover, dcr-2(RNAi) 
did not detectably alter the expression of components of the miRNA pathway, Dcr-1, 
Loqs, Drosha, or Ago1 (Figure 2B). We can imagine two explanations for the reduction 
in miR-277 function when Dcr-2 was depleted. Dcr-1 and Dcr-2 might both act in the 
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production of miR-277, with each contributing to the conversion of pre-miR-277 to miR-
277/miR-277* duplex. Alternatively, Dcr-1 alone might excise miR-277 from pre-miR-
277, remanding the resulting miR-277/miR-277* duplex to the RISC-loading complex 
(RLC), whose core constituent is the Dcr-2/R2D2 heterodimer and which is required to 
load siRNA duplexes into Ago2. 
To distinguish between these two explanations, we examined in adult flies the 
expression of the same GFP reporter bearing two fully complementary miR-277-binding 
sites that we used in our S2 cell experiments. The dcr-2G31R allele (Lee et al., 
2004)separates siRNA production from Ago2 loading because it selectively inactivates 
the nuclease function of Dcr-2. The GFP miR-277-reporters were expressed in transgenic 
flies heterozygous and homozygous for the dcr-2G31R mutation. We also examined GFP 
reporter expression in dcr-2L811fsX mutant flies, which produce no Dcr-2 protein and can 
neither produce siRNA duplexes nor load them into Ago2. We prepared protein extracts 
from adult flies and measured GFP expression by western blotting and fluorescence 
(Figure 5 and data not shown). 
By both measures, expression of the reporter bearing two perfectly 
complementary miR-277-binding sites increased significantly in homozygous dcr-2L811fsX 
mutant flies, relative to that measured in extracts from their heterozygous siblings 
(Figure 5), corroborating our observation that expression of this reporter was increased in 
S2 cells treated with dcr-2 dsRNA (Figure 3A). However, reporter expression was 
unaltered in homozygous dcr-2G31R mutant flies, relative to their heterozygous siblings 
(Figure 5). Reporter expression similarly increased in flies lacking R2D2 (Figure 5); 
R2D2 acts together with Dcr-2 to load Ago2 but is not required for siRNA production 
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(Liu et al., 2003). We conclude that the requirement for Dcr-2 in miR-277-directed 
silencing of the GFP reporter bearing two fully complementary miR-277-binding sites  
Figure II-5.  In Adult Flies, Repression of the miR-277 Reporter via Perfectly 
Complementary Sites Requires the Loading Activity of Dcr-2 and R2D2, But 
Repression via Bulged Sites Does Not    
(A) Representative western blotting data for -tubulin and GFP in total lysates from adult 
flies of the indicated heterozygous (+/–) and homozygous (–/–) mutant genotypes.  (B) 
The average (± standard deviation) GFP expression in homozygous mutant flies, relative 
to heterozygotes, for three (r2d2) or four trials of the experiment in (A). The dcr-2L811fsX 
mutant lacks detectable Dcr-2 protein, whereas the dcr-2G31R point mutant produces a 
Dcr-2 protein that cannot dice long dsRNA, but can nonetheless load siRNA and 
miRNA/miRNA* duplexes into Ago2. 
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reflects a role for Dcr-2 in loading miR-277 into Ago2, rather than in the conversion of 
pre-miR-277 into mature miR-277. 
 In contrast to the perfectly matched reporter, the GFP reporter bearing four bulged 
miR-277-binding sites was unaltered in flies homozygous for either the dcr-2L811fsX null 
allele or the dcr-2G31R separation-of-function allele. Thus, repression of this reporter in 
vivo does not require Ago2 loading, strong support for our conclusion that the bulged  
reporter is regulated by miR-277-programmed Ago1-RISC. In fact, we observed a small 
but statistically significant increase in the repression of the bulged reporter in flies 
homozygous for the r2d21 allele (Figure 5B). These data suggest that as in vitro (Tomari 
et al., 2007) and in cultured cells (see above), Ago1 and Ago2 compete in vivo for 
loading with miR-277 and that in the absence of the Ago2-loading machinery, more miR-
277-programmed Ago1-RISC is produced. 
 
Ago1 Cleaves Target RNAs with Low Efficiency 
Drosophila Ago1 retains the ability to catalyze endonucleolytic cleavage of a 
perfectly matched target RNA (Okamura et al., 2004; Miyoshi et al., 2005). Thus, it is 
surprising that for the reporter bearing two perfectly complementary miR-277-binding 
sites, the subpopulation of miR-277 associated with Ago1 did not detectably rescue the 
loss of silencing caused by depletion from S2 cells of Ago2 or the loss in adult flies of 
Dcr-2—a core component of the Ago2-loading machinery. To assess the molecular basis 
for the distinct functional capacities of Ago1 and Ago2, we analyzed in vitro the kinetics 
of target cleavage by each protein (Figure 6). 
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In Drosophila, the structure of a small RNA duplex governs into which 
Argonaute protein—Ago1 versus Ago2—it is loaded (Tomari et al., 2007). For the let-7  
Figure II-6. Ago1 Is a Poor Endonuclease 
(A) Distinct cleavage kinetics distinguish Ago1- and Ago2-RISC. At approximately 
equal enzyme concentrations, the initial velocity for Ago2-RISC was 12-fold greater than 
that of Ago1-RISC. Cleavage by Ago2-RISC was linear throughout the reaction, as long 
as the substrate remained in vast excess, whereas cleavage by Ago1-RISC was biphasic, 
suggesting that product release is the rate-determining step. The RISC concentration 
estimated by burst analysis (3.2 nM; red arrow) correlated well with that measured by 2′-
O-methyl ASO affinity capture (4.6 nM).  (B and C) Pseudo-Michaelis-Menten (B) and 
Michaelis-Menten (C) analyses of Ago1- and Ago2-RISC, respectively. Michaelis-
Menten parameters are summarized in Table 1. 
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miRNA sequence, an siRNA duplex containing let-7 as its guide strand loads Ago2 
almost exclusively, whereas the let-7/let-7* duplex loads only Ago1. By adjusting the 
time allowed for RISC assembly, we generated approximately equal concentrations (4.6–
4.7 nM) of Ago1- and Ago2-associated let-7. For each let-7-programmed RISC, we 
measured the rate of cleavage of a 5′ 32P-radiolabled RNA target containing a single site  
with complete complementarity to let-7 (Figure 6A). 
Our data reveal two differences between Drosophila Ago1 and Ago2. First, Ago2 
is a faster enzyme than Ago1: the initial rate of target cleavage for Ago2 was at least 12-
fold greater than that of Ago1 (Figure 6A). Second, Ago1, unlike Ago2, failed to 
efficiently catalyze multiple rounds of target cleavage in vitro, even in the presence of 
ATP. That is, for Ago2-RISC, the rate of target cleavage was the same throughout the 
steady-state phase of the reaction, while the rate of target cleavage for Ago1-RISC was 
biphasic (Figures 6A). Such biphasic behavior was reported previously for both 
Drosophila and human Ago2-mediated target cleavage in the absence of ATP and 
suggests that product release is rate determining for Ago2 under these conditions (Haley 
and Zamore, 2004; Rivas et al., 2005). The first phase of the Ago1 reaction in the 
presence of ATP likely corresponds to a presteady state period in which most Ago1 
proteins have not yet released the product of their first target cleavage event. The second 
phase may correspond to a steady-state period in which the products of target cleavage 
are slowly released from Ago1. Supporting this view, the second phase fit well to a line 
whose y intercept, 3.2 nM, was similar to the amount of Ago1-RISC, 4.7 nM, measured 
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by affinity purification using an immobilized 2′-O-methyl let-7 ASO. 
The difference in efficiency between Ago1- and Ago2-catalyzed target cleavage 
might reflect a difference in the rate of catalysis or in the affinity for the target RNA. To 
distinguish between these two explanations, we performed a kinetic analysis of Ago1- 
and Ago2-RISC programmed with let-7 in Drosophila embryo lysate. We estimated the 
amount of active let-7-programmed RNAi enzyme complex from the size of the burst for 
Ago1-RISC in the presence of ATP and for Ago2-RISC by depleting ATP after RISC 
assembly. In the presence of ATP, Ago2-RISC conforms to a simple Michaelis-Menten 
scheme (Haley and Zamore, 2004): 
Ago2-let-7 + target RNA <—> [Ago2-let-7•target RNA] —> Ago2-let-7 + cleaved target RNA 
 
In contrast, Ago1-RISC appears to follow a more complex kinetic scheme, even in the 
presence of ATP: 
Ago1-let-7 + target RNA <—> [Ago1-let-7•target RNA] —> 
[Ago1-let-7•cleaved target RNA] <—> Ago1-let-7 + cleaved target RNA 
 
Because Michaelis-Menten parameters are determined from the initial velocity of the 
enzyme observed at different concentrations of substrate (target RNA), we analyzed 
Ago1 as if it followed the same kinetic scheme as Ago2. This pseudo-Michaelis-Menten 
analysis allows the Ago1 KM to retain the same meaning—an approximation of the 
affinity of the enzyme for its substrate—as that determined for Ago2. Our data 
(Figure 6B and Table 1) suggest that let-7-programmed Ago1 and Ago2 bind the let-7 
complementary sequence in the target RNA with nearly the same affinity. In vitro, Ago1 
binds its target RNAs as well as Ago2 but cleaves them much more slowly than Ago2. 
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This suggests that in vivo, Ago1 is too inefficient to silence a perfectly matched target by 
endonucleolytic cleavage. 
 
II-Table 1. Kinetic analysis of Drosophila Ago1- and Ago2-RISC. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 KM (nM) 
Vmax 
(nM s-1) 
[RISC] 
(nM) 
kcat 
(s-1) 
kcat 
(relativ
e) 
kcat/KM 
(nM-1 s-
1) 
kcat/KM 
(relativ
e) 
Ago
1 
13.3 ± 
3.2 
0.0096 ± 
0.0013 1.9 ± 0.4 
0.005 ± 
0.0013 1 0.4 ± 0.1 1 
Ago
2 8.4 ± 1.0 
0.0125 ± 
0.006 
0.058 ± 
0.006 
0.215 ± 
0.025 43 
25.5 ± 
4.3 64 
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Discussion 
 In lysates from Drosophila embryos, in cultured Drosophila S2 cells, and in adult 
flies, miRNA can be loaded into both Ago1 and Ago2. Our data suggest that sorting 
miRNAs into Ago1- and Ago2-RISC generates silencing complexes with distinct 
functional capacities: Ago1-RISC represses expression of targets with which its guide 
miRNA matches only partially, whereas Ago2 silences fully matched target RNAs. These 
differences result, in part, from the surprisingly different catalytic efficiencies of Ago1 
and Ago2: only Ago2 catalyzes robust, multiple-turnover target cleavage. 
 
Why Does Drosophila Ago1 Retain Its Endonuclease Activity? 
 In mammals, only Ago2 retains the ability to catalyze guide RNA-directed 
endonucleolytic cleavage of RNA; the three other mammalian Argonaute proteins, Ago1, 
Ago3, and Ago4, lack a functional active site that is presumed to have been present in the 
evolutionarily ancestral Argonaute protein. Why then has Drosophila Ago1 retained any 
endonuclease activity at all, if it is so inefficient at target cleavage that it cannot 
measurably contribute to small RNA-directed RNAi? One potential explanation is that 
the primary role of the Ago1 endonuclease activity is to facilitate loading of Ago1-RISC. 
That is, the predominant substrate for the Ago1 endonuclease is not target RNA but, 
rather, miRNA* strands and perhaps the occasional siRNA passenger strand. Because 
miRNA* strand cleavage would occur only in cis and only once per loaded Ago1-RISC, 
efficient, multiple-turnover cleavage of target RNA would not be required. 
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Our data reveal an important biochemical difference between Ago2 and Ago1, but they 
do not explain the molecular basis for the inefficiency of Ago1-directed cleavage of 
target RNA. We can envision two explanations for the more than 40-fold lower kcat of 
Ago1 compared to Ago2. First, the active site of Ago1 might be less well suited to 
catalyzing phosphodiester bond cleavage. Alternatively, Ago1 might be slow to assume a 
catalytically active conformation. In this second model, the rate of a conformational 
rearrangement would limit the speed of target RNA cleavage by Ago1. Such a 
conformational rearrangement of the siRNA guide has been proposed previously for 
Ago2 (Filipowicz, 2005; Tomari and Zamore, 2005). 
 
Implications for the Mechanism of Guide Strand Choice 
 Neither the current genome sequence of Drosophila melanogaster nor GenBank 
in its entirety contains a Drosophila mRNA with complete complementarity to miR-277. 
Why then do flies load miR-277 into Ago2-RISC? Perhaps there are—yet unknown—
viral RNAs targeted by Ago2-loaded miR-277. Such an innate immune response function 
has previously been proposed for miRNAs in mammals (Lecellier et al., 2005). 
Regardless of the biological purpose for loading miR-277 into Ago2, miR-277 provides 
an important in vivo test of the controversial proposal that the production of small RNA 
duplexes by Dicer is uncoupled from the loading of Argonaute proteins (Khvorova et al., 
2003; Schwarz et al., 2003; Aza-Blanc et al., 2003). That Dcr-2 and R2D2 act in vivo to 
load Ago2 with miR-277, a miRNA produced by Dcr-1 and Loqs, confirms previous in 
vitro data suggesting that both ends of a small RNA duplex are available for examination 
by the Ago2 loading machinery (Schwarz et al., 2003; Tomari et al., 2004; Preall et al., 
2006). Our results suggest that the miR-277/miR-277* duplex dissociates from Dcr-1 
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after the dicing of pre-miR-277 and is then bound by the Dcr-2/R2D2 heterodimer, which 
loads it into Ago2; Sontheimer and colleagues reached similar conclusions about small 
RNA loading from in vitro experiments that asked if Dicer processing and Ago2 loading 
were coupled (Preall et al., 2006). 
We reason that Ago1 loading is also uncoupled from dicing. In all animals, some 
miRNAs are found on the 5′ and others on the 3′ arm of their pre-miRNA stem loops. In 
contrast, the geometry of Dcr-1 with respect to the two arms of the pre-miRNA stem is 
essentially the same for all miRNAs: Dcr-1 always makes staggered cuts that separate the 
pre-miRNA loop from the miRNA/miRNA* duplex. If Dcr-1 were to load miRNAs 
directly into Ago1, without first releasing the miRNA/miRNA* duplex, we would expect 
that all miRNAs would reside on the same arm of the pre-miRNA stem. The simplest 
explanation, and one most consistent with the partitioning of miR-277 into both Ago1- 
and Ago2-RISCs, is that miRNA/miRNA* duplexes are released from Dicer immediately 
after their production, then rebound by the Ago1- and Ago2-loading machineries. Such a 
model allows both the terminal thermodynamics of the miRNA/miRNA* duplex to 
determine the mature miRNA strand (rather than its position within the pre-miRNA) and 
the pattern of mismatches within the duplex to determine how the miRNA partitions 
between Ago1 and Ago2. 
 
Why Are Ago1 and Ago2 Functionally Specialized? 
 In mammals, siRNAs produce off-target effects largely by acting like miRNAs 
(Jackson et al., 2003; Lim et al., 2005; Jackson et al., 2006). In flies, siRNAs loaded into 
Ago2 are believed to defend against viral infection (Wang et al., 2006; Galiana-Arnoux et 
al., 2006). Virus-derived siRNAs might therefore trigger widespread, off-target silencing 
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of host genes as flies mount an antiviral RNAi response. The partitioning of siRNAs into 
Ago2-RISC appears to circumvent this problem, because silencing by Drosophila Ago2 
requires greater complementarity between the siRNA and its target than silencing by 
Ago1. It is tempting to speculate that a similar functional specialization among 
Argonaute proteins has gone undetected in mammals. 
 
Experimental Procedures 
Construction of reporter plasmids and RNAi trigger dsRNAs 
To create an expression vector for both cultured cells and transgenic flies, we PCR 
amplified the 3′ UTR and SV40 poly-A signal from plasmid pEGFP-N1 (Clontech, 
Mountain View, CA, USA) with oligonucleotides 5´-ATC ACT CTC GGC ATG GAC 
GAG-3´ and 5´-GTG AAT TCA TAC ATT GAT GAG TTT GGA C-3´ and inserted the 
resulting PCR product into pUbi-Casper2 (a kind gift of Dr. Siu Ing The) using the NotI 
and EcoRI restriction sites, creating vector pKF60. For the GFP-insert, we transferred a 
BamHI-NotI fragment from pEGFP-N1 (Clontech) into pBluescript (Stratagene, La Jolla, 
CA, USA) cut with BamHI/NotI, creating pKF20. Subsequently, we annealed the oligos 
5´-CAT GGA ACA AAA ACT TAT TTC TGA AGA AGA CTT GGG-3´ and 5´-CAT 
GCC CAA GTC TTC TTC AGA AAT AAG TTT TTG TTC -3´, encoding a myc-tag, 
and ligated this DNA-fragment into NcoI-cut pKF20. After sequencing, one clone was 
selected that contained a triple insertion in the correct orientation (pKF30). From this 
plasmid, the myc3-GFP-sequence was transferred as a BamHI-NotI-fragment into pKF60, 
resulting in plasmid pKF62. To remove an XbaI-site from the pCASPER2 polylinker, 
pKF62 was cut with XbaI, the ends treated with Klenow polymerase (New England 
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Biolabs, Ipswitch, MA, USA), and the vector was re-ligated, creating pKF63. This 
plasmid was transformed into dam/dcm negative bacteria (strain GM2163, New England 
Biolabs), which rendered a second XbaI-site in the 3´-UTR, adjacent to the NotI-site, 
cleavable. To insert the miR-277 target sites, we annealed oligos 5´-GGC CTG TCG 
TAC CAG ATA GTG CAT TTA CAG TGT CGT ACC AGA TAG TGC ATT TA-3´ 
and 5´-CTA GTA AAT GCA CTA TCT GGT ACG ACA CTG TAA ATG CAC TAT 
CTG GTA CAG CA-3´ for the two perfectly matched sites, and oligos 5´-GGC CTG 
TCG TAC CAG AGG ATG CAT TTA CAG TGT CGT ACC AGA GGA TGC ATT 
TAT GTC GTA CCA GAG GAT GCA TTT ACA GTG TCG TAC CAG AGG ATG 
CAT TTA -3´ and 5´-CTA GTA AAT GCA TCC TCT GGT ACG ACA CTG TAA ATG 
CAT CCT CTG GTA CGA CAT AAA TGC ATC CTC TGG TAC GAC ACT GTA 
AAT GCA TCC TCT GGT ACG ACA-3´ for the four bulged sites, then ligated the DNA 
fragments into NotI-XbaI-cut pKF63, creating pKF67 and pKF68, respectively. 
These pCASPER2-derived expression plasmids were used both for the generation 
of stable S2-cell lines and for the P-element-mediated genetic transformation Drosophila 
melanogaster (Rubin and Spradling, 1982). 
Constructs to make dsRNA directed against GFP, dcr-1, dcr-2, loqs and drosha 
were described previously (Förstemann et al., 2005). Templates for the synthesis of 
dsRNA directed against ago1 and ago2 were generated by T/A-cloning PCR products 
generated using the oligonucleotides 5´-CGC ACC ATT GTG CAT CCT AAC GAG-
3´and 5´-GGG GAC AAT CGT TCG CTT TGC GTA-3´ for ago2 and 5´-ATT TGA TTT 
CTA TCT ATG CAG CCA-3´ and 5´-GCC CTG GCC ATG GCA CCT GGC GTA-3´ 
for ago1 into the modified Litmus28i vector described previously (Förstemann et al., 
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2005). The template for producing dsRNA targeting r2d2 was generated by PCR using 
oligonucleotides 5´-CGT AAT ACG ACT CAC TAT AGG CAT ACA CGG CTT GAT 
GAA GGA TTC-3´ and 5´-CGT AAT ACG ACT CAC TAT AGG TTG CTT GTG CTC 
GCT ACT TGC-3´. Templates for in vitro transcription were generated by PCR-
amplification of each plasmid construct using a single primer corresponding to the T7 
promotor (5´-CGT AAT ACG ACT CAC TAT AGG-3´) and dsRNA for knock-down 
was generated as described in (Haley et al., 2003) 
Construction of Cell Lines with Increased miR-277 Expression 
A 270 nt fragment of genomic DNA encompassing the miR-277 sequence was PCR 
amplified from S2-cell genomic DNA using the oligonucleotides 5′-GCG GAT CCG 
GTA CCT ATA CAT ATA TAA CGA GGC CTA ACG-3′ and 5′-ATG CGG CCG CAA 
AAC AGT GTC TTA CAA ACA AGT GG-3′ and cloned BamHI to NotI into pKF62, 
yielding a mini-pri-miR-277 transgene under the control of the ubiquitin promotor. 
Cell Culture and Flow Cytometry 
Drosophila Schneider 2 (S2) cells were cultured at 28°C in Schneider's medium 
(Invitrogen; Carlsbad, CA) supplemented with 10% (v/v) fetal bovine serum (Invitrogen). 
GFP expression plasmids were transfected with siLentfect (see below) at 1 µg of plasmid 
per well of a 24-well plate. For selection of stable transformants, 20 ng of phsNeo (Steller 
and Pirrotta, 1985) was cotransfected with 1 µg each GFP reporter plasmid. Five days 
after transfection, cells were split 1:5 into medium supplemented with 1.2 mg/ml G418 
(Invitrogen) and diluted 1:5 every 7 days into G418-containing medium for 3 weeks; 
then, serial dilutions were plated in a 96-well plate in growth medium supplemented with 
1% (v/v) sterile-filtered conditioned medium. After 2 weeks, wells with a single colony 
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of cells were expanded and analyzed by flow cytometry. Cell clones that produced a 
single peak in the flow cytometer were retained as reporter lines. 
For dsRNA transfection, cells were seeded at a density of 1 × 106 cells/ml in 24-
well plates (500 µl/well) using Schneider's medium without G418. One hundred 
microliters of liposome/nucleic acid complexes (prepared by incubating at room 
temperature for 45 min 1.5 µl siLentfect (BioRAD; Hercules/CA) or Dharmafect 4 
(Darmacon; Lafayette, CO) and either 1 µg of dsRNA or 10 pmol of 3′ cholesterol-
conjugated, 2′-O-methyl modified antisense-oligonucleotide (see Figure S1B) in 100 µl 
Schneider's medium without serum) were added per well of a 24-well plate. After 6 days, 
cells were analyzed by FACS (BD FACScan flow cytometer; Becton Dickinson; Franklin 
Lakes, NJ). GFP expression was quantified as the arithmetic mean of fluorescence 
(CellQuest; Becton Dickinson). 
Anti-Dcr-1 and Ago2 Antibodies 
Keyhole limpet hemocyanin-conjugated peptides (Dcr-1: CQGLIAKKD; R2D2: 
CSDEYESSKDKAMD) or the Ago2 PAZ domain fused to glutathione-S-transferase 
(Lingel et al., 2003) were used to immunize rabbits (Covance Research Products; Denver, 
PA, or ProSci, Poway; CA) or chickens (Gallus Immunotech; Cary, NC) and the 
antiserum affinity purified using immobilized peptide (Sulfolink, Pierce; Rockford, IL) or 
NusA-Ago2-PAZ fusion protein (Aminolink Plus, Pierce). 
Western Blotting 
Proteins from cultured S2 cells or from hand-dissected adult fly heads and thoraces were 
extracted in PBS containing 1% Triton X-100 (Sigma; St. Louis, MO) and protease 
inhibitors (Complete without EDTA, Roche Molecular Biochemicals; Basel, 
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Switzerland). To quantify myc3-GFP expression in transgenic flies, 20 µg of total protein 
was resolved by electrophoresis through a 12% polyacrylamide/SDS gel and transferred 
to PVDF membrane (Immobilon-P, Millipore; Billerica, MA) by semidry transfer 
(BioRAD; Hercules, CA) at 20 V for 120 min in 25 mM Tris (pH 8.3), 250 mM glycine, 
10% (v/v) methanol as anode buffer, and 20 mM CAPS (pH 11.0) as cathode buffer. The 
blot was incubated for 90 min at room temperature with purified monoclonal anti-myc 
9E10 (Sigma #M4439) diluted 1:1000 in 25 mM Tris, 137.5 mM NaCl, 2.5 mM KCl, and 
0.02% (v/v) Tween-20 (Sigma) for 90 min at room temperature and then horseradish 
peroxidase (HRP)-conjugated goat anti-rabbit secondary antibody diluted 1:1000, then 
developed with Pierce SuperSignal West Dura kit (Pierce). HRP-conjugated rabbit anti-
chicken secondary antibody (Gallus Immunotech), diluted 1:15,000, was used to detect 
the affinity purified anti-R2D2 chicken IgY. Western blot images were acquired using a 
Fuji LAS-3000 (Fujifilm Life Sciences; Stamford, CT) and quantified using ImageGauge 
(Fujifilm Life Sciences). -tubulin was detected with DM1A antibody (Sigma #T6199) 
diluted 1:1000. myc3-GFP western blot signals were corrected using a standard curve for 
created by diluting extract from pKF63-transgenic flies into extract from yw flies. 
For S2 cell proteins, 50 µg total protein was resolved by electrophoresis through an 8% 
polyacrylamide/SDS gel, transferred to PVDF, incubated with primary antibodies 
(1:2000) overnight at 4°C, and secondary antibodies for 120 min at room temperature. 
Anti-Dcr-2 antibody was the kind gift of Qinghua Liu (Liu et al., 2003). 
Ago1 and Ago2 Target Cleavage Kinetics 
Target cleavage reactions were performed essentially as described (Haley et al., 2003; 
Haley and Zamore, 2004). In Figure 6A, 50 nM let-7 siRNA or let-7/let-7* duplex was 
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incubated with Drosophila 0–2 h embryo lysate for 2 min to program Ago2-RISC (4.7 
nM) or 5 min to program Ago1-RISC (4.6 nM). In Figure 6B, 20 nM let-7 siRNA or let-
7/let-7* duplex was incubated with lysate for 3 min or 8 min to program Ago2- or Ago1-
RISC. For Ago2 cleavage in Figure 6B, RISC was diluted 10-fold in N-ethyl maleimide 
(NEM)-treated embryo lysate (Nykanen et al., 2001; Haley and Zamore, 2004). let-7 
siRNA assembled little or no active RISC in ago2414 lysate, whereas let-7/let-7* was as 
active in ago2414 as in wild-type lysate, indicating that the let-7 siRNA and let-7/let-7* 
duplex are almost exclusively loaded into Ago2- and Ago1-RISC, respectively. 
RISC assembly was stopped by treatment with NEM followed by DTT to quench 
unreacted NEM for both Ago1- (Figure S4A) and Ago2-RISC (Nykanen et al., 2001). 
Control experiments (Figure S4B) established that the biphasic kinetics of Ago1-RISC in 
the presence of ATP were not a consequence of treatment with NEM. RISC concentration 
was estimated by 2′-O-methyl ASO affinity purification in Figure 6A and by the size of 
the presteady-state burst in Figure 6B (Schwarz et al., 2002; Haley and Zamore, 2004). 
The concentration of RNA target was 100 nM in Figure 6A and 0.5–100 nM in 
Figure 6B. Data were analyzed using IGOR 5 (WaveMetrics) and VisualEnzymics 2005 
(Softzymics) software. 
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Figure II-S1. Regulation of GFP reporter expression in cultured Drosophila S2 cells 
by endogenous miR-277 
 Clonally derived stable cell lines were generated that expressed control GFP unregulated 
by miR-277, GFP bearing two miR-277-complementary sites in its 3´ untranslated region 
(UTR), and GFP bearing in its 3´ UTR four miR-277-complementary sites, each 
containing three mismatches to miR-277 at nucleotides 9, 10 and 11, producing a ‘bulge.’ 
Each cell line was transfected with a cholesterolconjugated, 2´-O-methyl modified, 
antisense oligonucleotide (ASO) complementary to miR-277 or to an unrelated luciferase 
sequence. In cultured cells and in vivo, ASOs inhibit the function of miRNAs to which 
they are complementary, relieving repression of their mRNA targets (Hutvágner et al., 
2004; Meister et al., 2004a; Krutzfeldt et al., 2005; Berger et al., 2005). As a control, the 
unregulated GFP reporter cell line was transfected with GFP dsRNA. GFP expression 
was quantified by flow cytometry. (A) Representative FACS profiles from a single 
experiment. (B) The average ± standard deviation for the mean fluorescence recorded in 
three trials. P-values were calculated using a two-sample T-test assuming equal 
variances. 
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Figure II-S2. siRNA, siRNA-binding-site, and antisense oligonucleotide (ASO) 
structures  
(A) Structure of the miR-277-binding sites in 3´ UTR of the perfectly complementary or 
the partially complementary GFP reporter mRNAs. (B) Structure of the 3´-cholesterol 
conjugated, 2´-O-methyl modified, antisense oligonucleotides (ASOs) used as a control 
(luciferase-specific) or used to inhibit miR-277 expression in cultured S2 cells. Every 
ribose 2´ hydroxyl in each ASO was replaced with a methoxy group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 75
 
 
 
 
Figure II-S2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 76
 
 
Figure II-S3. Endogenous miR-277-programmed Ago2, not Ago1, represses a GFP 
reporter containing a single, perfectly complementary site in its 3´ UTR 
At left, clonally derived S2 cells bearing the GFP reporter were transfected with the 
indicated antisense oligonucleotide (ASO), including an ASO complementary to miR-
277. At right, the cells were transfected with dsRNA corresponding to the indicated gene. 
Each bar represents the average ± standard deviation for three independent experiments. 
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Figure II-S4. miR-277 regulates reporter mRNA steady state abundance 
Inhibition of miR-277 by a specific ASO increased both the mRNA abundance (A) and 
the production of GFP protein (B) for the perfect and bulged GFP reporters, but not the 
unregulated control, even when additional miR-277 (”+miR-277”) was expressed from a 
transgene. After 72 hrs, mRNA abundance was measured by qRT-PCR and GFP protein 
expression measured by FACS analysis. Three replicate transfections were performed for 
the cell line containing the 4x bulged reporter and expressing additional miR-277; single 
transfections were performed for all other cell lines. For qRT-PCR, total RNA was 
extracted from ~107 cells with Trizol (Invitrogen, Carlsbad, CA). Reverse transcription 
was performed with Superscript II (Invitrogen) according to the manufacturer’s 
instructions, using gene specific primers (forward primer and RT/reverse primer) for the 
GFP and RP49 coding regions: 5´-CCG CTT CAA GGG ACA GTA TCT G-3´ and 5´-
ATC TCG CCG CAG TAA ACG C-3´ for RP49; 5´-TGT CGG GCA GCA GCA C-3´ 
and 5´-AAC GGC ATC AAG GTG AAC TTC-3´ for GFP. Relative GFP mRNA 
abundance was calculated using the 2-ΔΔCt method. Values were normalized to the no 
treatment control. Error bars represent the standard deviation of three PCR replicates. For 
the 4x bulge+miR277 sample, error bars represent standard deviation of the means of 
three independent transfection experiments. (C) miR-277 does not affect the ratio of 
reporter GFP protein to RNA. For each cell line tested, the ratio of the mean GFP 
fluorescence to the relative GFP mRNA abundance is shown, normalized to the no 
treatment control. 
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Figure II-S5. N-ethyl maleimide (NEM) inactivates assembly of Ago1-RISC, but 
does not alter the kinetics of Ago1-mediated target cleavage 
(A) Ago1 was programmed with the kinetics of Ago1-mediated target cleavage. let-7 in 
vitro using 50 nM let-7/let-7* duplex, then the reaction treated NEM at the indicated 
time. Unreacted NEM was quenched with DTT. The relative amount of Ago1-RISC 
assembled was then determined by measuring the rate of cleavage of 50 nM target RNA 
containing a single let-7-complementary site. (B) 50 nM let-7/let-7* duplex was 
incubated with embryo lysate for 60 min to program Ago1-RISC, then the reaction 
treated with NEM, followed by DTT. As a control, DTT was added before the NEM. The 
cleavage of 200 nM target RNA by let-7 programmed Ago1-RISC was then assayed. 
Both reactions displayed the burst kinetics characteristic of Ago1-mediated target 
cleavage. 
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Chapter III: 
The Drosophila RNA methyltransferase, DmHen1, modifies germ line piRNAs 
and single-stranded siRNAs in RISC 
 
Contributions: The work presented in this chapter was a collaborative effort. The author 
performed experiments shown in Figures 2A, 2D, 3A, 3B, 3C (repeated for publication 
by CM), S3, S4 with Peng Wang, and S6. Chengjian Li performed experiments in figures 
1A, 2B, 2C, S1, and S2. Christian Matranga performed experiments in figure 3C, 4A, 4B, 
and S7. Gwen Farley purified the protein in figure S5. Vasia Vagin and Peng Wang 
tested the in vitro siRNA modification assay. Phillip Zamore wrote the paper.  
 
Summary 
In plants and animals, small silencing RNAs guide Argonaute proteins to repress gene 
expression by a set of related mechanisms collectively called RNA silencing pathways 
(Zamore and Haley, 2005; Meister and Tuschl, 2004). In the RNA interference (RNAi) 
pathway (Fire et al., 1998), small interfering RNAs (siRNAs) defend cells from invasion 
by foreign nucleic acids, such as those produced by viruses. In contrast, microRNAs 
(miRNAs) sculpt expression of endogenous mRNAs (Bartel and Chen, 2004). In animals, 
a third class of small RNAs, Piwi-interacting RNAs (piRNAs), defends the genome from 
molecular parasites such as transposons (Aravin et al., 2003; Aravin et al., 2007; Aravin 
et al., 2001; Vagin et al., 2006; Brennecke et al., 2007). Here, we report that piRNAs in 
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flies contain a 2´-O-methyl group on their 3´ termini, a modification previously reported 
for miRNAs and siRNAs in plants (Yang et al., 2006) and piRNAs in mice (Kirino and 
Mourelatos, 2007a; Ohara et al., 2007) and rats (Houwing et al., 2007). In plants, small 
RNA methylation is catalyzed by the HEN1 protein and serves to protect miRNAs and 
siRNAs from degradation (Li et al., 2005; Yang et al., 2006; Yu et al., 2005). We find 
that the Drosophila homolog of HEN1, DmHen1, methylates the termini of both siRNAs 
and piRNAs. In the absence of DmHen1, both the length and abundance of piRNAs are 
decreased, and piRNA function is perturbed. Unlike plant HEN1, the Drosophila enzyme 
acts on single-stranded rather than duplex small RNAs, explaining how it can use as 
substrates both siRNAs—which derive from double-stranded precursors—and piRNAs—
which do not (Houwing et al., 2007; Vagin et al., 2006). 2´-O-methylation of siRNAs 
may be the final step in assembly of the RNAi-enzyme complex, RISC, occurring after an 
Argonaute-bound siRNA duplex is converted to single-stranded RNA. 
 
Results and Discussion 
Drosophila piRNAs are 2´-O-methylated at their 3´ termini  
In flies, both piRNAs (also known as repeat-associated siRNAs, rasiRNAs) and siRNAs, 
but not miRNAs, are modified at their 3´ termini (Pelisson et al., 2007; Vagin et al., 
2006). We selectively labeled (Figure S1) the terminal nucleotide of Drosophila 
melanogaster 0–2 h embryo and mouse and bull testicular piRNAs. The resulting 32P-
radiolabeled nucleoside 2´ or 3´-monophosphates were resolved by two-dimensional thin-
layer chromatography (2D TLC) using a solvent system that can resolve nucleoside 2´ 
monophosphates, nucleoside 3´ monophosphates, and 2´-O-methyl nucleoside 3´ 
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monophosphates (Figure S2). Modified nucleoside monophosphates derived from the 3´ 
termini of piRNAs were identified by comparison to modified and unmodified nucleoside  
Figure III-1. 2´-O-methylation of piRNAs in Drosophila 
(A) Drosophila piRNAs are 2´-O-methylated at their 3´ termini. The modified 
nucleotides on the 3′ termini of piRNAs from 0–2 h fly embryos, and mouse and bull 
testes were selectively 32P radiolabeled. The radiolabeled modified mononucleotides from 
each species were resolved by 2D-TLC individually (piRNA), with 32P-radiolabeled 3′ 
mononucleotide standards (piRNA+3′NMPs), and with 32P-radiolabeled 2’-O-methyl, 3′ 
phosphate mononucleotide standards (piRNA+2’mNMPs). The modified nucleotides 
from the piRNA from all three animals co-migrated with 2’mNMPs standards, but not 
with 3′NMPs standards. Ap, 3′AMP; Gp, 3´GMP; Cp, 3´CMP; Up, 3′UMP; 2´mAp, 2’-
O-methyl AMP; 2´mGp, 2’-O-methyl GMP; 2´mCp, 2’-O-methyl CMP; 2´mUp, 2’-O-
methyl UMP; and Pi, phosphate. The asterisk marks a contaminant, likely 3′ AMP, 
present in the [5´ 32P] cytidine 5´,3´ bis-phosphate used to radiolabel the piRNA. † marks 
a contaminant present in the 2’-O-methyl, 3′ phosphate mononucleotide standards. (B) 
Drosophila hen1 gene (CG12367), mRNA, and protein. The piggyBac transposon, 
PBac(WH)CG12367[f00810], is inserted 207 bp upstream of the second exon. The open 
arrow indicates the predicted start of transcription. The closed arrows denote the position 
of the qRT-PCR primers used in Figure 2A. The first intron of hen1 contains another 
gene, CG8878, transcribed in the opposite direction, whose expression is unaltered by the 
piggyBac insertion (Figure S3). 
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2´ and 3´ monophosphate standards (Figure 1A). The terminal nucleotide of the piRNAs 
of all three animals co-migrated with 2´-O-methyl nucleoside 3´ monophosphate 
standards, but not with any unmodified nucleoside monophosphate standard. Since mouse 
piRNAs were previously shown to contain 2´-O-methyl modified 3´ termini using both 
mass spectrometry (Ohara et al., 2007) and a 2D TLC system (Kirino and Mourelatos, 
2007a) distinct from ours, we conclude that Drosophila and bull piRNAs also contain a 
2´-O-methyl group at their 3´ termini. 
 
DmHen1 is required for piRNA modification in vivo 
In Arabidopsis, the RNA methyltransferase, HEN1, modifies the terminal 2´ hydroxyl 
group of small silencing RNAs. In Drosophila, predicted gene CG12367, whose 1559 
nucleotide mRNA encodes a 391 amino acid protein with a 220 amino acid evolutionarily 
conserved methyltransferase domain (Tkaczuk et al., 2006), most closely resembles 
Arabidopsis HEN1 (Figure 1B)(Park et al., 2002). For simplicity, we call this gene 
Drosophila melanogaster (Dm) hen1. When homozygous, a piggyBac transposon 
insertion (PBac(WH)CG12367[f00810]) within the first intron of the fly hen1 gene 
reduces the accumulation of hen1 mRNA by 1,000-fold in testes and by more than 
40,000-fold in ovaries (Figures 2A) and can therefore be considered a null mutation, 
which we refer to as hen1f00810. 
We examined the 3´ termini of two types of highly abundant piRNAs in the germ 
line of flies heterozygous or homozygous for hen1f00810. In testes, the Suppressor of 
Stellate (Su(Ste)) locus produces 24–27 nt rasiRNAs, a subclass of piRNAs that directs 
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silencing of the selfish genetic element Stellate. Su(Ste) rasiRNAs, like other Drosophila 
piRNAs, are modified at their 3´ termini and therefore do not react with NaIO4  
Figure III-2. DmHen1 is required for normal piRNA biogenesis and complete 
silencing of the HeT-A Transposon  
(A) Quantitative RT-PCR of hen1 mRNA in testes and ovaries from wild-type or 
hen1f00810 flies, relative to rp49. Bars report the average ± standard deviation for at least 
four independent experiments. (B, C) Northern hybridization to detect modification of 
small RNAs in wild-type and hen1f00810 testes (B) or ovaries (C). The same blot was 
probed sequentially to detect the most abundant Su(Ste) rasiRNA (B) or the three most 
abundant roo rasiRNAs (C), miR-8, and 2S ribosomal RNA. (D) Quantitative RT-PCR of 
HeT-A transposon mRNA in ovaries. HeT-A mRNA levels were measured relative to 
rp49 using total RNA prepared from wild-type, hen1f00810 heterozygous or homozygous 
ovaries. Bars report the average ± standard deviation for at least four independently 
prepared samples. 
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(Vagin et al., 2006). In contrast, Su(Ste) rasiRNAs from hen1f00810/hen1f00810 mutant testes 
reacted with NaIO4 and could therefore be β-eliminated to remove the last nucleotide of 
the RNA, increasing their gel mobility (Figure 2B) and indicating that in the absence of 
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DmHen1 protein, they are not modified. Similarly, rasiRNAs that guide silencing of roo, 
the most abundant retrotransposon in Drosophila melanogaster, were not modified in 
hen1f00810 homozygous ovaries (Figure 2C). The Su(Ste) and roo rasiRNAs were also 
shorter in the hen1f00810 homozygotes. In contrast, the length and amount of miR-8, which 
is expressed in both the male and female germ line, was unaltered in hen1f00810 
homozygotes. For both Su(Ste) and roo, rasiRNAs were on average shorter and less 
modified even in hen1f00810 heterozygotes, compared to wild-type, suggesting that the 
abundance of DmHen1 protein limits the stability or production of piRNAs in flies. 
 
DmHen1 is required for piRNA function in vivo 
Modification of the termini of Drosophila piRNAs plays a role in their function: 
mRNA expression from HeT-A, the element whose expression is most sensitive to 
mutations that disrupt piRNA-directed silencing in the female germ line (Vagin et al., 
2006; Vagin et al., 2004; Savitsky et al., 2006), quadrupled in hen1f00810 heterozygotes 
and was increased more than 11-fold in homozygotes, relative to wild-type tissue (Figure 
2D). We conclude that Hen1 protein is required for piRNA-directed silencing in the 
Drosophila germ line. 
 
DmHen1 is required for siRNA modification 
To test if DmHen1 is required for modification of the 3´ termini of siRNAs, we depleted 
Hen1 by RNAi in cultured Drosophila S2 cells. We transfected the cells with  
Figure III-3. DmHen1 modifies Ago2-associated small RNAs  
(A) Modification of siRNAs and miRNAs in Drosophila S2 Cells. A stable S2 cell line 
expressing GFP was treated with the indicated dsRNA alone (day 1 and 5), then together 
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with GFP dsRNA (day 8). Two non-overlapping dsRNAs were used to target hen1. Total 
RNA was collected on day 9, treated with NaIO4/β elimination, then dsGFP-derived 
siRNA, miR-277 and bantam detected by sequential Northern hybridization of the same 
blot. (B) In vitro siRNA modification in dsRNA-treated S2 cell lysates. (C) In vitro 
siRNA modification in Drosophila mutant ovary lysates. 
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long double-stranded RNA (dsRNA) targeting hen1 on day 1 and day 5, then co-
transfected them with both GFP dsRNA and hen1 dsRNA on day 8. Total RNA was 
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harvested on day 9, probed for modification with NaIO4/β-elimination, and analyzed by 
Northern hybridization using a 5´ 32P-radiolabeled DNA probe complementary to the 
most abundant GFP-derived siRNA (MDH, Megha Ghildiyal, and PDZ, unpublished  
data). DsRNAs targeting two different regions of the fly hen1 mRNA both reduced the  
amount of GFP siRNA modified at its 3´ terminus, whereas all the GFP siRNA 
remainedmodified when a control dsRNA was used (Figure 3A).  
Surprisingly, RNAi-mediated depletion of Ago2, but not Ago1, prevented the 
GFP siRNA from being modified. This result suggests that Ago2, but not Ago1, plays a 
role in the modification of siRNAs by DmHen1. To test this idea, we examined the 
modification status of the 3´ terminus of miR-277, an siRNA that partitions into both 
Ago1 and Ago2 complexes in vivo(Förstemann et al., 2007). Drosophila miRNAs 
associate predominantly or exclusively with Ago1 (Okamura et al., 2004) and have 
unmodified 3´ termini (Hutvágner et al., 2001; Pelisson et al., 2007; Vagin et al., 2006). 
In contrast, about half the miR-277 in cultured S2 cells failed to react with NaIO4 (Figure 
3A), suggesting that about half of miR-277 is modified at its 3´ terminus. The fraction of 
miR-277 that was modified was reduced when two different dsRNAs were used to 
deplete DmHen1 by RNAi. When the cells were treated with dsRNA targeting ago1, all 
detectable miR-277 was modified, whereas all miR-277 became unmodified when 
dsRNA targeting ago2 was used. In contrast, bantam, a miRNA that associates nearly 
exclusively with Ago1 (Okamura et al., 2004), was unmodified under all conditions 
(Figure 3A).  
siRNA modification correlates with Ago2-RISC assembly in vitro 
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siRNA modification can be recapitulated in lysates of embryos, ovaries, or 
cultured S2 cells. Modification of siRNA in vitro was inhibited by S-adenosyl 
homocysteine, but not by S-adenosyl methionine, consistent with DmHen1 transferring a 
methyl group from S-adenosyl methionine to the terminal 2´ hydroxyl group of the RNA, 
thereby generating S-adenosyl homocysteine as a product (Figure S4).  
Our data from cultured S2 cells suggested that DmHen1 modifies that portion of 
miR-277 that enters the Ago2-RISC assembly pathway, but not the population of miR-
277 that assembles into Ago1-RISC. To further test the idea that small RNA modification 
requires both Hen1 and the Ago2-RISC assembly pathway, we prepared cytoplasmic 
lysates from dsRNA-treated cultured S2 cells. Lysate from control-treated cells modified 
the 3´ terminus of a 5´ 32P-radiolabeled synthetic siRNA duplex, but not lysate from 
hen1-depleted cells (Figure 3B). The addition of either of two different preparations of 
purified, recombinant DmHen1, expressed in E. coli as a ~74 kDa glutathione S-
transferase fusion protein (GST-DmHen1; Figure S5), restored the ability of the lysates to 
modify the siRNA, indicating that loss of DmHen1 caused the loss of siRNA 
modification. Moreover, lysates depleted for Ago2, but not Ago1, could not modify the 
32P-siRNA in vitro (Figure 3B). These in vitro data, together with our S2 cell 
experiments, suggest that modification of the 3´ terminus of siRNAs and miRNAs is 
coupled to assembly into Ago2-RISC. 
Dcr-2 and R2D2 act to load double-stranded siRNAs into Ago2. We prepared 
lysates from ovaries homozygous mutant for hen1, dcr-2, r2d2, and ago2 using alleles 
unable to produce the corresponding protein (Lee et al., 2004; Liu et al., 2003; Okamura 
et al., 2004). A 5´ 32P-radiolabeled siRNA duplex was incubated in each lysate to 
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assemble RISC. At each time point, we determined if the siRNA was 3´ terminally 
modified by assessing its reactivity with NaIO4 (Figure 3C). No modified siRNA 
accumulated when the duplex was incubated in hen1f00810, dcr-2L811fsX, r2d21, or ago2414 
mutant lysate. Adding 250 nM purified, recombinant GST-DmHen1 restored siRNA 
modification to the hen1f00810 but not the ago2414 lysate. We conclude that the defect in 
ago2414 reflects a requirement for Ago2 in small RNA modification by DmHen1, rather 
than an indirect effect, such as destabilization of DmHen1 in the absence of Ago2. GST-
DmHen1 similarly rescued lysate from hen1(RNAi) but not ago2(RNAi) treated S2 cells 
(Figure S6). Together, the results of our experiments using cultured S2 cells—a somatic 
cell line—and ovaries, which comprise mainly germ line tissue, suggest that a functional 
Ago2-RISC assembly pathway is required for siRNA modification in Drosophila. 
 
siRNAs are modified only after Ago2-RISC maturation 
To test at which step in the Ago2-RISC assembly pathway siRNAs become modified, we 
determined if siRNAs are 2´-O-methylated by DmHen1 as single-strands or as duplexes. 
In vitro, assembly of siRNAs into Ago2-RISC follows an ordered pathway in which the 
siRNA duplex first binds the Dicer-2/R2D2 heterodimer to form the RISC-loading 
complex (RLC). The RLC determines which of the two siRNA strands will become the 
guide for Ago2 and which will be destroyed (the passenger strand). The siRNA is then 
loaded into Ago2 as a duplex, with the passenger strand occupying the same position as 
future target RNAs, generating pre-RISC (Kim et al., 2006). Cleavage of the passenger 
strand by the Ago2 endonuclease domain converts pre-RISC to mature RISC (Leuschner 
et al., 2006; Matranga et al., 2005; Rand et al., 2005; Miyoshi et al., 2005). No single-
stranded guide or passenger RNA is produced prior to this maturation step. Thus, all 
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single-stranded siRNA produced in vitro or in vivo (Kim et al., 2006) corresponds to 
mature RISC. 
We assembled Ago2-RISC in vitro using an siRNA designed to load only one of 
its two strands into Ago2 (Schwarz et al., 2003). We then sampled the reaction over time, 
isolating the 5´ 32P-radiolabeled siRNA under conditions previously demonstrated to 
preserve its structure (Nykanen et al., 2001), and separated single- from double-stranded 
siRNA by native gel electrophoresis (Figure S7). (Full-length siRNA duplexes and 
siRNA heteroduplexes comprising a full-length guide paired to a cleaved passenger 
strand co-migrate as double-stranded siRNA in these gel conditions (Matranga et al., 
2005).) The RNAs were then isolated from the gel and tested for reactivity with NaIO4 to 
determine the presence of modification at their 3´ termini (Figure 4, A and B). At each 
time, total siRNA was analyzed in parallel. 3´ terminal modification increased over the 
course of RISC assembly and, at all times, was restricted to single-stranded siRNA: 
within our limits of detection, all double-stranded siRNA was unmodified, even after 3 h. 
We conclude that siRNA modification is coupled to RISC assembly and occurs only after 
the conversion of pre-RISC to mature RISC. 
 
Recombinant DmHen1 modifies single-stranded small RNA 
While Arabidopsis HEN1 contains an N-terminal double-stranded RNA-binding motif 
(Yu et al., 2005), DmHen1 does not. To test if DmHen1 modifies double-stranded small 
RNAs, we incubated purified, recombinant, GST-DmHen1 with either single-stranded or 
double-stranded siRNAs. We detected modification, evidenced by loss of reactivity with 
NaIO4, only for the single-stranded RNA, suggesting that DmHen1 modifies single- 
Figure III-4. siRNAs are modified after the conversion of pre-RISC—which 
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contains double-stranded siRNA—into mature RISC, which contains only single-
stranded siRNA 
siRNA duplexes with a 5´ 32P-radiolabeled guide strand were incubated in Drosophila 
embryo lysate, and then tested for the presence of a 3´ terminal modification. (A) Total 
RNA from each time point in RISC assembly, without (–) and with (+) reaction with 
NaIO4 and β-elimination. (B)  At each times in (A), single- and double-stranded siRNA 
were resolved and purified by first native gel electrophoresis (Figure S7), then analyzed 
by denaturing electrophoresis separately for the presence of a 3´ terminal modification on 
the siRNA guide strand. (A) and (B) are the left and right halves of a single gel. (C) 
Recombinant, purified GST-DmHen1, but not GST alone, can modify single-stranded 21 
nt RNA, but not double-stranded siRNAs or blunt 21 nt RNA duplexes. However, in 
contrast to GST-DmHen1 incubated with hen1f00810 mutant ovary lysate (Figure 3C), the 
enzyme alone is inefficient. All samples were oxidized with NaIO4, then β-eliminated. 
(D) A model for 2´-O-methylation of siRNAs. (E) A proposed role for 2´-O-methylation 
in piRNA biogenesis. 
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stranded substrates, but not siRNAs or blunt RNA duplexes (Figure 4C). A preference for 
single-stranded RNA would explain how DmHen1 could act on both siRNAs, which are 
born double-stranded, and piRNAs, which are not. We note that the purified, recombinant 
GST-DmHen1 protein was more than 50-fold less active on its own than when 
supplemented with ovary lysate from hen1f00810 homozygous flies. We speculate that the 
Ago2-RISC machinery is required for Hen1 function in flies, although we cannot yet 
exclude the possibility that the lysate contains a factor (e.g. a kinase) required to activate 
Hen1. 
Modification of single-stranded siRNAs—that is, those loaded in fully mature 
Ago2-RISC, but not double-stranded siRNAs (Figure 4D) might allow cells to distinguish 
siRNAs loaded successfully into functional complexes from those that fail to assemble. 
For example, if a 3´-to-5´ nuclease acts to degrade single-stranded siRNAs, 2´-O-
methylation of single-stranded siRNAs in Ago2-RISC may protect them from 
destruction. Moreover, such a nuclease might trim the 3´ end of piRNAs. 2´-O-
methylation of the piRNA 3´ terminus may occur only when the length of RNA 
extending beyond the Piwi family protein is short enough to permit the simultaneous 
binding of the final ribose sugar to the active site of DmHen1 and the interaction of 
DmHen1 with the Piwi protein itself (Figure 4E). Modification of the terminus of the 
trimmed piRNA would then block further 3´-to-5´ trimming of the small RNA, 
generating its Piwi-, Aubergine-, or Ago3-specific length. Our observation that piRNAs 
are shorter in hen1f00810 mutants supports this model. 
We note that all 2´-O-methyl modified small RNAs identified thus far are 
associated with RISC complexes that efficiently cleave their RNA targets—i.e., Ago1-
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associated plant miRNAs (Baumberger and Baulcombe, 2005; Qi et al., 2005), animal 
piRNAs (Lau et al., 2006), and Ago2-associated siRNAs in flies (Hammond et al., 
2001)—whereas Drosophila miRNAs are typically both unmodified and associated with 
Ago1-RISC, which does not catalyze mRNA target cleavage in vivo(Förstemann et al., 
2007). We speculate that DmHen1 is recruited to RISC complexes containing single-
stranded small silencing RNAs according to the identity of their Argonaute protein. This 
model predicts that DmHen1 will bind only to complexes containing fly Ago2 or the 
three fly Piwi proteins, Piwi, Aubergine, and Ago3, but not Ago1. Clearly, future 
experiments will need to test this hypothesis. 
 
Experimental Procedures 
General Methods 
Preparation of 0–2 h embryo, ovary, and S2 cell lysates and in vitro RISC assembly and 
RNAi reactions, and Northern hybridization were as described (Haley et al., 2003; 
Förstemann et al., 2005; Vagin et al., 2006). Sequences of synthetic RNA and DNA 
oligonucleotides are available online (Table S1). 
 
32P-radiolabeled 3´ mononucleotide standards 
Synthetic RNA oligonucleotides (Table S1) were radiolabeled in a 20 µl reaction 
containing 50 mM Tris-HCl (pH 7.8), 10 mM MgCl2, 1 mM ATP, 10 mM dithiothreitol, 
10% (v/v) DMSO, 10 µg/ml BSA, 2 units/µl RNasin (Promega, Madison, WI), 1.5 µCi/µl 
[5´ 32P] cytidine 5´,3´ bis-phosphate ([5´ 32P]-pCp; Perkin-Elmer, Waltham, MA), 1 
unit/µl T4 RNA Ligase 1 (New England Biolabs, Ipswich, MA) at 4°C, overnight. The 
radiolabeled small RNAs were purified from a 15% denaturing urea-polyacrylamide 
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sequencing gel, and then digested with 1.5 U/µl micrococcal nuclease (Takara Mirus Bio, 
Madison, WI) in a 40µl reaction containing 20 mM Tris-HCl pH 8.0, 5 mM NaCl, 2.5 
mM CaCl2. 3´ 32P-mononucleotides were further purified from a 22.5% denaturing urea-
polyacrylamide sequencing gel. 
2D-TLC 
Small RNAs (21-29 nt, containing both modified piRNAs and unmodified small RNAs) 
from 0–2 h wild-type (Oregon R) fly embryos and small RNAs (26-31 nt, containing 
mostly modified piRNAs) from mouse and bull testes were purified from a 10% 
denaturing urea-polyacrylamide gel stained with SYBR® Gold (Invitrogen). About 100 
pmol purified small RNAs were radiolabeled as described above, except in a 40 µl 
reaction using 3µCi/µl [5´ 32P]-pCp and 1 unit/µl T4 RNA Ligase 1, and then gel 
purified. The purified, 32P-radiolabeled RNA was hydrolyzed in 200mM Na2CO3 at 
100°C for 1h, then neutralized with an equal volume of 200 mM HCl, dephosphorylated 
with 0.5 units/µl calf intestinal alkaline phosphatase (New England Biolabs) in a 200 µl 
reaction containing 50 mM Tris-HCl pH 7.9, 100 mM NaCl, 10 mM MgCl2, 1 mM 
dithiothreitol. Alkaline phosphatase was inactivated by extraction with phenol 
/chloroform, RNA in the aqueous phase was oxidized with 80 mM NaIO4 in borax/boric 
acid buffer (60 mM borax, 60 mM boric acid, pH 8.6) at room temperature for 30 min, 
and then β-eliminated with 200 mM NaOH at 45°C for 90 min. 5 µl of this reaction was 
mixed with an equal volume of formamide loading buffer (98% deionized formamide, 10 
mM EDTA (pH 8.0), 0.025% (w/v) xylene cyanol, 0.025% (w/v) bromophenol blue), and 
resolved on a 22.5% denaturing urea-polyacrylamide sequencing gel. Equal intensities of 
modified mononucleotides and standards were spotted on 20 x 20 cm PEI-cellulose F 
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glass TLC plates (EMD Chemicals, Gibbstown, NJ) and separated first with isobutyric 
acid/25%ammonia/water (66:1:33, v:v:v) and then 0.1 M sodium phosphate 
pH6.8/ammonium sulfate/1-propanol (100:60:2, v:w:v). 
 
Analysis of RNA 3´ termini 
RNA was incubated for 30 min at room temperature with 25 mM NaIO4 in borax/boric 
acid buffer (60 mM borax, 60 mM boric acid, pH 8.6), then 45.2 mM (f.c.) NaOH added, 
and incubation continued for 90 min at 45°C (β-elimination). The reaction was stopped 
by the addition of 300 mM (f.c.) NaCl, 1 µg glycogen, and three volumes absolute 
ethanol. After 30 min on ice, the precipitated RNA was collected by centrifugation. 
 
Recombinant Drosophila Hen1 Protein 
DmHen1 coding sequence was amplified from Drosophila ovary cDNA and inserted into 
pEnt-D-Topo (Invitrogen, Carlsbad, CA). The entire hen1 sequence was confirmed by 
sequencing. The entry plasmid was recombined with the N-terminal GST expression 
vector, pDest-15, using LR Clonase (Invitrogen). GST-Hen1 was expressed in BL21 Star 
DE3 cells (Invitrogen) grown at 37°C in LB broth containing 100 ug/ml ampicillin until 
to OD600 reached 0.50. The culture was then cooled to 25°C and 0.4 mM IPTG added to 
induce protein production. The culture was incubated at 25°C with vigorous shaking for 
three hours. The cells were harvested by centrifugation at 7,300 x g for 20 min, washed 
with PBS, centrifuged again, and then the cell paste frozen in liquid nitrogen and stored 
at -80°C. 
Hen1 fusion protein was purified using the GST Purification Kit (Clontech, 
Mountainview, CA). Cells were resuspended in 40 ml of Extraction/Loading buffer and 
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lysed by sonication (duty 30% for 6 minutes; Branson Sonificator II, Danbury, CT), with 
cooling in an ice bath. Two ml of clarified lysate was added to the column resin, and the 
column inverted several times to disperse the resin. The resin was then allowed to pack, 
and the remaining 38 ml passed through the column by gravity flow. Subsequent steps 
were according to the manufacturer’s directions. 
 
Analysis of double- and single-stranded siRNA                                                       
Double and single-stranded, 5´ 32P-radiolabeled siRNA guide strands (10 nM; Figure S7 
and 4) were separated as described (Nykanen et al., 2001). Briefly, RISC assembly 
reactions were stopped with 2x Proteinase K buffer, 2 mg/ml Proteinase K, 1 µg 
glycogen, and 250 nM unlabeled siRNA guide strand to prevent reannealing. After 
incubation for 30 min at 25˚C, 3 volumes absolute ethanol were added, and the RNA 
precipitated for 30 min on ice. The precipitates were collected by centrifugation, washed 
with 80% (v/v) ethanol, then dissolved in 2 mM Tris-Cl (pH 7.5), 3% (w/v) Ficoll-400, 
0.04% (w/v) bromophenol blue, 100 mM KOAc, 30 mM HEPES-KOH, 2 mM 
Mg(CH3CO2)2, and resolved by electrophoresis through a 15% native polyacrylamide gel 
(19:1 acrylamide:bis; 89 mM Tris-Borate, pH 8.3, 2 mM Na-EDTA, 2.5 mM 
Mg(CH3CO2)2). The region of the native gel corresponding to double-or single-stranded 
siRNA was excised, and the RNA eluted overnight in 1 M NaCl. 1 µg glycogen and 
ethanol (60% final volume) was added to the eluate, the RNA collected using MegaClear 
filter cartridges (Ambion), eluted with H2O, and then precipitated for 30 min on ice by 
adding 500 mM (f.c.) NH4CH3CO2 and 2.5 volumes absolute ethanol. The precipitate was 
collected by centrifugation, washed with 80% (v/v) ethanol, and the samples reacted with 
NaIO4 and subsequent β-elimination (see above). The precipitated RNA was dissolved in 
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98% deionized formamide, 10 mM EDTA (pH 8.0), 0.025% (w/v) xylene cyanol, 0.025% 
(w/v) bromophenol blue, and then resolved on a 15% denaturing urea-polyacrylamide 
sequencing gel. 
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Figure III-S1. Scheme for selectively labeling the 3´ terminal nucleotide of modified 
small RNAs 
Because Rnl1 will use either a 2´ or a 3´ hydroxyl as a ligation donor, the scheme will 
also label 3´ modified RNAs. Only phosphodiester linkages flanked by a 2´ hydroxyl are 
subject to base hydrolysis and only adjacent 2´ and 3´ hydroxyls react with NaIO4, a 
prerequisite for b-elimination. X, 2´ or 3´ modification; *p, 32P-radiolabeled phosphate 
group. 
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Figure III-S1 
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Figure III-S2. Comparison of 2D TLC systems  
For both, the first dimension was Isobutyric acid/25% ammonia/water (66:1:33, v:v:v). 
Neutral second dimension (0.1 M sodium phosphate/(NH4)2SO4/1-propanol [100:60:2, 
v:w:v]) this paper;  acidic second dimension (2-propanol/HCl/H2O [70:15:15, v:v:v]), 
Kirino Y., and Mourelatos Z. (2007). Mouse Piwi-interacting RNAs are 2´-O-methylated 
at their 3´ termini, Nat Struct Mol Biol. 14, 347-348. 2´ and 3´ NMPs were prepared by 
base hydrolysis, and 3´ NMP spots identified by their comigration with 3´ NMPs 
generated by complete digestion of RNA with micrococcal nuclease.  
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Figure III-S2 
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Figure III-S3. PBAC(WH)CG12367[f00810] disrupts hen1 but not CG8878  
(A) The gene CG8878 resides in the first intron of Drosophila hen1 and is transcribed in 
the opposite orientation. The location of the qRT-PCR primers are shown as closed 
arrows. (B) We performed qRT-PCR to determine the effect on CG8878 expression of 
the PBAC(WH)CG12367[f00810] transposon insertion, which disrupts hen1 (Figure 2A). 
In both testes and ovaries, we can detect no statistically meaningful effect of this 
piggyBac transposon insertion on the expression of CG8878. We conclude that the 
PBAC(WH)CG12367[f00810] insertion disrupts only hen1. We therefore rename this 
insertion hen1f00810. Bars show average ± standard deviation for four or five independent 
trials. 
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Figure III-S3 
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Figure III-S4. S-adenosyl homocysteine (SAH), an inhibitor of S-adenosyl 
methionine (SAM) dependent methyltransferases, inhibits modification of single-
stranded siRNA in lysate prepared from either 0–2 h embryos or cultured S2 cells 
RNA was purified from the reactions at the indicated times and then tested for 
modification by reaction with NaIO4 followed by b-elimination. The RNA was resolved 
by denaturing electrophoresis.  
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Figure III-S4 
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Figure III-S5. GST-DmHen1 
(A) Schematic of the 74,254 Da fusion protein, comprising the 220 amino acid 
glutathione S-transferase (GST) module, a 30 amino acid linker, and the entire 391 amino 
acid DmHen1 protein, terminated at its native stop codon. (B) Purified, recombinant 
GST-DmHen1 protein (3 µg) was resolved by electrophoresis through a 4–20% 
polyacrylamide gradient SDS-gel, then stained with colloidal Coomassie G-250. The 
apparent masses of molecular weight markers (M) are indicated. 
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Figure III-S5 
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Figure III-S6. Purified, recombinant GST-DmHen1 protein rescues S2 cells depleted 
by RNAi of Hen1, but not Ago2 
S2 cells were transfected as described with dsRNA targeting ago2, hen1, or a control 
sequence, then lysate prepared. siRNA was incubated in the S2 cell lysate to allow RISC 
assembly, then siRNA guide strand modification was assayed by reaction with NaIO4 
followed by b-elimination (b). Without the addition of GST-DmHen1 protein, 
hen1(RNAi) and ago2(RNAi) lysates are deficient in Hen1 activity, relative to the control 
dsRNA treated cells (Figure 3B). M, 5´-phosphorylated synthetic RNA size markers. 
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Figure III-S6 
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Figure III-S7. Strategy for testing when during RISC assembly siRNAs are modified 
at their 3´ termini 
Double-stranded siRNA was incubated in embryo lysate to assemble RISC, then the 
siRNA purified away from protein using a procedure that preserves the single- or double-
stranded structure of the siRNA at the time assembly was stopped. The siRNAs were then 
resolved on a native gel, and the single- and double-stranded siRNA was isolated from 
the gel, reacted with NaIO4 followed by b-elimination and analyzed by denaturing gel 
electrophoresis (shown in Figure 4B). 
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Figure III-S7 
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Table III-S1 Cont’d. 
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Table III-S1 Cont’d. 
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Chapter IV: 
Summary and General Discussion 
 
 Our studies give new mechanistic insight into Drosophila small RNA silencing. 
Our data suggest that, (1) small RNA duplexes are sorted into different RISCs in vivo. (2) 
Duplex structure, not Dicer identity or precursor structure, appears to determine how 
small RNAs partition between the Ago1 and Ago2 RISC; perfectly paired siRNAs 
assemble into Ago2, well paired miR-277/miR-277* duplexs partition between Ago1 and 
Ago2,  bulged bantam/bantam* duplexes assemble into Ago1. (3) Sorting impacts target 
identity because Argonaute proteins have distinct target specificity and silencing 
capacity. Although both Ago1 and Ago2 can cleave targets in vitro, Ago1 cannot silence 
a perfect target efficiently in vivo, likely because it lacks the robust multiple turnover 
activity of Ago2. (4) DmHen1 is a single standed RNA 3′ terminal methyltransferase that 
modifies small RNAs bound to Ago2 or Piwi proteins, but not Ago1. (5) piRNAs in hen1 
mutants are smaller. (6) Hen1 is required for normal silencing of at least one 
retrotransposon, Het-A, in the female germline. Figure 1 depicts an updated model that 
incorporates our findings. 
 
Small RNA Sorting 
 Our studies suggest that processing of dsRNA or pre-miRNA is uncoupled from 
RISC loading. This is in contrast to previous studies that suggest fly small RNA 
biogenesis and RISC loading consists of two parallel pathways, Dicer1/Loqs/Ago1 for 
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Figure IV-1: Model for Drosophila Small RNA Silencing Pathways 
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miRNAs and Dicer2/R2D2/Ago2 for dsRNA or siRNAs (Okamura et al., 2004; Miyoshi 
et al., 2005; Saito et al., 2005). Several observations predicted that siRNA and miRNA 
duplexes are released from Dicer after processing, and re-bind during RISC assembly. (1) 
Although Dicer binds the Drosha generated 3′ ends of pre-miRNAs using its Paz domain, 
positioning the loop near its RNAseIII domain (MacRae et al., 2007), miRNAs can be 
derived from either arm of the hairpin pre-miRNA and they generally follow the 
asymmetry rules (Schwarz et al., 2003). In the flies siRNA asymmetry is sensed by the 
RISC loading complex (RLC), where the more stable end binds R2D2. This orients the 
duplex and allows the correct guide to assemble into RISC (Tomari et al., 2004). It is 
unlikely that thermodynamic asymmetry can be sensed by R2D2 while the duplex is 
restricted in its orientation, bound to the Dicer Paz domain—release and re-binding of a 
miRNA duplex in the correct orientation is a more likely scenario. (2) Supporting this 
idea Preall and colleagues found that in fly extracts and eggs, siRNAs mediate RNAi 
better than short Dicer substrate equivalents. Furthermore, asymmetry rules are 
maintained, even when the end that gets diced is switched (Preall et al., 2006). While 
these studies suggested that siRNAs or miRNAs are released to rebind the same Dicer, it 
was undexpected that released small RNA duplexes could actually assemble into distinct 
loading complexes. Because pre-miR-277 is processed by the Dicer1/Loqs heterodimer 
(Förstemann et al., 2005), but enters the RNAi pathway via the RLC, even in non-dicing 
Dicer2 mutants, it must be released Dicer1/Loquacious as miR/miR* duplex, and sorted 
into the Ago2 loading pathway. 
 Is small RNA sorting a fly-specific phenomenon? Recent data suggest it is not. 
Steiner and colleagues came to remarkably similar conclusions in their studies of a 
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hairpin let-7 precursors in worms. They found that the extent of pairing in a let-7 hairpin 
trigger determined whether let-7 entered either the RNAi or miRNA pathway. Let-7 from 
perfectly paired hairpins assembled into Rde-1, while centrally bulged hairpins 
assembled into Alg-1. Their data also suggest that Dicing and RISC loading are 
uncoupled—in the absence of Rde-4 or Rde-1, perfectly paired let-7 duplex is made, but 
its accumulation as let-7/let-7* suggests that it cannot be loaded (Steiner et al., 2007). 
Sorting also occurs in plants, but it appears to be mainly defined by the identity of the 
terminal nucleotide, not duplex structure (Mi et al., 2008; Montgomery et al., 2008). With 
10 specialized Argonautes, but only 4 terminal nucleotides it is anticipated that more 
sorting principles are at play in plants, such as cellular compartmentalization of 
biogenesis. 
 Do small RNA duplexes get sorted in vertebrates? Initial studies suggest they do 
not. Two groups reported that all four affinity tagged human Argonaute proteins associate 
indiscriminately with miRNAs and siRNAs when overexpressed in tissue culture cells 
(Liu et al., 2004; Meister et al., 2004b). Given that sorting phenomena have now been 
observed in plants, worms, and flies, this is surprising and should be revisited. It remains 
possible that sorting phenomenae went undetected due to an artifact of over expression; 
because Argonautes compete for small RNAs (Tomari et al., 2007) excess of one 
Argonaute may artificially favor its loading. It also remains possible that miRNAs or 
siRNAs bound to some Argonaute complexes do not correspond to mature single-
stranded RISC, but rather consist of pre-RISC, complexes that contain small RNA 
duplexes. Ago1 pre-RISC was observed by Tomari and coworkers’ who found that 
although fly Ago1 associates with siRNAs in vitro, it mostly corresponds to siRNA 
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duplex, not mature single-stranded RISC (Tomari et al., 2007). Similarly, an allele of fly 
Ago2 with a mutation in its catalytic residues fails to produce mature RISC efficiently, 
with accumulation of pre-RISC (Kim et al., 2006). These findings support the idea that 
efficient loading of human and fly Ago2 involves passenger strand cleavage (Matranga et 
al., 2005; Rand et al., 2005; Miyoshi et al., 2005). It would be interesting to test if 
siRNAs associated with human Ago1, 3, and 4, the non-cleaving Argonautes, are 
associated with siRNA duplexes rather than mature single-stranded guides. Perhaps well 
paired miRNA duplexes also associate with non-cleaving Argonautes to form pre-RISC, 
but not mature RISC. A recent study that identified putative miRNA targets by 
immunoprecipitating endogenous human Ago1 and Ago2 also suggests that miRNAs 
may be sorted preferentially into human Ago1 or Ago2; co-immunoprecipitating mRNAs 
had minimal overlap, despite similar total numbers of predicted miRNA targets 
(Beitzinger et al., 2007).  
 How mammals load their Argonaute proteins and how flies load Ago1 is currently 
unknown. Although a functional human RISC loading complex has been reconstituted 
containing Dicer, TRBP, and Ago2 (MacRae et al., 2008), it is unclear whether its 
mechanics mirror those of fly Dicer2/R2D2/Ago2, with respect to asymmetry sensing and 
the essential loading function of fly Dicer2. Although two reports that use RNAi to 
deplete Dicer suggest Dicer is required for siRNA mediated RNAi (Doi et al., 2003; 
Chendrimada et al., 2005), two studies using Dicer knockout ES cells suggest that siRNA 
mediated RNAi is Dicer independent (Murchison et al., 2005; Kanellopoulou et al., 
2005). Further studies using reconstituted RISC should help determine how analogous 
mammalian RISC loading its Drosophila counterpart. Because Drosophila Ago1 is more 
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closely related to mammalian Ago proteins (Tolia and Joshua-Tor, 2007), studying 
mammalian RISC loading may give insight into how it is loaded.  
 
Target Specificity of Slicing Argonautes and its Implications 
 The remarkable result of small RNA sorting is that information contained in a 
small RNA duplex’s structure can be converted into distinct silencing outputs—highly 
bulged duplexes can silence bulged targets via Ago1 while highly paired duplexes can 
silence near perfect targets via Ago2. The inability of Ago1 to efficiently silence a perfect 
target was unanticipated, since in vitro target cleavage was observed previously 
(Okamura et al., 2004; Miyoshi et al., 2005). This suggests that the ability of an 
Argonaute protein to cleave targets does not mean it can do so efficiently—robust 
multiple turnover activity is needed. An interesting area of enquiry will be distinguishing 
what endows Ago2 with this ability, distinguishing it from Ago1. Conversely, it is 
unclear what prevents Ago2 from silencing bulged targets. Potential differences include: 
(1) Ago2’s unique N-terminal domain that is rich in poly-glutamine repeats. Mutations in 
this domain were previously reported to interact genetically with Ago1, perhaps allowing 
Ago2 to interfere with Ago1 function (Meyer et al., 2006). (2) Only Ago1 contains a 
conserved phenylalanine motif in its Mid domain proposed to bind mRNA cap structures 
to repress translation (Kiriakidou et al., 2007). However recent studies by the Izaurralde 
group suggest that mutation of these residues prevents binding of GW182, a component 
essential for miRNA mediated translational repression and mRNA decay (Eulalio et al., 
2008). Lacking these residues, Ago2 may not interact with GW182. This is supported by 
data showing a high correlation between Ago1 and GW182 regulated mRNAs, but not 
Ago2 regulated mRNAs in S2 cells (Behm-Ansmant et al., 2006). Given that GW182 
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association and consequent P-body formation appears to be conserved for miRNA 
associated Argonautes in flies, worms, and humans, the importance of this interaction for 
bulged target silencing seems plausible (Behm-Ansmant et al., 2006; Ding et al., 2005; 
Liu et al., 2005). (3) Another difference (discussed below) is that Ago2 bound small 
RNA guides have 2-O-Me modified 3′ ends. Although this modification does not appear 
to be required for perfect target silencing in vivo (MDH and C. Li unpublished), it may 
affect target specificity. Domain swapping experiments might shed light on the essential 
features of each protein required for perfect or bulged target silencing, as well as guide 
modification.  
 Because we could not immunoprecipitate Ago2, it was satisfying to see our 
results confirmed in the Hannon group’s recent study cloning small RNAs from tagged 
Ago2 in S2 cells (Czech et al., 2008). In this study miR-277 was present in both Ago1 
and Ago2 immunoprecipitates at about equal amounts relative to each total library sizes. 
This agrees with our data, showing that ~50% of miR-277 has a 3′ terminal modification 
(because it is loaded in Ago2). By contrast the Siomi group did not clone miR-277 in 
their S2 cell Ago2 immunoprecipitations using a monoclonal antibody (Kawamura et al., 
2008). These two studies differed substantially in the number of miRNAs that were 
cloned in Ago2—while miRNAs accounted for 7.7% of Ago2 associated small RNAs 
from S2 cells (and 20% from fly ovaries) for Czech et al., Kawamura found only 1.4% of 
reads. We are not certain what accounts for this difference. One possibility is that the 
Ago2 loading pathway is activated and more accessible to miRNAs under certain cellular 
conditions, such as viral infection, high transposon activity, or active transgene silencing. 
Upon cloning small RNAs Czech et al. noticed that their S2 cells were concurrently 
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fighting a case of Flock house virus. Our experiments were done in cells stably 
expressing a GFP transgene. Notably, we cloned many small RNAs derived from the 
white gene, a marker on the integrated plasmid. We also noted that our cells expressed 
high levels of the Mdg1 retrotransposon mRNA, which was actually became more 
abundant than a ribosomal protein mRNA after Dicer2 depletion. Perhaps dsRNA 
abundance in these cells is high and RISC loading is enhanced as a response. Increasing 
the concentration of the RLC improves Ago2 loading (Tomari et al., 2007). To test this 
RLC concentration could be compared in these three cell lines by western blotting for 
Dicr2 and R2D2. miRNAs associated with Ago2 could also be examined in the presence 
and absence of a virus in Kawamura et al.’s S2 cell line to see if this alters the repertoire 
of Ago2 associated miRNAs.  
Regardless of the exact nature of miR-277 partitioning in our S2 cells, it allowed 
us to show that Argonaute identity affects target specificity. An important implication of 
this is that siRNA directed knockdowns using the Drosophila Ago2 pathway should 
produce minimal off target effects. Because off-target effects are a major problem for 
experimentalists and for therapeutic applications (Jackson et al., 2003; Jackson et al., 
2006), understanding the strategies animals already use to limit them may suggest better 
approaches for RNAi. We are currently testing the hypothesis that Ago2 bound small 
RNAs have reduced off target effects using mRNA expression arrays and transfected 
Ago1 or Ago2 directed duplexes in S2 cells.  
 What is the purpose of small RNA sorting? The likely answer is that Argonaute 
activities have evolved to best silence their respective targets. Ago1 associated miRNAs 
(97.6% of its associated small RNAs in S2 cells (Czech et al., 2008)) regulate 
 130
endogenous mRNAs and while Ago2 bound small RNAs defend against endogenous and 
exogenous parasitic nucleic acids. Because animal miRNAs have evolved to primarily 
use seed sequences as a minimal targeting determinant (Grimson et al., 2007; Lewis et 
al., 2005; Lewis et al., 2003), Ago1 loaded small RNAs should be capable of engaging 
and repressing mRNAs appropriately. Ago2 however appears to play an important role in 
defense against exogenous viral infection, as well as endogenous transposon and 
repetitive element silencing. Several recent studies, including one by our group 
(Appendix III), catalogue the small RNAs associated with Ago2. While those studies 
mentioned above cloned small RNAs from Ago2 immunoprecipitates (Czech et al., 2008; 
Kawamura et al., 2008), we selectively cloned small RNAs with 3′ terminal 
modifications from dsRNA treated S2 cells and fly heads expressing an inverted repeat 
RNAi trigger(Ghildiyal et al., 2008). Collectively, these studies show that Ago2’s natural 
partner small RNAs consist of a diverse array of transposon and repeat derived siRNAs. 
Analysis of ago2 and dcr2 mutant flies and S2 cell knockdowns suggest that Ago2 and 
Dicer2 direct somatic and germline transposon silencing. Because Czech et al.’s cells 
fortuitously had flockhouse virus, they also showed that Ago2 and Dicer2 limit 
flockhouse virus expression, consistent with previous reports demonstrating anti-viral 
roles for Ago2 and Dicer2 (Zambon et al., 2006; van Rij et al., 2006). With such a diverse 
array of sequences bound to Ago2, staying “on-target” might be important to avoid 
unintended silencing of critical mRNA upon viral infection or transposon activation. 
miRNAs that are sorted into Ago2 may also have roles in anti-viral or transposon 
responses. In human cells, endogenous miRNAs have been shown to prevent infection by 
Primate foamy virus and limit replication of Hepatitis C virus (Lecellier et al., 2005; 
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Pedersen et al., 2007). Perhaps Ago2 associated miRNAs can play a similar role. Because 
few fly viruses have been characterized, testing the generality of this mechanism may be 
difficult.      
 Alternatively, loading miRNAs into Ago2 may be a posttranscriptional negative 
regulation mechanism for miRNAs. miR-277 has no annotated perfect or near perfect 
targets in the Drosophila genome, thus it should be relatively inert when loaded into 
Ago2. Because miR-277 appears to be ubiquitously expressed in adults, shunting it 
into Ago2 might prevent productive seed:target interactions that would take place if it 
were in Ago1. Thus Ago2 loading could act as an off-switch, or at least a rheostat, in the 
absence of transcriptional downregulation. Notably, miRNA specific regulation of 
biogenesis has been observed in mammals at the level of pri-miRNA processing 
(Thomson et al., 2006; Viswanathan et al., 2008). Perhaps miRNA sorting offers another 
level of posttranscriptional regulation of miRNAs via production of inert or less 
functional RISCs. Perhaps such RISCs could even bind and stabilize targets under some 
circumstances, blocking target sites from more potent RISCs. Our finding that bulged 
target silencing is modestly enhanced in r2d2 flies is consistent with this idea.   
  
2’-O-Methylation and Transposon Silencing 
 In data not shown, Ebashir and colleagues reported that incubation of dsRNA in 
Drosophila embryo lysate produced periodate sensitive siRNAs with 2′, 3′ hydroxyl 
ends, consistent with their production by an RNAseIII enzyme (Elbashir et al., 2001b). 
However, six years later, Pellison and colleagues unexpectedly found that like piRNAs, 
siRNAs in flies also have modified 3′ ends (Pelisson et al., 2007). We had already begun 
building reagents to test if the piRNA modification was a 2′-O-Methyl modification, like 
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in plants, and if the plant methyltransferase orthologue, DmHen1, is the small RNA 
methylase in flies (Yu et al., 2005). Our studies quickly suggested that DmHen1 modifies 
both classes of small RNAs in flies.  
 Our studies suggest several differences in the nature of small RNA modification 
in animals versus plants. In plants Hen1 has a dsRNA binding domain that is absent in 
animals. In vivo and in vitro plant Hen1 can modify both strands of 21-24 nt duplexes, 
whether they are perfectly paired siRNA or imperfectly paired miR/miR* duplexes (Yang 
et al., 2006; Yu et al., 2005). In animals this does not appear to be the case—rather 
single-stranded siRNAs appear to be modified while bound to Ago2. This was suggested 
by our experiments that showed, (1) in vitro siRNA modification in ovary extracts 
requires RLC and Ago2, (2) in vivo modification of siRNAs and miRNAs in S2 cells 
requires Hen1 and Ago2, but not Ago1, (3) only single-stranded siRNAs are detected 
during RISC assembly, and (4) recombinant Hen1 can modify single-stranded siRNAs, 
but not siRNA duplexes in vitro. Because single-stranded siRNAs are only stable when 
bound to Argonaute proteins a direct interaction between Ago2 and DmHen1 is 
suggested. This also leads to the prediction that DmHen1 might directly interacts with 
Piwi proteins to modify piRNAs derived from single-stranded precursors. Indeed, a 
parallel study by Saito and colleagues confirmed a direct interaction of DmHen1 with the 
piwi protein Aubergine using in vitro translated Aubergine and GST-Hen1 (Saito et al., 
2007). We plan to confirm the Ago2:DmHen1 interaction by coimmunoprecipitation 
once we have unambiguously confirmed the specificity of our polyclonal anti-DmHen1 
antibodies.  
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In contrast to the plieotropic effects of hen1 in plants, flies carrying the intronic 
PiggyBac insertion allele hen1f00810, a transcript null, are fertile with no visible defects, 
despite loss of all detectable piRNA and siRNA modification activity. In contrast to Saito 
and colleagues who found no changes in germline transposon expression, we found that 
ovaries from hen1f00810 flies had modest ~3 fold elevation of Het-A mRNA versus 
heterozygotes (spindle-E, armitage, piwi, and aubergine by contrast cause 25-200 fold 
increases in Het-A mRNA (Vagin et al., 2006)). Consistent with this modest effect, we 
saw a reduction in both average size and abundance of Roo and Suppressor of Stellate 
piRNAs in ovaries and testes respectively, by northern blot. Saito and colleagues reported 
no change in piRNA size or abundance, but unlike our northern blot, which detects 
piRNAs in vivo, they examined 5′ end labeled piRNAs that co-immunoprecipitated with 
piwi proteins. Their approach might not capture all piRNAs, especially those in nucleic, 
such as those bound to Piwi. It is also possible that shorter piRNAs are degraded during 
lysis or immunoprecipitation, preventing their detection. A modest reduction of small 
RNA size and abundance in hen1f00810 mutants was also reported in a recent study of 
Ago2 bound endogenous siRNAs (endo-siRNAs) derived from long hairpin transcripts 
(Okamura et al., 2008); northern blots showed a 2-6 fold reduction of Ago2 bound small 
RNAs. Supporting our previous findings, they observed that Ago2 associated endo-
siRNAs regulate perfect targets, but not bulged targets. However, the functional impact 
Hen1 loss was not assessed.  
All 2-O-methylated small RNA species reported to date (plant small RNAs, Ago2 
associated siRNAs and miRNAs, and piRNAs) appear to use a target cleavage 
mechanism to silence perfect targets. This striking correlation suggests that terminal 
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methylation may play a conserved role in target cleavage. Moreover, the recent 
discoveries that Drosophila Ago2 binds endo-siRNAs corresponding to transposons 
suggests that 2′-O-Methylation endows small RNA guides, both siRNAs and piRNAs 
with properties uniquely suited for transposon silencing (Czech et al., 2008; Ghildiyal et 
al., 2008; Kawamura et al., 2008). It is tempting to speculate that the primary difference 
in the ability of Ago1 and Ago2 to cleave perfect targets derives from the different 3′ end 
chemistry of their guides. Studies of the human Paz domain, suggest that 2′-O-Me ends 
have roughly 15 fold lower affinity (Ma et al., 2004). Perhaps 3′ end release by the Paz 
domain is part of Argonautes’ catalytic cycle, and lack of modification limits target 
release, as we observed for Ago1.  
However, our preliminary data suggest that loss of Hen1 function has little affect 
on RNAi in our fly assays—target cleavage occurs in hen1f00810 ovary lysates, inverted 
repeat silencing in fly eyes does not appear to be affected in hen1f00810 (C. Li 
unpublished), and knocking down Hen1 in S2 cells has little if any affect on perfect 
reporter expression or RNAi (MDH unpublished). In vitro studies from plants also 
suggest that terminal methylation does not affect target cleavage in vitro (Qi et al., 2005). 
We are currently conducting experiments to determine if unmodified siRNAs in 
hen1f00810 are multiple turnover enzymes. We are also performing experiments to confirm 
that hen1f00810 is truely a null allele. Some of our data hints that it may not be; supporting 
this possibility, quantitative RT-PCR using primers contained in either the first or last 
exon, rather than primers that span the Piggybac insertion, imply that the transcript is in 
fact made and polyadenylated (MDH unpublished). Additionally, an affinity purified N-
terminal polyclonal antibody reacts on western blot with recombinant Hen1 protein, an 
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epitope tagged Hen1 transgene expressed in flies or S2 cells, and a ~45 kD band in 
ovaries (the correct size for Hen1), but this band is not consistently reduced in hen1f00810 
ovaries. We currently cannot rule out the possibility that this is a cross-reacting band of 
the same size, but it could also be a non-catalytic Hen1 protein that is similar in size, and 
retains some key aspect of Hen1 function—for instance, Ago2 or Piwi binding. We are 
testing if a weaker allele containing a P-element insertion in its 5′UTR (hen1ey22392) gives 
reduced signal on western when transheterozygous with a chromosomal deletion. 
hen1ey22392 is also being used to generate a P-element excision allele. The fact that siRNA 
modification in hen1f00810 ovary lysate is fully rescued with recombinant protein however, 
suggests it is a null allele. 
So what is the function of Hen1 and terminal methylation? Assuming our allele is 
in fact a null, the results from plants and flies suggest its role is to protect the 3′ end of 
small RNA guides from exo-nucleases or poly-uridylation machinery. In plants northern 
blots show poly-uridylation and degradation clearly—many small RNAs show reduced 
gel mobility and reduced abundance (Li et al., 2005). Cloning of small RNAs from plant 
hen1 mutants revealed that small RNAs are both degraded from their 3′ ends by 
exonucleases and poly-uridylated.  However, the extent of both varied depending on the 
particular RNA examined. Some miRNAs were uridylated, but not reduced in abundance. 
Interestingly, miR* strands were remarkably unaltered relative to their miR counterparts. 
Although there is no evidence suggesting that fly small RNAs get polyuridylated in hen1, 
our results and those of Okamura and colleagues (Okamura et al., 2008) suggest that 
modification by DmHen1 does protect 3′ ends from nucleases to some extent, both for 
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piRNAs and endo-siRNAs. Both species are reduced in mobility and abundance. 
However, these appear to be modest affects.  
One possibility consistent with our data is that terminal modification does not 
enhance target cleavage directly, but perhaps it potentiates small RNA silencing by 
protecting guides in multiple turnover cleaving RISCs. Tomari and Zamore proposed a 
two-state model for target cleavage (Tomari and Zamore, 2005). In their model of target 
cleavage by RISC the 3′ end of the guide is bound to the Paz domain, but released during 
the target cleavage cycle to create an A form helix that can position the target in the 
Argonaute’s catalytic site. Cleaved target is then released and the 3′ end re-binds the Paz 
domain. If this is correct, the 3′ end of a small RNA that silences its targets by multiple 
turnover catalysis would spend less time protected in the Paz binding pocket than that of 
animal miRNAs for instance, that are predicted to silence targets stoichiometrically using 
only seed sequences. This may make 2′, 3′ hydroxyl ends of cleaving Argonautes more 
vulnerable to nuclease activities that normally act to degrade cleaved targets, which also 
bear 2′,3′ hydroxyl ends. It is reasonable to suspect that RISCs are in close contact with 
other nucleases; for instance, Tudor-SN is a conserved nuclease found in fly Ago2 RISC 
that facilitates target degradation (Caudy et al., 2003). RISC may also be in close contact 
with the exosome, a collection of 3′ to 5′ exonucleases that were shown to mediate target 
degradation after cleavage (Orban and Izaurralde, 2005) or an unidentified conserved 
uridylation activity that acts on 3′ target ends after target cleavage (Shen and Goodman, 
2004); indeed, non-templated 3′ U’s have been detected on miRNAs in flies (Seitz et al., 
2008). The prediction of such a model is that degradation in hen1 mutants ought to be 
proportional to the number of rounds of target cleavage. This could be one explanation 
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for the heterogeneity of plant miRNA degradation in hen1 mutants—maybe miRNAs 
whose abundance is most reduced are those that have the largest pool of targets to 
silence, relative to their levels of expression. Perhaps this also explains why plant miR* 
strands are not affected by hen1 (because they do not have targets to cleave). This might 
also explain why we only see modest effects on piRNA silencing and minimal effects on 
RNAi—relative to target levels, small RNAs that are abundant would be less affected 
than those that are not. Perhaps our RNAi assays used to date (dsRNA treatment of S2 
cells, inverted repeat silencing in eyes, mRNA cleavage in enzyme excess) produce 
excess small RNAs relative to the target. Consistent with this, mRNA levels from Het-A 
a retrotransposon maintained in multicopy arrays at fly telomeres (Danilevskaya et al., 
1994), are most greatly affected in hen1f00810, but we have been unable to detect Het-A 
piRNAs by northern blot. mRNA from Roo, the most abundant retrotransposon in flies, 
however is not affected in hen1f00810, yet a modest decrease in its piRNAs is observed. 
Perhaps the ratio of piRNAs to target mRNA explains this difference. More extensive 
analysis of cloned small RNAs in hen1f00810 mutants, coupled with global analyses of 
mRNA expression using oligonucleotide arrays may give more insight into which 
piRNAs and targets are most affected. The hypothesis that target cleavage induces 
degradation of an unmodified small RNA guide is also easily testable in vitro; using 32P-
labeled siRNA in wt or hen1f00810 mutant ovary extracts we can determine if addition of 
excess perfect target or a bulged target causes degradation of the guide RNA. 
 
Small RNA Methylation Complexes 
To better understand how piRNAs and siRNAs are made and to confirm our 
model that predicts direct interactions of Hen1 with piwi proteins and Ago2, we are 
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conducting fractionation/proteomics experiments using a UASp epitope tagged DmHen1 
rescue transgene expressed in germline cells (Nanos-Gal4 driver) or ubiquitously 
(Tubulin-Gal4 driver). It will be especially interesting to see if we can identify putative 3′ 
exonucleases in germline cells that might be involved in piRNA biogenesis.   
 
Structure and Function of DmHen1  
Our in vitro studies indicated two important features of DmHen1 catalysis. (1) 
DmHen1selectively modifies single-stranded RNA, and (2) the rate of catalysis is greatly 
enhanced in the presence of Drosophila lysate. We predict that this rate enhancement is 
due to DmHen1 binding of Ago2. We have begun studies to test this hypothesis and to 
understand small RNA modification structurally. We produced soluble pure DmHen1 by 
Tev mediated cleavage of a GST-DmHen1 fusion protein expressed in E.coli, but failed 
to obtain crystals in an initial screen. We are now collaborating with Tracy Hall’s group 
on this project and intend on studying both DmHen1 alone and in complex with Ago2.  
 
 
In sum these studies have shed light on several principles of small RNA silencing 
in Drosophila. They show the existence of a small RNA sorting step that gives small 
RNA duplexes from differing origins equal access to RISC loading pathways. Ultimately, 
duplex structure rather than origin determines function. Function is also correlated with 
guide chemistry—2′-O-methylation of guides in target cleaving RISC by DmHen1 
affects transposon directed silencing by piRNAs and perhaps endo-siRNAs. This 
common modification also highlights the emerging functional connection between 
piRNA and endo-siRNA pathways, which offer distinct defenses in the ongoing struggle 
of eukaryotic genomes and their selfish repetitive elements.  
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Appendix I:Design and Delivery of Antisense Oligonucleotides to Block 
microRNAFunction in Cultured Drosophila and Human Cells 
 
Note: This is a revised manuscript currently under review at Nature Protocols. The author 
conducted all experiments and wrote the paper with Phillip Zamore. 
 
Abstract 
MicroRNAs (miRNAs), ~21 nt RNAs that mediate post-transcriptional regulation of 
mRNAs in animals and plants, are a diverse class of regulatory genes whose specific 
biological functions are largely unknown. Here, we detail a protocol to design and 
introduce into cultured Drosophila and human cells sequence-specific antisense 
oligonucleotides (ASOs) that block the function of individual miRNAs. Coupled with 
recent studies that catalog the miRNAs expressed in diverse cultured cells, our method 
offers a rapid (< 1 week) approach to validate miRNA targets and to study the cellular 
functions of individual human and Drosophila miRNAs. ASO-based inactivation of 
miRNAs is faster and simpler than comparable genetic or “sponge” based approaches, for 
which extensive recombinant DNA manipulation is required. We present our ASO design 
principles and an optimized transfection protocol in which transfection efficiency of 
Drosophila Schneider 2 cells can approach 100%. Our 3′-cholesterol modified ASOs 
have enhanced potency, allowing miRNA inhibition for at least 7 days from a single 
transfection. 
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Introduction 
MicroRNAs (miRNAs) are an ancient class of ~21 nt small silencing RNAs that mediate 
post-transcriptional regulation of mRNAs in animals and plants . When bound to partially 
complementary sequences in their target mRNAs, animal miRNAs tune gene expression 
by repressing translation or accelerating mRNA decay(Bagga et al., 2005; Lee et al., 
1993; Lim et al., 2005; Wightman et al., 1993; Olsen and Ambros, 1999). This regulation 
is critical for diverse biological processes, including stem cell maintenance; 
musculoskeletal, circulatory, and nervous system development; insulin secretion; and 
oncogenic transformation(Förstemann et al., 2005; Hatfield et al., 2005; Sokol and 
Ambros, 2005; Zhao et al., 2007; Giraldez et al., 2005; Poy et al., 2004; He et al., 2005). 
More than 1000 miRNA genes have now been identified in animals, of which a large 
fraction are conserved between vertebrates and invertebrates. However, few specific 
functions have been described for individual miRNAs. 
To accelerate the study of miRNA function and mechanism, we developed a 
method to disrupt individual miRNAs using antisense oligonucleotides (ASOs) in human 
tissue culture cells(Hutvágner et al., 2004) and adapted it for use in Drosophila S2 
cells(Förstemann et al., 2007). ASOs bind complementary miRNAs and selectively block 
silencing in cell extracts, in cultured cells, and in vivo in worms, flies, mice, and 
primates(Boutla et al., 2003; Hutvágner et al., 2004; Krutzfeldt et al., 2005; Leaman et 
al., 2005; Meister et al., 2004a; Davis et al., 2006; Esau et al., 2006; Esau et al., 2004; 
Elmen et al., 2008a). Studying miRNA function using classical genetic approaches is 
challenging, as miRNAs often form multi-gene families with common mRNAs targets, 
reside in introns of protein coding genes, or derive from polycistronic non-coding 
transcripts(Lau et al., 2001; Lagos-Quintana et al., 2001; Abbott et al., 2005; Baskerville 
and Bartel, 2005; Kim and Kim, 2007; Okamura et al., 2007; Ruby et al., 2007). ASOs 
can be designed to inactivate a specific miRNA and its paralogs knowing only the 
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sequences of the mature miRNAs. Recent studies cataloguing miRNA sequences and 
expression profiles in flies, worms, mice, humans, and cultured cells provide a road map 
for the use of ASOs to study miRNA targets and the biological pathways they 
regulate(Aravin et al., 2003; Ruby et al., 2006; Berezikov et al., 2006; Gaur et al., 2007; 
Blower et al., 2007; Landgraf et al., 2007). Here, we describe the principles used in our 
laboratory to design ASO miRNA inhibitors and provide protocols for the efficient 
delivery of ASO inhibitors into cultured Drosophila Schneider 2 (S2) and human cells. 
 
miRNAs and Their Targets 
miRNAs are transcribed as hairpin precursors, then sequentially processed by the RNase 
III enzymes, Drosha and Dicer, to yield double-stranded intermediates bearing 2 nt, 3′ 
overhanging ends(Lee et al., 2003; Hutvágner et al., 2001; Grishok et al., 2001; Ketting et 
al., 2001). These imperfectly paired duplexes are then assembled into long-lived, 
cytoplasmic protein-RNA complexes called RISCs (RNA-Induced Silencing Complexes) 
that mediate RNA silencing. Every RISC contains a single-stranded small RNA guide 
bound to a member of the Argonaute family of proteins(Bernstein et al., 2001; Hutvágner 
and Zamore, 2002). The miRNA and Argonaute protein act together to bind and silence 
target mRNAs (Fig. 1). Perfectly complementary targets are efficiently silenced by the 
endonucleolytic cleavage activity of some Argonaute proteins(Hutvágner and Zamore, 
2002; Yekta et al., 2004; Davis et al., 2005), but  the vast majority of predicted targets in 
animals are only partially paired(Grun et al., 2005; Krek et al., 2005; Rajewsky and 
Socci, 2004; Ruby et al., 2006; Lewis et al., 2005; Lewis et al., 2003; Brennecke et al., 
2005) and likely cannot be cleaved(Haley and Zamore, 2004). Instead, they bind RISC 
using the “seed” of the miRNA, nucleotides 2-7, and are translationally repressed and/or 
degraded by a pathway distinct from the endonucleolytic activity of RISC(Doench and 
Sharp, 2004; Lewis et al., 2003; Aleman et al., 2007). 
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Figure AI-1 
 
 
 
 
Figure AI-1. Model for Antisense Oligonucleotide Disruption of miRNA Silencing. 
Single-stranded, mature miRNAs bound to an Argonaute protein can cleave perfectly 
complementary mRNA targets. Imperfectly paired mRNAs are translationally repressed 
or degraded. ASOs bind miRNAs in RISC, thereby preventing miRNA from binding its 
target mRNA. In some cases, ASOs may secondarily promote miRNA degradation by an 
unknown mechanism. 
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The remarkably small number of nucleotides required for miRNA-directed target 
repression suggests that each miRNA may regulate hundreds of mRNA species(Grun et 
al., 2005; Krek et al., 2005; Rajewsky and Socci, 2004; Ruby et al., 2006; Lewis et al., 
2005; Lewis et al., 2003; Brennecke et al., 2005). Experimentally validating 
computationally predicted miRNA targets and proving the biological significance of each 
mRNA candidate remains a daunting challenge. Selective inactivation of miRNAs with 
ASOs has already helped accelerate this task. 
 
Selection of Antisense Oligonucleotide Chemistry 
miRNA activity has been blocked effectively using ASOs containing several distinct 
nucleic acid modifications. In general, an effective ASO is (1) resistant to non-specific 
cellular ribonucleases, (2) resistant to miRNA-directed cleavage by RISC, and (3) binds 
miRNAs in RISC with high affinity, effectively out-competing binding to target mRNAs. 
We designed ASO inhibitors containing exclusively 2´-O-methyl (2´-O-Me) ribose 
sugars (Fig. 2). 2’-O-Me oligonucleotides are resistant to cleavage by both RISC and 
other cellular ribonucleases(Inoue et al., 1987; Hutvágner et al., 2004; Meister et al., 
2004a). Moreover, 2´-O-methyl-modified RNA:RNA hybrids are more 
thermodynamically stable than either RNA:RNA or DNA:RNA duplexes(Inoue et al., 
1987; Tsourkas et al., 2002). Other base modifications with enhanced hybridization 
stability have also been used successfully to inhibit miRNA function, including ASOs 
combining 2´-deoxy and Locked Nucleic Acid (LNA) nucleotides(Chan et al., 2005; 
Lecellier et al., 2005; Orom et al., 2006; Elmen et al., 2008b), 2´-O-methyl and 
LNA(Fabani and Gait, 2008), all 2´-O-methoxyethyl (2´-O-MOE) ASOs, and ASOs 
incorporating pyrimidines bearing 2´-O-fluoro modifications(Davis et al., 2006; Esau et 
al., 2006) (2´-O-MOE-modified oligonucleotides are not available commercially.)  
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Figure AI-2. Chemical Structures of Antisense Oligonucleotides Used to Block 
miRNA Function. Anti-miR-277 is represented to illustrate the design principles used in 
different studies. All ASOs contain core sequences that are perfectly complementary to 
mature miR-277. A number of flanking sequence, backbone, base, and terminal 
modifications have been incorporated in the indicated studies. Chemical structures 
correspond to color coded sugar, backbone, and terminal modifications. The linkers used 
for 3´-cholesterol conjugation by Dharmacon and Alnylam (not commercially available) 
are also illustrated. 
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Nuclease-resistant phosphorothioate backbone linkages, in combination with ribose 
modifications, have also been employed in cultured cells, in vivo in mice and non-human 
primates (Davis et al., 2006; Esau et al., 2006; Krutzfeldt et al., 2007; Krutzfeldt et al., 
2005; Elmen et al., 2008a)(Fig. 2). miRNA inhibition by peptide nucleic acid 
oligonucleotides has been reported for cultured cells(Fabani and Gait, 2008). 
A 3´ terminal cholesterol group appears to aid delivery of ASOs to cells. 
Originally used to enhance delivery of ASOs targeting mRNAs(Desjardins et al., 1995; 
Krieg et al., 1993; Letsinger et al., 1989), cholesterol modification has been adapted to 
deliver both small interfering RNAs and miRNA-blocking ASOs to the liver and other 
tissues in mice(Soutschek et al., 2004; Krutzfeldt et al., 2005). We find that 3´ 
conjugation of cholesterol to ASOs makes them ~8-fold more potent when transfected 
into S2 cells (Fig. S2)(Förstemann et al., 2007). While cholesterol conjugation likely aids 
ASO delivery into cells, it may have properties that further enhance ASO activity, such as 
improved intracellular escape from liposomes, relocalization of the targeted miRNAs, or 
enhancement of ASO stability. Recent studies in mice support such ideas(Krutzfeldt et 
al., 2007). 
 
Does Length Really Matter? 
To make the ASO more “target-like,” we added 5 extra nucleotides to its ends, for a total 
of 31 nucleotides(Hutvágner et al., 2004). 21 nt 2´-O-Me ASOs have also been used in 
cultured human and Drosophila cells and in fly embryos(Meister et al., 2004a; Leaman et 
al., 2005; Esau et al., 2006). Esau and coworkers reported no significant difference 
between 21 nt and longer ASOs in HeLa cells, but Hutvágner et al. found that 21-mer 
ASOs were measurably less potent. Similarly, Berger and co-workers observed only 
partial inhibition of miR-2 in Drosophila S2 cell reporter assays using a 21-mer 
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ASO(Berger et al., 2005). Vermeulen and coworkers found that increasing ASO length 
by adding as many as 16 nt to each side of the miRNA-complementary core increased 
ASO potency as much as 10-fold(Vermeulen et al., 2007). 
Consistent with these observations, Ameres and colleagues recently described a 
sequence-independent, single-stranded RNA-binding activity associated with human 
RISC(Ameres et al., 2007). Non-sequence-specific binding by RISC of ASO sequence 
flanking the miRNA-complementary core may account for the enhanced potency of 
ASOs longer than 21 nt. These additional ASO sequences might also protect the core 
from cellular exonucleases. Krutzfeldt suggests this possibility to explain a “tendency” 
toward improved disruption of miR-122 in vivo when they extend the ASO by only 1 
base on each end(Krutzfeldt et al., 2007). Interestingly, Vermeulen observed that addition 
of double-stranded, 8 base-pair hairpins to the ends of the ASO increased its potency 
more than the addition of 16 single-stranded nucleotides(Vermeulen et al., 2007). 
Double-stranded ends may protect the ASO from exonucleolytic destruction or the 
terminal hairpins may participate in coaxial stacking interactions with the ASO:miRNA 
duplex, increasing its thermodynamic stability(Walter et al., 1994). Supporting the idea 
that ASOs must have high thermodynamic stability, Elmen and colleagues recently 
showed that full complementarity of an ASO is not required if a very high affinity 16-mer 
LNA targeting the 5´ end of the miRNA is used(Elmen et al., 2008a; Elmen et al., 
2008b). In our experience, 21 nt LNA-substituted ASOs and 31-mer 2´-O-Me ASOs 
performed similarly in S2 cells (PDZ and MDH, unpublished). While the higher affinity 
of LNAs may permit design of shorter effective ASO inhibitors, we believe that the bulk 
of published data suggest that the addition of single- or double-stranded sequences 
flanking the 21 ASO nucleotides complementary to the targeted miRNA potentiates 
miRNA inhibition by 2´-O-Me ASOs. 
 
The Mechanism of miRNA Inhibition 
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The mechanism by which ASOs block miRNA function remains controversial. Initial 
studies suggested that ASOs block miRNA function by binding mature miRNAs in RISC. 
31-mer 2´-O-Me ASOs act as stoichiometric inhibitors in vitro and in HeLa cells and 
bind miRNAs in RISC in vivo in C. elegans(Hutvágner et al., 2004). Unexpectedly, ASO-
targeted miRNAs could not be detected by northern hybridization in mice that were 
injected with “antagomirs”, cholesterol modified, 2´-O-Me ASOs with terminal 
phosphorothioate modifications, (Fig. 2)(Krutzfeldt et al., 2007; Krutzfeldt et al., 2005). 
Similarly, Esau and coworkers found that fully modified 2’-O-methoxyethyl 
phosphorothioate ASOs targeting the same miRNA, miR-122, induced the apparent 
destruction of the miRNA. Potentially, the phosphorothioate modification used in these 
studies triggered miRNA degradation. Chan and colleagues also report that 2’-O-methyl 
or LNA/DNA ASOs bearing phosphodiester backbones reduced apparent miRNA levels, 
but these authors suggest that standard northern hybridization probes may be unable to 
disrupt the high affinity of miRNA:ASO duplexes, even under denaturing 
conditions(Chan et al., 2005). 
Consistent with this possibility, we find that when synthetic let-7 was incubated 
with ~1000-fold excess of 2’-O-methyl ASO in vitro, only ~38% of the input let-7 was 
detectable by northern hybridization using a DNA probe. However, when an LNA probe 
was used in conjunction with a higher hybridization temperature, virtually all the let-7 
was detectable (Fig. 3a). We see similar interference with Northern detection in S2 cells 
treated a miR-277 LNA ASO. Mature and pre-miR-277 was undetectable by northern 
blot with a DNA probe in total RNA samples from miR-277 LNA-transfected S2 cells 
(Fig. 3b). However, when an LNA northern probe was used ~ 30% of the miR-277 and 
pre-miR-277 signal becomes detectable. Interestingly, we observed two distinct types of 
Northern signal interference depending on the amount of LNA transfected. At 100 nM 
LNA, both the mature miRNA and pre-miRNA have reduced mobility. This suggests that 
even in a denaturing gel, the highly stable LNA:miRNA  or LNA:pre-miRNA duplex is  
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Figure AI-3. Improved Detection of Synthetic let-7 and Endogenous miR-277 in the 
Presence of High Levels of Antagomir ASO using an LNA Northern Probe. (A) 1 
nM synthetic 21 nt let-7 RNA was incubated with 1 nM, 10 nM, 100 nM, or 1 μM let-7 
antagomir (21 nt 2´-O-Me with partial pS backbone and 3´-Chl as in Fig. 2(Krutzfeldt et 
al., 2007)) in 30 mM HEPES-KOAc, pH 7.4, 100 mM KOAc, 2 mM MgSO4 for 1 min at 
95°C, then 20 min at 37°C. Samples were mixed with an equal volume of formamide 
loading dye, heated to 95°C for 2 min and then electrophoresed through a denaturing 
15% acrylamide gel containing 7.5 M urea. RNA was transferred to a Hybond N+ 
membrane (Amersham) and probed with a 5´ 32P-radiolabeled DNA oligo at 37°C. The 
membrane was stripped in 0.1% (w/v) SDS and reprobed with an LNA probe at 69°C. 
Percent detection values are normalized to the no antagomir lane for each probe. (B) and 
(C) Drosophila S2 cells containing two copies of the perfect miR-277 reporter were 
transfected with miR-277 ASOs with the indicated chemistry at very high concentration 
(100 nM) or at a concentration that gave 80-90% derepression of the GFP reporter (1–10 
nM depending on chemistry) in three replicate wells of a 6 well plate. An ASO targeting 
firefly luciferase (100 nM) was used as a control. Three days after transfection, cells were 
split and analyzed for Northern Blot or FACS. (B) For Northern analysis, cells from 
replicate transfections were pooled and RNA was extracted using Trizol with 20 μg 
glycogen as a carrier. Ten μg total RNA was loaded per well and Northern hybridization 
was performed using either a miR-277 DNA or LNA probe as in (A). Percent detected 
corresponds to the miR-277 ASO signal normalized to the control signal. Transfected 
LNA ASO was identical to the LNA probe, which incorporated an LNA base at every 
third nucleotide(Valoczi et al., 2004). (C) Fold derepression represents the mean +/- 
standard deviation of the GFP FACS values for three replicate transfections, normalized 
to the control. 
 
 
 149
Figure AI-3 
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maintained, blocking access of lower affinity DNA northern probe. However, at lower 
ASO transfection concentration (2.5 nM LNA), there is a partial mobility shift for mature 
miRNA, but none for pre-miRNA. Nonetheless, miRNA and pre-miRNA were not 
detected with a DNA probe, but were detected with an LNA probe. 
A likely explanation for this effect is that the LNA and miRNA are both 
denatured and migrate as single-stranded 23 nt oligonucleotides during electrophoresis, 
but hybridize to each other during transfer to the positively charged nylon membrane, 
blocking subsequent access of the lower affinity DNA probe to the miRNA. At high 
hybridization temperature, the LNA probe can compete with the ASO, giving a partial 
signal on Northern. Surprisingly, treating S2 cells with 2’-O-methyl ASOs did not 
substantially reduce mature miR-277 levels measured by Northern blotting, using an 
LNA or DNA probe. Nor did addition of 3′ cholesterol or phosphorothioate linkages alter 
miR-277 levels. In each case, whether miR-277 was >80% inhibited (1-10 nM ASO) or 
100% inhibited (100 nM ASO), we did not observe a corresponding change in miR-277 
level by northern blot (Fig. 3b and 3c). These data suggest that ASOs act as inhibitors, 
rather than directing degradation of miRNAs in S2 cells. Whether ASOs act as 
competitive inhibitors or target miRNAs for destruction in mammalian cells will clearly 
require further study. 
 
Alternatives to ASOs for Studying miRNA Function 
A number of alternative approaches are available to study the loss of function of specific 
miRNA genes. 
Gene targeting using homologous recombination is possible in mice and 
flies(Thomas and Capecchi, 1986; Rong and Golic, 2000), and has elucidated roles for 
individual miRNAs in the mouse immune system(Rodriguez et al., 2007) and heart(Zhao 
et al., 2007) and in the development of fly muscle(Sokol and Ambros, 2005) and sensory 
organs(Li et al., 2006). While roles for miRNAs in development had been suggested by 
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the analysis of fly embryos injected with 2’OMe ASOs(Leaman et al., 2005) or 
developing zebrafish injected with pre-miRNA-complementary “morpholinos” (~25 nt 
oligonucleotides containing 6-carbon morpholine rings and a phophoramadite backbone 
instead of ribose sugars and a phosphodiester backbone)(Kloosterman et al., 2007), ASOs 
have yet to be utilized in developing mice. Thus, targeted deletion is currently the only 
way to study loss of miRNA function in mouse development. 
Gene targeting is also possible in human and mouse tissue culture 
cells(Mortensen et al., 1992). Only a single study to date has used this approach(Bommer 
et al., 2007), likely because gene targeting in somatic cells is technically challenging and 
laborious, requiring construction of a targeting vector, recombination selection schemes 
that can vary widely in efficiency depending on the gene to be targeted, and screening to 
verify genotype. Moreover, the results obtained by Bommer and colleagues closely 
mirrored those obtained in parallel using ASOs (see Anticipated Results for more 
discussion). 
A “knock-out” phenotype in an intact animal is, of course, the most convincing 
proof of the biological function of a miRNA. Often, however, no observable phenotype 
results from miRNA loss of function. In a recent study in which deletions were reported 
for 83% of known miRNA genes in C. elegans, loss of most individual miRNA genes 
caused no obvious phenotype(Miska et al., 2007). Functional redundancy likely explains 
this result, as combining deletions of several let-7 family members that alone had no 
phenotype caused distinct phenotypes(Abbott et al., 2005). In mice, deletion of the miR-
17~92 cluster produced dramatic defects in heart, lung, and B-cell development, 
accompanied by inappropriate apoptosis, but deletion of two other paralogs (miR-
106a~363 or miR-106b~25) produced no obvious phenotype(Ventura et al., 2008). Still, 
it is unclear if one or all of the 6 miRNAs in the cluster contribute to the observed 
phenotype. Highlighting the utility of ASOs as an adjunct for rapid functional studies of 
individual miRNAs, Matsubara and colleagues had already found that lung cancer cell 
 152
lines expressing the miR-17~92 cluster undergo apoptosis when miR-17 or miR-20a are 
inhibited with ASOs(Matsubara et al., 2007). Thus, while gene deletion remains the 
biological gold standard, its technical difficulty paired with the complex organization of 
miRNA genes makes it a high risk, time consuming approach. 
 “miRNA sponges” offer a new alternative approach to inhibit miRNA function 
that may be superior for inhibiting whole miRNA families. Sponges are highly expressed 
transgenes bearing multiple, bulged (i.e., non-cleavable) miRNA-binding sites 
complementary to a miRNA of interest. These abundant RNAs compete with endogenous 
targets, and thus “soak up” RISC(Ebert et al., 2007). miRNA sponges have been 
transfected into tissue culture cells and appear to function as well as ASOs. Ebert and 
colleagues observed that sponges can inhibit miRNAs whose only shared sequence is 
their seed. This should be considered when targeting a single miRNA that is part of a 
family—sponges may not distinguish among family members, while ASOs appear to 
selectively silence family members that differ by more than two bases(Esau, 2008). In 
theory miRNA sponges could be used to make transgenic animals, but to date they have 
only been tested in cultured cells. Limitations of sponges, compared to ASOs, include 1) 
the time needed to design, build, and test the recombinant sponge vectors, 2) the reliance 
on plasmid DNA transfection, which is less efficient than oligonucleotide transfection, 
and 3) their limited selectivity for a single member of a miRNA family. 
Transfected siRNAs directed against pre-miRNA loop regions have been 
reported to decrease miRNA abundance in human tissue culture cells(Lee et al., 2005; 
Vasudevan et al., 2007). This method should be used with caution as it appears to be 
comparatively inefficient, reducing the level of a mature miRNA ~80% at best, with the 
remaining 20% free to interact with targets. A number of issues likely account for the 
relative inefficiency of siRNA-directed depletion of miRNAs, including the secondary 
structure of pre-miRNAs which likely limits access to RISC. Secondary structure 
surrounding target sites is a well documented anti-determinant for RNAi(Ameres et al., 
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2007; Kertesz et al., 2007). An siRNA targeting a pre-miRNA must also be able to cleave 
the pre-miRNA before Dicer converts it to a mature miRNA. To date, no evidence 
suggests that RISC has a kinetic advantage over Dicer. Additionally, miRNA depletion 
by pre-miRNA-directed siRNAs is limited by mature miRNA turnover. In contrast, ASOs 
directly inhibit mature miRNAs in RISC. Because RISC-bound miRNAs may be quite 
stable, this is an important consideration. 
 
Advantages and Limitations of miRNA inhibition by ASOs 
In principle, transfected ASOs can be used to study the loss-of-function 
phenotype for any miRNA expressed in cultured cells by measuring growth rate, 
induction of apoptosis, or changes in mRNA or protein abundance. Derepression of 
miRNA-regulated genes in the presence of an ASO is especially convincing evidence for 
a proposed miRNA:target interaction. In contrast to target validation approaches that use 
cloned 3´ UTR reporters and over-express miRNAs, ASO approaches can demonstrate 
that an endogenous miRNA interacts with an endogenous target mRNA. 
To study miRNA function in human somatic cells, where genetic knockouts are 
difficult at best, ASO transfection is an essential tool. Studies using cell lines are, of 
course, limited by the repertoire of miRNAs expressed and by the cellular processes that 
can be recapitulated in immortalized or transformed cells. To study the role of miRNAs 
in complex developmental or physiological processes involving the interaction of 
multiple cell types, the use of model organisms in which miRNAs can be inactivated in 
vivo with ASOs or by targeted deletions (see above) may be preferable. However, even 
when studying miRNA function in vivo, validation of miRNA:target regulation in cell 
lines has the advantage that all the cells studied are essentially identical. 
The main technical limitations on the use of ASOs are their delivery, duration of 
action, and specificity. Delivery and duration of action can be assessed using miRNA 
sensors, genes engineered to place a reporter, such as green fluorescent protein (GFP) or 
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luciferase, under the control of the miRNA of interest (see Experimental Design and 
Anticipated Results). Using the protocol described below, transfection is efficient (>90%) 
and miRNA inhibition is long lasting (>7 days). ASOs likely do not discriminate among 
miRNAs that differ by a single nucleotide. This can be a limitation or an advantage. 
Because many miRNAs are members of highly related families, i.e., they contain 
identical seeds, a single ASO likely blocks the function of more than one miRNA in a 
family. However, a single ASO may not strongly inhibit miRNAs whose only common 
sequence is the seed(Ebert et al., 2007; Davis et al., 2006). For such applications, co-
transfection of multiple ASOs targeting various isoforms is possible(Bommer et al., 
2007). In this respect, genetic approaches are superior for studying individual miRNA 
family members, whereas miRNA sponges or multiple ASOs are appropriate for studying 
miRNA families whose members only contain a common seed sequence; single ASO 
studies may simplify the study of nearly identical miRNA paralogs. 
Combinations of ASOs targeting unrelated miRNAs have also been used to 
disrupt more than one miRNA in the same transfected cells, obviating the need to make 
and combine multiple genetic knockouts. Because combinatorial control of targets by 
miRNAs may be common(Bartel and Chen, 2004), this approach may prove particularly 
important for uncovering networks of miRNAs that act together. Vermeulen and co-
workers showed that co-transfection of a six-ASO mixture can effectively de-repress 
reporters for each individual miRNA(Vermeulen et al., 2007). Functional studies also 
suggest that co-transfection of ASOs is effective. For instance, Pedersen and colleagues 
asked if five interferon-β induced miRNAs with seed matches to Hepatitis C genes had 
anti-viral effects; indeed simultaneous cotransfection of all five ASOs, but not controls, 
significantly enhanced Hepatitis C RNA production(Pedersen et al., 2007). 
 
Experimental Design 
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Control experiments are required to ensure that miRNAs are indeed inactivated by the 
transfected ASOs. All experiments should employ a miRNA-specific ASO and a 
mismatched or unrelated control ASO. Suitable controls include 
a) Antisense sequence of a non-homologous gene from another species, 
b) A randomly scrambled version the experimental ASO, 
c) A sequence derived from the experimental ASO incorporating purine:purine 
mismatches in at least 4 evenly spaced positions spanning the sequence of the 
miRNA. In theory, an ideal control would be a single mismatch in the miRNA seed 
region, but the enhanced binding affinity of 2´-O-Me:RNA may compensate for a 
single seed mismatch. 4 mismatches spanning the miRNA sequence should be 
sufficient to disrupt binding. 
After transfecting cells with these ASOs, miRNA inhibition can be assessed by 
measuring the abundance of a protein encoded by (1) a validated miRNA target, relative 
to a control gene or (2) a reporter protein that is regulated by one or more miRNA-
binding site(s) in the 3′ UTR of its mRNA. If miRNA mediated repression is blocked by 
the ASO, expression of target genes will increase compared to control genes. miRNA 
reporter or “sensor” constructs typically place one or two perfectly complementary 
miRNA sites in the 3´ UTR of reporter gene. In mammalian cells, we use a dual 
luciferase reporter system in which Photinus pyralis luciferase containing a perfectly 
paired 3´ UTR miRNA site is cotransfected with an unregulated Renilla Reniformis 
luciferase control gene (or vice versa). The relative expression of these two enzymes can 
be easily quantified by measuring luminescence activity(Hutvágner et al., 2004) (Box 4). 
In Drosophila S2 cells, we typically use stably integrated GFP sensor reporters 
and derive clonal cell lines(Förstemann et al., 2007). Changes in GFP expression are 
measured by flow cytometry (FACS). An advantage of this approach is that transfection 
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efficiency can be assessed by observing the fraction of cells that have increased GFP 
levels after ASO transfection (Fig. 4). 
After miRNA inhibition is established, any number of functional assays can be 
performed in the absence of reporters. Examples are discussed in Anticipated Results. 
Gain-of-function studies can also be conducted to complement ASO loss-of-
function studies. The finding that introduction of a miRNA into cultured cells has the 
opposite effect of ASO inhibition on an mRNA provides strong support for a regulatory 
relationship between the miRNA and the mRNA target. Importantly, it also reduces the 
likelihood that a cellular phenotype observed with an ASO is due to a non-specific effect. 
miRNAs can be introduced using a pri-miRNA expression plasmid(Zeng et al., 2002; 
Chen et al., 2004; Voorhoeve et al., 2006; Förstemann et al., 2007), an siRNA whose 
sequence corresponds to a miRNA(Doench et al., 2003; Lim et al., 2005), or a synthetic 
pre-miRNA(Wang and Wang, 2006). For instance, we used a pri-miR-277 expression 
vector to augment miR-277 levels and thus increase silencing of GFP 
reporters(Förstemann et al., 2007). Pedersen and colleagues complemented their ASO 
loss-of-function studies (see above), with a gain-of-function study in which they 
transfected a mix of 5 miRNA-like siRNAs into cultured cells and found that Hepatitis C 
virus replication was reduced, even in the absence of IFN-β induction(Pedersen et al., 
2007). 
 
MATERIALS 
REAGENTS 
· Fetal Bovine Serum, Heat Inactivated (Invitrogen, 10082-139) 
· Dharmafect 4 Transfection Reagent (Dharmacon, T-2004) 
· siLentFect (Bio-Rad, 170-3360)  
· Lipofectamine 2000 (Invitrogen, 11668-027)  
· Dulbecco’s Phosphate Buffered Saline, no Calcium or Magnesium (Invitrogen, 14190) 
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· Antisense oligonucleotides (Dharmacon, Sigma, or many other oligo synthesis vendors) 
· Trypan Blue (Invitrogen, 15250-061) 
· Sterile deionized H2O 
· Drosophila Schneider 2 (S2) cells (Invitrogen, R690-07) 
· Schneider’s Drosophila Medium (Invitrogen, 11720-034) 
· HeLa cells (ATCC, CCL-2.2) or NTera2 cells (ATCC, CRL-1973) 
· Dulbecco’s Modified Eagle Media (Invitrogen, 11965) 
· Trypsin-EDTA Solution (Invitrogen, 12605) 
· psiCheck 2 Vector (Promega, C8021) 
 
EQUIPMENT 
· Sterile 24-well Dishes (Beckton Dickinson, 35 3047) 
· Sterile 6-well Dishes (Beckton Dickinson, 35 3046) 
· Sterile 10 cm Plate (Nunc, 172958) 
· Laminar Flow Hood (class II) 
· Stereomicroscope with 50x magnification and a bright field setting 
· Hemocytometer 
· Sterilized standard 100-1000 µl, 20-200 µl, 1-20 µl, and 0.1-10 µl pipette tips 
· Micropipettors, P-1000, 200, 20, and 10 (Gilson) 
· Serological Pipets: 5 ml, 10 ml, and 20 ml 
· Pipet-aid (Becton Dickinson, 357565) 
· Sterile Plasticware: 1.5 ml Eppendorf tubes (Eppendorf, 22 36-411-1), 15 ml conical 
tubes (Beckton Dickinson, 35 2097) 
· Centrifuges for 1.5 ml and 15 ml tubes  
· Tissue Culture Incubator at 25°C (without CO2; NuAire, 8700) 
· Tissue Culture Incubator at 37°C with 5% CO2 (NuAire, 8700) 
· BD FACScan Flow Cytometer (Becton Dickinson) or equivalent 
 158
· Veritas Microplate Luminometer (Tuner Biosystems, 9100-000) or equivalent 
 
REAGENT SETUP 
Antisense Oligonucleotide Stock Solution. Dilute antisense oligo to 100 µM with sterile 
dH2O. To be certain the concentration is correct, we check the stock concentration by 
measuring its absorbance at 260 nM using a spectrophotometer. Extinction coefficients 
and molecular weights are usually provided with the oligo. 2´-O-Me oligonucleotides do 
not require deprotection. For pipetting accuracy it may also be necessary to make a 10 
µM stock, especially when transfecting a single well or very small wells with an ASO. 
ASO stock solutions can be stored short term (<1 month) at -20°C and long term at -
80°C. 
S2 + FBS Media. Combine Schneider’s media with 1/10 volume of fetal bovine serum. 
Warm to room temperature (~23°C) before use. Store at 4°C. 
S2 Media. Schneider’s Drosophila Medium (no serum) used for transfection mixes 
Warm to room temperature before use. Store at 4°C. 
DMEM + FBS  Media. Combine DMEM with 1/10 volume of fetal bovine serum. 
Warm to 37°C before use. Store media at 4°C. 
DMEM. DMEM (no serum) used for transfection should be warmed to room 
temperature. 
Trypsin-EDTA. Pre-warm Trypsin-EDTA solution to 37°C. 
PBS. Pre-warm Dulbecco’s Phosphate Buffered Saline solution to 37°C. 
 
PROCEDURE 
Design of Antisense Oligonucleotides to Disrupt miRNA Function: Timing — ~1 
hour 
1. Retrieve the sequence of the miRNA(s) of interest from miRBase 
(http://microrna.sanger.ac.uk/sequences/)(Griffiths-Jones et al., 2006).  
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2. Record the reverse complement of the miR strand sequence. 
3. Add 5 arbitrary bases to both the 5´and 3´ ends of the antisense miR sequence. 
Our inhibitors have used the sequence 5´-UCUUA—antisense miRNA—
ACCUU-3´. 
4.  Check the full length sequence for potential secondary structure using mFold: 
http://mfold.bioinfo.rpi.edu/cgi-bin/rna-form1-2.3.cgi(Zuker, 2003). We use the 
default settings. 
5. If the flanking sequences are predicted to be involved in formation of strong 
secondary structure elements (∆G> user defined cutoff value), alter the flanking 
sequence base composition and repeat step 4.  
6.  Perform a BLAST search using the full length oligonucleotide. If fortuitous 
stable base pairing to an mRNA is predicted involving the flanking sequences and 
13 or more bases within the targeting sequence, repeat step 3-6. 
7. Design a control oligo (see Experimental Design for a discussion of appropriate 
controls). Flanking sequences can be identical to those in the experimental ASO. 
All control oligos should also be checked for strong secondary structure or 
unintended complementarity to mRNAs as detailed in Steps 4–6. Strong 
secondary structure elements in any part of the sequence should be minimized by 
altering that part the sequence. 
8. Order 2´-O-Me-modified oligonucleotides (Dharmacon, Sigma, or many other 
oligo synthesis vendors). We find that 3´ conjugation of cholesterol enhances the 
potency of miRNA inhibition in Drosophila S2 cells (Fig. S2A). We order custom 
cholesterol conjugated oligonucleotides from Dharmacon using the custom RNA 
module (www.dharmacon.com/rna/rna.aspx). 
 
Cell culture, transfection and analysis of inhibition 
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9. If using Drosophila S2 cells to study miRNA function, follow option A. If using 
mammalian cells, follow option B; in our lab, this strategy has been used 
successfully to transfect both HeLa and NTera2 cells. These transfection 
protocols can be adapted for RNAi using siRNA and dsRNA by altering only a 
few steps, as outlined in Box 1. 
 
Option A: Culture and Transfection of S2 Cells: Timing – Up to 14 days 
i. Grow S2 cells in S2-FBS Media in a 25°C incubator to a density of 8–10 
x 106 cells/ml with at least 90% viability; cell number and viability 
should be checked using Trypan blue and a hemocytometer (see Box 2). 
If starting from a frozen stock, up to two weeks of growth may be 
necessary to reach >90% viability. Cells can be propagated in one well 
of a 6 well plate with 2 ml total volume per well. 
CRITICAL STEP: Having S2 cells at high density before transfection is 
important because at lower densities S2 cells form clumps that may limit 
transfection efficiency. As the cells reach high density these clumps 
disperse. 
 
ii. In a laminar flow hood, dilute cells from a density of 8–10 x 106 cells/ml 
to a density of 2.75 x 105 cells/ml with S2 + FBS media. Cells can be 
removed from the 6-well plate and diluted in a 50 ml conical tube, and 
then dispensed into the desired dishes. 
CRITICAL STEP:  Diluting the cells to this density is very important. 
Transfection of too few cells will result in cell death. Transfection of too 
many cells will cause uptake of the ASO to be inefficient (see Fig. 5). 
iii. For a 24-well plate add 450 µl of diluted cells per well (i.e., 90% of the 
500 µl final volume per well) and place the plate in the 25°C incubator. 
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For other types of plates or dishes, all the transfection mixes can be 
scaled linearly. See Table 1. 
iv. Vortex the ASO stock. In a new 1.5 ml Eppendorf tube mix 1.25 µl of a 
10 µM ASO stock solution with 23.75 µl of Schneider media per well of 
a 24 well plate. Gently mix by tapping the side of the tube. If 
transfecting multiple wells with the same ASO, make 5% extra to avoid 
running short due to pipetting errors (1.31 µl 10 µM ASO/well X 
number of wells, and 25 µl S2 Media/well X number of wells). 
CRITICAL STEP: Cholesterol-modified ASOs can pool near the walls 
of the tube. It is important to mix both the ASO stock and the S2 Media-
ASO mixture. 
v. In a new 1.5 ml Eppendorf tube, mix 1 µl Dharmafect 4 transfection 
reagent with 24 µl of S2 media per well of a 24 well plate. If transfecting 
multiple wells with the same ASO, add 5% extra to compensate for 
pipetting errors. 
vi. Combine the mixtures from step iv and v by adding the Dharmafect 4 
mixture to the tube containing the ASO. Gently mix by tapping the side 
of the tube. 
vii. Incubate transfection mixture(s) at room temperature for 20 minutes. 
viii. Remove cells from the incubator and add 50 uL of the ASO-Dharmafect 
4 transfection mix (10% total volume) to each well of the diluted cells. 
Try to distribute drops evenly over the wells and mix by gentle agitation 
after the mix is added. 
CRITICAL STEP: Move the plate back and forth in straight lines rather 
than circles to evenly distribute cells and transfection mix. Circular 
motions cause cells to pool in the middle, which may reduce transfection 
efficiency. 
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ix. Allow cells to grow for 1–8 days depending on experimental design. For 
example, if validating the effectiveness of miRNA inhibition with a dual 
luciferase miRNA sensor system (Box 4), transfect sensor/control 
reporters at 48 h with siLentfect (Bio-Rad); perform dual luciferase 
assay at 72 h. Alternatively, if checking miRNA inhibition with a stable 
GFP cell line, FACS can be performed at 72 h. Because S2 cells are 
semi-adherent, GFP reporter cells can be transferred to test tubes and 
assayed directly in the FACS machine according to the manufacturer’s 
instructions. Because Dharmafect 4 is not very toxic to S2 cells, media 
does not need to be changed until cells reach a density of 1 x 107 
cells/ml. The effects of miRNA inhibition on the expression of regulated 
mRNAs and proteins can be seen as early as 24 h and persist beyond 8 
days (Fig. S2C). 
 
Option B: Culture and Transfection of HeLa or NTera2 (NT2) Cells: Timing — 72 h 
i. Grow cells to confluence in 10 ml DMEM + FBS in a 10 cm dish in a 
37°C incubator with 5% CO2. 
ii. 24 h before transfection, treat cells with Trypsin-EDTA and split cells 
(Box 3) into a 6-well plate so that they will be 30–40% confluent at the 
time of transfection (~2 x 105 cells/well in 2 ml DMEM + FBS in one 
well of a 6-well plate). For other types of plates or dishes, cell and 
transfection mixes can be scaled linearly. See Table 2 for volumes. 
iii. Check that cells are ~30-40% confluent. 
CRITICAL STEP: Transfection of too few cells can be toxic. 
Transfection of too many cells is inefficient. Be sure your cells are at the 
correct density before transfection. 
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iv. Remove media and replace with 1.8 ml of fresh pre-warmed DMEM + 
FBS. 
v. Vortex 10 µM ASO stock solution. For each well of a 6-well plate, to be 
transfected, add 5 µl of a 10 µM ASO stock solution to 95 µl of DMEM 
in a sterile 1.5 ml Eppendorf tube. Gently mix by tapping the side of the 
tube. If transfecting multiple wells with the same ASO, add 5% extra to 
compensate for pipetting errors. 
vi. For each well of a 6-well plate, add 4 µl Dharmafect 4 to 96 µl of 
DMEM in a sterile 1.5 ml Eppendorf tube. If transfecting multiple wells 
with the same ASO, add 5% extra to compensate for pipetting errors. 
Gently mix by tapping the side of the tube.  
vii.  Combine mixtures from step v and vi by adding the Dharmafect 4 
mixture to the tube containing the ASO. Gently mix by tapping the side 
of the tube. 
viii. Incubate the transfection mixture(s) at room temperature for 20 min. 
ix. Remove the cells from incubator and add 200 µl of the ASO/Dharmafect 
4 mix to each well of the 6-well plate. Try to distribute drops evenly 
over the dish or plate and mix by gently agitating after the mix is added. 
CRITICAL STEP: Move the plate back and forth in straight lines rather 
than circles to evenly distribute cells and transfection mix. 
x. Allow cells to grow for 24–48 h depending on experimental design; for 
example, if validating the effectiveness of miRNA inhibition with a dual 
luciferase miRNA sensor (Box 4), transfect the sensor/control reporters 
at 24 h with Lipofectamine 2000 (Invitrogen) according to the 
manufacturer. Perform the dual luciferase assay at 48 h. With 
Dharmafect 4, the media does not need to be changed until cells reach 
confluence (~48 h). Effects of miRNA inhibition on target mRNA and 
 164
protein levels can be seen as early as 24 h post-transfection and are still 
present after 48 h. We have not defined the persistence of the miRNA 
inhibition in mammalian cells. 
 
TIMING 
ASO Transfection of Drosophila S2 Cells 
Step 1: 1–14 days 
Steps 2–8:  approximately 1 hour 
Step 9: 1–8 days 
 
Box 1: Design of Antisense Oligonucleotides 
Steps 1-7: approximately 1 h 
 
Box 2: ASO Transfection of Mammalian cells 
Step 1: 1–4 days 
Steps 2:  approximately 30 min, then wait 24 h 
Step 3-8:  approximately 1 h  
Step 9: 1–3 days 
 
Box 3: siRNA or dsRNA Transfection of Drosophila S2 Cells or siRNA Transfection 
of Mammalian cells 
Same as ASO Transfections above. 
 
TROUBLESHOOTING 
Troubleshooting advice can be found in Table 3. 
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ANTICIPATED RESULTS. 
Reporter Assays: 
In a typical experiment, a reporter mRNA is used to detect the activity of a 
specific endogenous miRNA and an ASO is used to inhibit that miRNA. In our 
experience, inhibiting a miRNA with an ASO typically produces a 3-5 fold increase in 
reporter protein expression when the reporter mRNA contains perfect target sites that can 
be cleaved by RISC (Fig. 4). miR-277, a miRNA that is expressed in Drosophila S2 cells, 
does not regulate a GFP reporter lacking target sites. Control and miR-277 ASOs did not 
change the levels of the non-targeted reporter, ruling out any non-specific effects of the 
ASOs on the reporter. When two miR-277-binding sites were placed in the 3´ UTR of the 
reporter mRNA, the miR-277-complementary ASO inhibited miR-277 regulation, 
increasing expression of the GFP reporter 4–5-fold ; the control ASO had no effect. miR-
277 directs repression of a reporter with two, fully complementary sites (4–5 fold 
increase) to a greater extent than of a reporter bearing four, imperfectly paired miR-277-
binding sites (~30% increase). For this reason, we recommend perfectly matched 
reporters for testing ASOs. miR-277 inhibition by our ASOs was nearly complete, 
because the degree of derepression was similar to that observed when Ago2 and Ago1, 
the core RISC proteins that guide miRNA silencing, were depleted by dsRNA-triggered 
RNAi (Förstemann et al., 2007). 
Using our optimized protocol we see a uniform shift in the FACS curve when 
miR-277 is inhibited indicating that transfection was very efficient (>90%) (Fig. 4 and 5). 
If transfection is incomplete, two peaks will be observed: one corresponding to cells that 
received the ASO and the other from those that did not. This is seen if cells are 
transfected at too high a density (Fig. 5). Unlike stable GFP cell lines in which 
fluorescence is measured in every cell, it is more difficult to assess transfection efficiency 
using the luciferase assay, in which an average from all cells is obtained. In the sequential 
transfection procedure detailed in Box 4, if ASO treatment derepresses the Renilla 
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Figure AI-4. A Sensitive Reporter System For miR-277 Silencing. Clonal Drosophila 
S2 cell lines bearing stably integrated GFP transgenes containing no sites, two perfect or 
four bulged miR-277-complementary sites in the 3´ UTR were transfected with control or 
miR-277-complementary ASOs (33 nt 2´-O-Me bearing a 3´ cholesterol modification). 
Five days after transfection, GFP was measured by FACS. 
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Figure AI-5. Efficient Transfection Requires Optimal Cell Density. S2 cells were 
transfected at 20 nM with 33 nt 2´-O-Me 3´-cholesterol modified miR-277 ASO, using 
Dharmafect 4 at the indicated cell density. 
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luciferase reporter to a level near that of the non-targeted reporter, ASO transfection must 
have been efficient (i.e., miRNA was inhibited by ASO in all cells that received the 
reporter). However, if miRNA repression cannot be inhibited by an ASO, low 
transfection efficiency may be an explanation. Low potency may also be an explanation. 
This can be tested by co-transfecting the ASO with the reporter instead of sequential 
transfection; all transfected cells should receive both the reporter and the ASO. If 
incomplete derepression is still seen, potency may be the problem rather than transfection 
efficiency. A dose response curve can be performed to ensure that maximal derepression 
is being achieved (sample dose response curve, Fig. S2A). 
Endogenous Target Validation 
Having established that an ASO disrupts the function of an endogenous miRNA, 
it is now possible to study the cellular consequences of miRNA loss of function. One 
common application of ASOs is miRNA target validation—testing if computationally 
predicted target mRNAs(Rajewsky, 2006) are, in fact, regulated by a given miRNA in 
cultured cells. For instance, the Bartel and Dutta groups studied the oncogene HMGA2, 
which contains seven predicted target sites for the miRNA let-7(Lee and Dutta, 2007; 
Mayr et al., 2007). HMGA2 protein and mRNA increase 4–6 fold in HeLa cells treated 
with a let-7 ASO, but not a control. Conversely, transfected let-7 siRNAs cause a ~3 fold 
reduction in HMGA2 protein. With so many sites, HMGA2 probably represents an 
extreme case for regulation by a single miRNA (Lee and coworkers note that the 
HMGA2 mRNA changed more than any other mRNA following Dicer or Drosha 
depletion by RNAi). 
Regulation of targets by miRNAs can be quite modest, depending on miRNA and 
target abundance; two-fold regulation or less is not uncommon. While mRNA abundance 
is often affected by miRNA regulation, some targets appear to be regulated solely by 
translational repression(Aleman et al., 2007; Naguibneva et al., 2006; Zhao et al., 2005). 
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Thus the absence of a change in mRNA abundance of a putative target is not always 
meaningful, especially if regulation at the mRNA level has not been previously 
demonstrated. When possible, measurements of the protein regulated is preferred, as 
changes in mRNA stability or translation should both affect protein levels. When direct 
measurement of target protein levels is not feasible, protein level regulation by a miRNA 
can be assessed using luciferase (Box 4) or GFP reporter assays in which the putative 
target 3′ UTR is cloned into the reporter mRNA. In this case, ASO treatment is predicted 
to increase reporter levels; conversely, increasing miRNA levels should reduce reporter 
levels. 
When specific target seed sequences are suspected, analysis of 3′ UTRs with 
mutant seeds can reveal the importance of a specific site for regulation. Such mutational 
analysis is especially convincing, as it shows miRNA:target complementarity is required 
for regulation in the context of a potentially quite large 3′UTR. However, the approach 
assumes that 1) the reporter target expression level is physiologically relevant, and 2) the 
target and the miRNA are in fact expressed in the same cells. Whenever possible it is 
preferable to examine endogenous target mRNA and/or protein levels. Reporter assays 
are best used to augment analysis and allow more focused studies of 3′ UTR sequence 
motifs. 
Proving that a miRNA regulates a given target may implicate it in a particular 
biological pathway, giving a hint at its function. However, with each miRNA having 
hundreds of putative targets, proving a biological function for any one interaction may be 
difficult – individual miRNAs’ critical function may be modest regulation of hundreds of 
genes, or more substantial regulation of just a few.  
Cellular Assays 
Functional analysis of loss of miRNA function in cultured cells can be performed 
using any number of cellular assays. Because a growing body of evidence implicates 
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miRNAs in cancer development, maintenance, and metastasis, several studies have now 
employed standard assays for proliferation, apoptosis, and metastasis. Using MTT assays 
and propidium iodide staining coupled with FACS analysis, Matsubara and colleagues 
found that blocking miR-20a and miR-17-5p with ASOs reduced cell viability and 
increased the proportion of sub G1 cells. They also used a TUNEL assay to show 
increased apoptosis when these same miRNAs are inhibited with ASOs(Matsubara et al., 
2007). Similarly, Bommer and colleagues used propidium iodide staining and FACS to 
show that miR-34 inhibition results in increased viability of colon cancer cells. In 
parallel, these authors demonstrated that ES cells genetically deleted of all three miR-34 
isoforms had essentially the same phenotype as pooled ASO inhibition of miR-34: 
increased cell viability and increased concentration of anti-apoptotic Bcl2 
protein(Bommer et al., 2007). 
Ma and colleagues found that miR-10b expression enhances metastasis; invasive 
breast cancer cells failed to migrate as far when treated with miR-10b ASO(Ma et al., 
2007). ASOs have also been used in xenograft cancer models to demonstrate that some 
miRNAs affect metastatic potential and in vivo growth of tumors. While Tavazoie and 
colleagues found that miR-335 limits breast cancer metastasis (ASO inhibition increases 
metastasis of xenografted cell lines)(Tavazoie et al., 2008), Corsten and colleagues saw 
that transplanted gliomas treated with miR-21-specific ASO were sensitized to a 
chemotherapeutic agent(Corsten et al., 2007). 
Several studies use ASOs in conjunction with in vitro differentiation systems to 
show the importance of individual miRNAs in cellular differentiation. Esau and 
colleagues showed that miR-143 expression increases during cultured  adipocyte 
differentiation and that this differentiation is inhibited by a miR-143 ASO(Esau et al., 
2004). Similarly, Naguibneva and colleagues showed that miR-181 expression is induced 
upon myoblast terminal differentiation and that an ASO prevents this differentiation by 
blocking repression of the miR-181 target mRNA, Hox-A11(Naguibneva et al., 2006). 
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Finally, multiple studies using ASOs suggest roles for endogenous miRNAs in 
viral defense or replication. Lecellier and colleagues found that ASO inhibition of miR-
32, a miRNA with potential target sites in primate foamy cell virus genes, permits 
enhanced production of viral RNA in human tissue culture cells(Lecellier et al., 2005). 
Similarly, inhibition of IFN-β induced miRNAs permits Hepatitis C viral 
production(Pedersen et al., 2007). However, ASO inhibition of liver specific miR-122 in 
cultured hepatocytes cripples Hepatitis C replication, suggesting its requirement in the 
Hepatitis C viral life cycle(Jopling et al., 2005; Pedersen et al., 2007). These ASO studies 
suggest that combinatorial expression of pro- or anti-viral miRNAs may affect tissue 
tropism of some viruses.    
In sum, miRNA function can be efficiently disrupted in cultured mammalian and 
Drosophila S2 cells. The approaches detailed here should be readily adaptable to study 
miRNA function in any cell line. 
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BOX 1: Transfection of siRNA and dsRNA for RNAi 
The same protocol can be adapted for RNAi using siRNA and dsRNA with just a few 
alterations, as detailed below. In our experience, transfection of dsRNA into 
Drosophila S2 cells is far more effective than soaking(Clemens et al., 2000) and 
dsRNA transfection is more effective than siRNA transfection in S2 cells (MDH 
unpublished).  
 
For Drosophila S2 cells: 
Step 8A(iv): Instead of ASO, use 10 pmol siRNA or 1 µg dsRNA per well of a 24 well 
plate (scaled linearly for other volumes).  
Step 8A(ix): Allow S2 cells to grow for 5 days, and then check protein or mRNA 
abundance. In our experience the best knock-down is achieved if a second transfection 
is performed at day 5. The cells are analyzed on day 10.  
 
For mammalian cells: 
Step 8B(v): Instead of ASO, use 10 pmol siRNA per well of a 24 well plate (scaled 
linearly for other volumes). 
Step 8B(x): For mammalian cells, reduction of protein from the gene targeted by the 
siRNA can usually be achieved after 3–4 days. A second transfection can be performed 
if knockdown is insufficient, e.g. if the protein half-life is long. 
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BOX 2: Analysis of cell number and viability 
i. To dislodge S2 cells, pipette media across the bottom of the well or plate several 
times. S2 cells are semi-adherent and form loose clumps at low density. As the cells 
approach the correct density they become less adherent and the clumps disperse. 
ii. Remove 50 µl of freshly dislodged cells and mix with 50 µl Trypan blue solution in 
a 1.5 ml Eppendorf tube. Wait 3 min. 
iii. Add ~20 µl of the cell suspension to the hemocytometer slide. 
iv. Count the number of live cells (clear) and dead cells (blue) contained in the largest 
box in the field. Count two other complete fields and calculate the average. 
v. Multiply by 2 x 104 to determine cells/ml. If the cell number is too great to count 
(>200 cells in the field), dilute the cells 1:5 in PBS, then proceed from step ii, and 
multiply by 1x105 to determine cells/ml. 
vi. When propagating S2 cultures, cells can be diluted to ~2.5 x 105 cells/ml and split 
each time they reach 8–10 x 106 cells/ml. Growth between these densities typically 
takes ~5 days. 
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BOX 3: Splitting Adherent Mammalian Cells 
i. To split cells using Trypsin-EDTA, pre-warm Trypsin-EDTA solution, PBS, and 
DMEM-FBS media to 37°C (45min). 
ii. Remove media and rinse cells twice with 10 ml pre-warmed PBS. 
iii. Add 1 ml Trypsin-EDTA solution evenly cover the cells and place cells in the 37°C 
, 5% CO2  incubator for ~5 min. 
iv. Briefly check to see that cells have been liberated from the dish and each other 
using a 50x bright field microscope. If not, place cells back in the 37°C, 5% CO2 
incubator for several additional minutes and re-check them. 
v. Add 9 ml pre-warmed DMEM-FBS to cells to inactivate the Trypsin. 
vi. Count cells using a hemocytometer and dilute to a density of 1 x 105 cells/ml with 
pre-warmed DMEM-FBS in a 15 ml conical. 
vii. Add 2 ml of cells for each well of a 6-well plate. 
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BOX 4: Assessing miRNA Inhibition with the Dual Luciferase Assay 
The dual luciferase system offers a relatively simple approach to assess miRNA 
inhibition. The psiCheck2 vector system from Promega is a commercially available 
vector which encodes both Photinus pyralis and Renilla Reniformis luciferase genes on 
a single plasmid with a multiple cloning site in the 3′ UTR of Renilla luciferase for 
insertion of synthetic oligonucleotides encoding the miRNA target sites (or other 
cloned regulatory sequences, such as target 3′UTRs). We have not tested this system in 
S2 cells, but it has been previously reported(Okamura et al., 2007). Here we briefly list 
the steps necessary to adapt this reporter system for miRNA sensing and assessment of 
miRNA inhibition in cultured cells.   Additional information is available from the 
manufacturer (Dual luciferase Assay Manual: www.promega.com/tbs/tm040/tm040.pdf 
): 
i. Design a miRNA Target Site Insert. Design a set of two oligonucleotides 
corresponding to two tandem copies of the miRNA of interest and its reverse 
complement. Add appropriate overhanging bases corresponding to the restriction 
enzyme(s) used to digest the psiCheck vector such that the mature miRNA’s reverse 
complement is in the 5′ to 3′ orientation (See manufacturer’s information for restriction 
map; www.promega.com/tbs/tb329/tb329.pdf). XhoI and NotI sites are convenient for 
directional cloning of inserts. For instance: 
 
                                miR-277 
              3′acagcauggucuaucacguaaau5′            
5′ggccgc tgtcgtaccagatagtgcattta  tgtcgtaccagatagtgcattta c  3′    
  3′  cg acagcatggtctatcacgtaaat  acagcatggtctatcacgtaaat gagct 5′ 
      NotI                     miR-277 site                                         miR-277 site                       
XhoI 
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ii. Clone the miRNA Site Insert Into psiCheck 2 Vector. Digest psiCheck 2 
vector, ligate miRNA site insert, transform into E. coli, and sequence the insert using a 
custom sequencing primer to confirm correct orientation of insert (Vector sequence is 
available in GenBank, accession number AY535007).  
iii. Transfect Mammalian or S2 Cells with ASO.   Prepare mammalian or S2 cells 
for 6 triplicate transfections (18 wells in a 24 well plate). Transfect 6 wells of cells with 
miRNA directed ASO and 6 wells with control ASO as described in procedure option 
A (S2 cells) or option B (mammalian cells). The remaining 6 wells will be used as a no 
transfection control. 
iv. Transfect Mammalian or S2 Cells with psiCheck 2 Vector. 24 hours later 
(mammalian cells) or 48 hour later (S2 cells) perform a second transfection with 
psiCheck2 (control) or psiCheck2+miR (miRNA sensor). Each vector should be 
transfected into 3 wells of miRNA ASO treated cells, 3 wells of control ASO treated 
cells, and 3 wells of untreated cells.  Lipofectamine 2000 (Invitrogen) can be used for 
mammalian cell transfection according to the manufacturers instructions (Promega 
recommends using 0.1 μg vector/ well of a 24 well plate). siLentFect can be used for 
transfection of psiCheck2 and psiCheck2+miR vectors into S2 cells as described above, 
with the following alterations:  step iv - DNA mix: 0.1 μg vector + Schneider media to 
25 μl final volume , step v - Lipid Mix: 2 μl siLentFect + 23 μl Schneider media. 
v. Perform Luciferase Assay. 24 hours (mammalian cells) or 48 hours (S2 cells) 
after transfection of psiCheck vectors, cells can be assayed for luciferase activity. 
Briefly, cells are washed with PBS, lysed in passive lysis buffer, luciferin reagents are 
added, and samples are read in a luminometer. Note: Adherent cells can be grown, 
washed, and lysed in the same plate. S2 cells must be pelleted in Eppendorf tubes (1000 
x g for 2 min) each time the media is changed. Details for the dual luciferase assay 
reagents and protocol are provided by Promega (see above). 
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 vi. Assessing miRNA Inhibition. The relative levels of Renilla luciferase should 
reveal first, whether the vector was regulated by the endogenous miRNA, and second, 
whether the ASO blocked this regulation. In control ASO treated cells, the endogenous 
miRNA should only regulate psiCheck2+miR, giving it lower Renilla luciferase levels 
than psiCheck2. However, when the miRNA is inhibited in miRNA ASO treated cells, 
Renilla luciferase levels should be similar in all samples. If they are not, miRNA 
silencing was not fully blocked. Potential problems are described below (see 
Troubleshooting). 
  
Supplementary Material 
Optimization and Comparison of 3′ Cholesterol-Modified ASOs 
To obtain the maximum possible transfection efficiency, we tested a panel of 
transfection reagents to find those that were most effective in S2 cells for either 3´-
cholesterol-conjugated or unconjugated ASOs. The two perfect-site reporter cell line was 
transfected with miR-277 or control ASOs, and then FACS analysis was performed three 
days later. For all seven reagents tested, the 3´ cholesterol-conjugated ASO derepressed 
the reporter more than the ASO without cholesterol (Fig. S1). Dharmafect 4 performed 
best. Addition of 1 µM or 5 µM cholesterol-conjugated ASO without a transfection 
reagent also inhibited miR-277 silencing. Although soaking may be useful in cell lines 
that cannot be easily transfected, the 80-fold higher concentration required makes soaking 
less cost effective. 
 Cell density is critical to the efficient transfection of S2 cells. Because 
Dharmafect 4 worked well in our survey of transfection reagents, we performed a cell 
density titration with the two perfect site reporter cell line, using the 3´-cholesterol-
conjugated ASO and Dharmafect 4 (Fig. 5). The fraction of transfected cells increased at 
lower cell density. Optimal transfection was achieved at 2.5 x 105 cells/ml. 
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Figure AI-S1. Optimization of ASO Transfection. S2 cells expressing a GFP reporter 
bearing two perfect miR-277-complementary sites were transfected with 20 nM 33 nt 2´-
O-Me miR-277-specific ASO or a control ASO. Both 3´-Chl and unmodified ASOs were 
tested for several different transfection reagents. Cells were transfected at 1 x 106 
cells/ml. GFP fluorescence was measured by FACS. For each transfection reagent, the 
mean GFP fluorescence of three separate transfections was normalized to the unmodified 
control ASO transfection. Error bars represent standard deviation of three transfections. 
Soaking experiments were done in single wells; ASOs were mixed as for transfections, 
but the transfection reagents were omitted. 
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Figure AI-S2. Enhanced miRNA Inhibition with 3´-Cholesterol Modified ASO. (A) 
Dose response of 3´-cholesterol modified and unmodified ASO. S2 cells expressing a 
GFP reporter bearing two perfect miR-277-complementary sites were transfected with an 
increasing concentration of the indicated ASO, and GFP was measured by FACS for 
three replicate wells. Percent repression was calculated by dividing the mean GFP levels 
for miR-277 ASOs at the indicated concentration by the GFP level in a control 
transfection. Error bars represent standard deviation of three separate transfections. IC50 
values were estimated by fitting to a sigmoidal curve (Hill coefficient = 1). (B) Indicated 
combinations of free cholesterol, 3´-cholesterol conjugated and unconjugated miR-277 
and control ASOs were mixed and transfected into S2 cells. After four days GFP 
fluorescence was measured by FACS. Percent repression was calculated by dividing the 
mean GFP levels for miR-277-specific ASO transfection by the GFP levels from a 
control transfection. IC50 values were estimated by fitting to a sigmoidal curve (Hill 
coefficient = 1). (C) Percent repression was calculated as described above. miR-277 
reporter cells were transfected with 10 nM ASOs. The structure of the miR-277 
“antagomir” is shown in Fig. 2,(Krutzfeldt et al., 2007). 
 
 
 
 
 
 
 
 
 
 
 
 180
Figure AI-S2 
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Next, we determined the optimal concentration of ASO for cholesterol-conjugated 
and unconjugated miR-277 ASO (Fig. S2A). Cholesterol-conjugated ASO maximally 
derepressed the reporter at 2.5 nM, while the ASO without cholesterol required 25 nM 
ASO for the same extent of derepression. 
How does cholesterol conjugation improve ASO-mediated inhibition of miRNAs? 
We can imagine that conjugation with cholesterol might enhance incorporation of the 
ASO into liposomes, improve liposome fusion with cells, or potentiate an intracellular 
step in ASO function, such as delivery of the ASO to the correct intracellular 
compartment. To assess how cholesterol enhances ASO function, we compared 
transfection of the cholesterol-conjugated ASO to transfection of an equal amount of a 
mixture of cholesterol-conjugated and unconjugated ASO and to unconjugated ASOs 
supplemented with free cholesterol. For each, we determined the IC50. We maintained a 
constant concentration of cholesterol conjugated and unconjugated ASO (10 nM each), 
but varied which oligo, miR-277 or control ASO, carried the cholesterol modification. To 
keep total modified and unmodified ASO constant in the ASO dilution series, miR-277 
ASO was mixed with control ASO with the same chemistry.  
We found that the IC50 for a mixture of 3´-chl miR-277 ASO with unmodified 
control mixture was ~5 fold lower than that of an unmodified miR-277 ASO mixed with 
a 3´-cholesterol-conjugated control ASO. These data demonstrate that the enhancement 
by cholesterol is greatest when it is linked to the miRNA-complementary ASO, 
suggesting that the cholesterol does not primarily improve ASO function by altering a 
property of the liposome. Supporting this view, free cholesterol only modestly enhanced 
the potency of an unmodified ASO, although the addition of a cholesterol-conjugated 
control ASO enhanced the potency of an unconjugated miRNA-specific ASO (Fig. S2B). 
We cannot currently distinguish between an effect of the 3´-cholesterol on the assembly 
of the ASO into the liposome and improved intracellular ASO function. Regardless of the 
mechanism, 3′-cholesterol-conjugated miR-277 ASO was ~8-fold more potent than 
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unconjugated ASO (Fig. S2A). This enhanced potency may allow inhibition of multiple 
miRNAs simultaneously by permitting concurrent transfection of many 3´-cholesterol-
conjugated ASOs. 
We also tested if cholesterol enhanced the duration of miR-277 inhibition (Fig. 
S2C). After reaching similar maximal inhibitions at 48 hrs, ~60% of the maximal miRNA 
inhibition persisted 8 days after transfection of the 3´-cholesterol-conjugated ASO, 
whereas <30% of the maximal inhibition remained for unmodified ASO. A miR-277 
“antagomir” performed similarly to the 3´-cholesterol-conjugated 31-mer, suggesting that 
it was the cholesterol moiety, not the phosphorothioate modifications that enhanced the 
persistence of inhibition. 
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Table AI-1. Cell, ASO, and Lipid Volumes for Transfection of Cultured Drosophila Cells 
 
 
 
 
 
Table AI-2. Cell, ASO, and Lipid Volumes for Transfection of Cultured 
Mammalian Cells 
ASO mix Lipid mix 
 
Volume fresh 
DMEM+10% 
FBS ASO (10 µM) DMEM Dharmafect 4 DMEM 
24 well plate 450 µl / well 1.25 µl 23.75 µl 1 µl 24 µl 
6 well plate 1.8 ml / well 5 µl 95 µl 4 µl 94 µl 
10 cm Dish 9 ml / dish 25 µl 475 µl 20 µl 480 µl 
 
ASO mix Lipid mix 
 Volume of cells (2.75 x 105 / ml) ASO (10 
µM) 
Schneider 
media Dharmafect 4 
Schneider 
media 
24 well plate 450 µl / well 1.25 µl 23.75 µl 1 µl 24 µl 
6 well plate 1.8 ml / well 5 µl 95 µl 4 µl 94 µl 
10 cm Dish 9 ml / dish 25 µl 475 µl 20 µl 480 µl 
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Table AI-3. TROUBLESHOOTING: 
PROBLEM POSSIBLE REASONS SOLUTION 
ASO does not 
derepress reporter. 
ASO forms strong secondary 
structure. 
 
 
ASO transfection was not 
efficient. 
 
 
 
 
 
 
 
Endogenous miRNA is not 
abundant enough to repress the 
reporter. 
 
 
 
 
 
 
 
Incorrect reporter target site. 
 
 
 
Cholesterol modified ASO was 
not mixed. 
 
Redesign flanking 
sequences. 
 
 
Co-transfect plasmid and 
ASO. If derepression is now 
observed, ASO transfection 
was inefficient. Repeat ASO 
transfection or optimize 
transfection. 
 
 
Check miRNA level by 
northern blot. Try co-
transfection with a frayed 
siRNA corresponding to the 
miRNA strand(Schwarz et 
al., 2003) to be sure it is not 
a problem with the reporter. 
A pri-miRNA expression 
vector could also be used. 
 
If the reporter cannot be 
repressed, check the miRNA 
target site in reporter 
sequence. 
 
Vortex ASO stock before use 
and mix ASO-S2 cell mix by 
tapping the tube. 
Cells die after ASO 
transfection. 
Too much transfection reagent 
or ASO used. 
 
 
 
 
 
 
 
Cell density was too low. 
 
 
Possible if cell death is seen 
in miRNA-specific ASO and 
control ASO transfected 
samples. Repeat with correct 
amount of transfection 
reagent or ASO or replace 
media after 12–24 h. 
 
Repeat with correct cell 
density. 
 
Possible if miRNA ASO kills 
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miRNA inhibited is required 
for cell survival. 
 
cells, but control ASO does 
not. Determine mechanism 
of cell death. Perhaps the 
miRNA is anti-apoptotic. 
Gain of function studies may 
also be informative (e.g. does 
overexpression protect cells 
from apoptosis?). 
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Feedback Control by the Human microRNA, let-7, Regulates Expression of 
the microRNA Processing Enzyme, Dicer 
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Summary 
 microRNAs (miRNAs) are small, ~21 nucleotide long RNAs that repress gene 
expression via the RNA silencing pathway. let-7 was the first human miRNA identified, 
but few of its regulatory target genes are known. Using microarray analysis of human cell 
lines in which let-7 miRNA function was either blocked or ectopically introduced, we 
identified Dicer, the ribonuclease that generates miRNAs, and HMGA2, an architectural 
transcription factor implicated in oncogenesis, as let-7 regulatory targets. The mRNAs of 
both genes contain multiple predicted let-7-responsive elements. Although none of the 
target sites have sufficient complementarity to support let-7-directed endonucleolytic 
cleavage, let-7 nonetheless represses the steady-state levels of both the mRNA and 
proteins encoded by these two target genes. Our human cultured cell data and 
experiments in vivo in adult mice indicate that feedback regulation by let-7 controls 
expression of Dicer, suggesting that let-7 is a global regulator of the small RNA 
biogenesis pathway. 
 
Introduction 
miRNAs are an abundant class of 21-22 nucleotide long RNAs. They constitute 
more than 1% of human genes and are thought to repress gene expression of target genes 
to which they are complementary (Bartel, 2004); one-third of all human protein coding 
genes have been proposed to be evolutionarily conserved regulatory targets of miRNAs 
(Bartel, 2004; Krek et al., 2005; Lewis et al., 2005). When miRNAs pair extensively with 
their mRNA targets, they direct target RNA cleavage at the phosphodiester bond across 
from miRNA nucleotides ten and eleven (Hutvágner and Zamore, 2002), much as small 
interfering RNAs (siRNAs) do in the RNA interference (RNAi) pathway (Elbashir et al., 
2001b). At least six animal miRNAs and most if not all plant miRNAs guide the cleavage 
of their targets in vivo (Davis et al., 2005; Llave et al., 2002; Reinhart et al., 2002; 
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Rhoades et al., 2002; Tang et al., 2003; Yekta et al., 2004). However, most animal 
miRNAs pair only imperfectly to sites within their mRNA targets.  Consequently, they 
repress the expression of their target genes without directing mRNA endonucleolytic 
cleavage (Doench et al., 2003; Doench and Sharp, 2004; Olsen and Ambros, 1999; Pillai 
et al., 2005). Originally, such translational regulation was thought to occur without 
altering target mRNA stability, but recent evidence suggests that miRNAs can destabilize 
the mRNAs to which they bind, even when they cannot direct mRNA cleavage (Bagga et 
al., 2005; Jing et al., 2005; Lim et al., 2005; Wu et al., 2006; Giraldez et al., 2006; Wu et 
al., 2006). 
First discovered in C. elegans (Reinhart et al., 2000), the let-7 miRNA family is 
conserved throughout bilaterally symmetric animals and was the first identified in 
humans (Pasquinelli et al., 2000). let-7 regulates developmental timing in C. elegans 
(Reinhart et al., 2000), its expression is dramatically increased at metamorphosis in flies 
(Bashirullah et al., 2003; Hutvágner and Zamore, 2002; Sempere et al., 2002), and has 
been proposed to repress expression of Ras proto-oncogenes in human cells (Johnson et 
al., 2005). Here, we report that Dicer, the ribonuclease that generates miRNAs, and 
HMGA2, an architectural transcription factor implicated in oncogenesis, are regulated in 
vertebrates by let-7. The mRNAs of both genes contain multiple, evolutionarily 
conserved let-7-responsive elements. Although none of the target sites has sufficient 
complementarity to support let-7-directed endonucleolytic cleavage, let-7 nonetheless 
represses the steady-state levels of both the mRNAs and proteins encoded by these two 
target genes. In adult mice, inhibition of let-7 function increases the steady-state 
concentration of Dicer mRNA. Our data indicate that let-7 controls expression of Dicer in 
vivo, suggesting that optimal Dicer mRNA levels are maintained by miRNA-directed 
negative feedback regulation. In plants, miR-162 directs a similar negative feedback loop 
to regulate expression of DICER-LIKE1, the plant Dicer protein that produces miRNAs 
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(Xie et al., 2003). Because the miRNA pathways in plants and animals evolved 
separately—no miRNA species are shared by the two kingdoms—negative feedback 
control of Dicer expression by miRNAs in plants and animals appears to have evolved at 
least twice, an example of the convergent evolution of a common strategy for regulating a 
key enzyme in the production of miRNAs. 
Results 
Identifying let-7-Regulated mRNAs by Expression Profiling 
We sought to identify experimentally human genes regulated by let-7. First, we 
compared the steady-state mRNA profile of cultured human HeLa cells, which express 
about 13,000 molecules of let-7 per cell (GH and PDZ unpublished), with that of HeLa 
cells in which let-7 function was experimentally inhibited. Then, we compared the 
mRNA profile of human embryonic carcinoma NT2 cells, which do not detectably 
express let-7 (Figure 1) and which do not repress expression of a let-7-responsive 
reporter plasmid (Figure S1A), with that of NT2 cells into which let-7a was introduced. 
For those genes expressed in both cell lines, we anticipated that expression of authentic 
let-7 target genes would be increased by blocking let-7 function in HeLa cells and 
decreased by introducing let-7a into NT2 cells. 
2´-O-methyl antisense oligonucleotides containing a central region 
complementary to the sequence of a miRNA are potent inhibitors of miRNA function in 
vitro and in vivo (Hutvágner et al., 2004; Meister et al., 2004a). To block let-7 function, 
we used a 31-nucleotide long, 2´-O-methyl oligonucleotide that had been shown 
previously to inhibit let-7 function in HeLa cell cytoplasmic extracts and in C. elegans 
larvae (Hutvágner et al., 2004). The let-7-specific 2´-O-methyl oligonucleotide 
effectively inhibited let-7-mediated repression of a reporter gene containing a single let-
7-responsive sequence element (LRE) (Kiriakidou et al., 2004), but had no effect on 
expression of a reporter bearing a non-functional, mutant LRE (Figure S1B). 
 190
 
Figure AII-1 
 
 
 
 
 
 
 
 
 
Figure AII-1. let-7 expression was determined by Northern analysis for human HeLa 
cervical carcinoma, NT2 embryonic carcinoma, retinoic acid-treated NT2N cells, and 
mouse NIH3T3 fibroblasts. tRNAile was used as a loading control. The let-7 probe 
was designed to detect let-7a, but cannot distinguish among the most closely related 
let-7 paralogs. 
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We used the let-7-specific 2´-O-methyl oligonucleotide to inhibit let-7 function in 
human HeLa cells and profiled mRNA expression levels by microarray analysis. A 2´-O-
methyl oligonucleotide with no complementarity to any known human miRNA or gene 
served as a control. mRNA expression was detected for 6,294 unique human genes, out 
of a possible 13,110 genes detectable by the array. Microarray analysis was performed on 
three independently prepared samples for both the experiment and the control. In parallel, 
we introduced into NT2 cells an siRNA in which the guide strand corresponded to let-7a 
or, as a control, an siRNA targeting the luciferase mRNA. The let-7a siRNA, but not the 
control siRNA, repressed expression of a let-7-responsive reporter in NT2 cells (Figure 
S1C). The transcriptional profiles of the cells treated with the let-7a siRNA and the cells 
treated with the control siRNA were determined by microarray analysis for three 
independent experiments. For NT2 cells, mRNA expression was detected for 6,458 
unique human genes. Eighty-six percent of the mRNAs whose expression was detected in 
NT2 cells were also expressed in HeLa cells. Of the 5,537 genes whose expression was 
detected in both HeLa and NT2 cells, we detected only two genes, Dicer and HMGA2, 
whose mRNA level was significantly increased when let-7 function was inhibited in 
HeLa cells (Dicer, 2.6-fold, p < 0.05, and HMGA2, 3.4-fold, p < 1.6 x 10-7) and whose 
mRNA level also showed a corresponding, statistically significant decrease in the NT2 
cells when the let-7a siRNA was introduced (Dicer, 2.5-fold, p < 1.1 x 10-8, and HMGA2 
3.4-fold, p < 6 x 10-17) (Figure 2A, Tables S1 and S2). 
let-7 reduces Dicer and HMGA2 mRNA and Protein Accumulation 
Quantitative reverse transcription/polymerase chain reaction (qRT-PCR) 
experiments confirmed our microarray results for Dicer and HMGA2 mRNAs (Figure 
2B). When let-7 function was blocked in HeLa cells, Dicer mRNA increased by a factor 
of 2.0 ± 0.9 (average of three trials ± standard deviation) and HMGA2 mRNA increased 
by a factor of 3.9 ± 1.7 in this assay. Conversely, when let-7a was introduced into NT2  
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Figure AII-2. let-7 regulates Dicer and HMGA2 mRNA stability in cells that express 
this miRNA. (A) Microarray analysis of steady-state mRNA levels when let-7 function 
was blocked in HeLa cells or when let-7a was introduced as an siRNA into NT2 cells. 
The average (n = 3) change in abundance, relative to the control, is reported for each 
mRNA versus the statistical significance of the change (adjusted p-value). (B) 
Quantitative PCR analysis of Dicer and HMGA2 mRNA levels after let-7 function was 
predicted to be a target of any miRNA known to be expressed in HeLa cells. 
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Figure AII-2 
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cells, Dicer mRNA decreased by a factor of 2.0 ± 0.5 and HMGA2 mRNA decreased by 
a factor of 3.5 ± 1.1. Like Dicer mRNA, Dicer protein increased when let-7 function was 
blocked in HeLa cells and decreased when let-7a was introduced into NT2 cells (Figure 
3). Inhibition of let-7 in HeLa cells using the let-7-specific 2´-O-methyl oligonucleotide 
nearly doubled Dicer protein levels (Figure 3A). Conversely, transfection of the let-7a 
siRNA into NT2 cells reduced Dicer expression (Figure 3B). In fact, the effect of the let-
7a siRNA was comparable to that of a perfectly matched siRNA targeting the Dicer 
mRNA for cleavage (Figure 3B). HMGA2 protein also decreased when the let-7a siRNA 
was introduced into NT2 cells (Figure 3C). The let-7a siRNA reduced HMGA2 protein 
expression more than 3-fold, comparable to the reduction caused by transfection of an 
siRNA with perfect complementarity to the HMGA2 mRNA (Figures 2B and 3C). Unlike 
HMGA2 mRNA, HMGA2 protein was not detectable in HeLa cells before (Figure 3D) or 
after increasing its steady-state transcript level by inhibiting let-7 (data not shown), 
suggesting that some other mechanism—perhaps miRNAs other than let-7—still 
represses its translation in the absence of let-7 function. To confirm that translation of the 
HMGA2 mRNA is regulated by let-7, at least in part, we examined HMGA2 in NIH3T3 
mouse fibroblast cells, where the HMGA2 protein was readily detected (Figure 3D). 
These cells express both let-7 (Figure 1A) and HMGA2 protein (Figure 3D). Inhibition of 
let-7 function in NIH3T3 cells more than doubled HMGA2 protein (Figure 3E). 
Conversely, transfection of let-7a siRNA into these cells, to increase the amount of let-
7a, reduced expression of HMGA2 protein. HMGA2 expression also paralleled the 
developmental expression of let-7. let-7 expression is induced when NT2 cell 
differentiate along a neuronal pathway following treatment with retinoic acid (Sempere et 
al., 2002) (Figure 1A), and HMGA2 protein significantly decreased upon retinoic acid-
induced neuronal differentiation of NT2 to NT2N cells (Figure 3D). HMGA2 is an 
architectural transcription factor that binds the minor groove of AT-rich DNA (Tessari et 
al., 2003) and is a component of the enhancesome (Reeves, 2000). Overexpression of 
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HMGA2 in mice leads to pituitary adenomas and natural killer cell lymphomas (Fedele et 
al., 2002). HMGA2 expression is increased in a wide range of tumors including 
pulmonary cancer (Wisniewski and Schwanbeck, 2000). Tantalizingly, the most 
aggressive lung cancers are those that have lost let-7 expression (Takamizawa et al., 
2004). 
 
Dicer and HMGA2 mRNAs Contain Conserved let-7-Responsive Elements 
 Small RNAs, such as miRNAs and siRNAs, bind their target RNAs primarily by 
sequence complementarity between the target and six or seven nucleotides in the 5´ end 
of the small RNA (Brennecke et al., 2005; Doench and Sharp, 2004; Haley and Zamore, 
2004; Krek et al., 2005; Lai, 2002; Lewis et al., 2005; Lewis et al., 2003; Mallory et al., 
2004). This specialized small RNA domain, the ‘seed’ sequence, is thought to reflect how 
small RNAs are bound to members of the Argonaute family of proteins, the core 
components of the ribonucleoprotein complexes called RISC (RNA-induced silencing 
complex), which mediate silencing by both miRNAs and siRNAs. Computational 
prediction of miRNA targets begins with the premise that pairing of the miRNA seed—
nucleotides 2–7 of the small RNA—recruits a miRNA-programmed RISC to a target 
RNA. In fact, both Dicer and HMGA2 were previously predicted to contain multiple let-
7-responsive elements (LRE) (Krek et al., 2005; Lewis et al., 2005). The Dicer mRNA 
contains four evolutionarily conserved, let-7 seed matches in its coding region (Figure 4). 
The HMGA2 mRNA contains seven evolutionarily conserved, let-7 seed matches in its 3´ 
untranslated region (UTR) (Figure 5), consistent with earlier findings that HMGA2 
mRNA translation is negatively regulated by elements in its 3´ UTR (Borrmann et al., 
2001). Historically, miRNA-binding sites were thought to reside mainly in 3´ UTRs, but  
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Figure AII-3. Dicer and HMGA2 protein expression are repressed by let-7. (A) 
Antisense inhibition of let-7 in HeLa cells increased Dicer protein expression, relative to 
an unrelated, luciferase-specific 2´-O-methyl antisense oligonucleotide. (B) Introduction 
of let-7a as an siRNA into NT2 cells, which do not normally contain detectable let-7, 
decreased Dicer protein expression, relative to the expression of tubulin. A GFP siRNA 
provided a negative control, and a Dicer-specific siRNA (targeting LRE 2, see 
Supplementary Table 3) provided a positive control. (C) Transfection of let-7a siRNA 
decreased HMGA2 protein level in NT2 cells. A GFP siRNA served as a negative 
control; an HMGA2-specific siRNA served as a positive control. (D) HMGA2 protein 
expression decreased when NT2 cells were differentiated by treatment with retinoic acid 
into NT2N cells. Retinoic acid-treatment induces let-7 expression in NT2 cells. (E) 
Inhibiting let-7 function in NIH3T3 cells using a 2´-O-methyl oligonucleotide increased 
HMGA2 protein levels >2-fold. Conversely, adding additional let-7 by transfecting a let-
7a siRNA decreased the expression of HMGA2 protein >3-fold. Above each lane, the 
fold-change in Dicer or HMGA2 protein levels, normalized to tubulin, are reported 
elative to the control treatment. 
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small RNAs can also repress expression of their target genes when they pair imperfectly 
to as few as one or two sites in the target mRNA coding region (Kloosterman et al., 2004; 
Saxena et al., 2003). The Dicer and HMGA2 LREs are conserved among at least nine and 
five vertebrates, respectively.  
 
let-7 Represses Dicer and HMGA2 mRNA Expression, but Does Not Direct mRNA 
Cleavage 
 Studies in C. elegans and in cultured human cells suggest that animal miRNAs 
repress translation of their target mRNAs without altering their steady-state levels 
(Doench et al., 2003; Olsen and Ambros, 1999). However, recent data suggest that 
miRNAs can alter mRNA target stability (Bagga et al., 2005; Jing et al., 2005; Lim et al., 
2005), even when they lack sufficient complementarity to direct Argonaute2-catalyzed, 
endonucleolytic cleavage of their mRNA targets. Since let-7 reduces the steady-state 
RNA level of Dicer and HMGA2, we asked if this decrease is the consequence of 
endonucleolytic cleavage of the target RNA or rather results from recruitment of the 
mRNA into a more general pathway for RNA destruction. Of the ten predicted LREs in 
Dicer and HMGA2, HMGA2 LRE 6 is most complementary to let-7 (Figure 5) and is 
thus the best candidate to direct Argonaute2-catalyzed mRNA cleavage (Chiu and Rana, 
2002; Haley and Zamore, 2004; Hutvágner and Zamore, 2002). We used 5´ RACE to 
identify stable cleavage products deriving from let-7-directed cleavage of the HMGA2 
mRNA within LRE 6. Such cleavage products are diagnostic of Argonaute2-catalyzed, 
small RNA-directed endonucleolytic cleavage (Llave et al., 2002; Yekta et al., 2004), and 
are prima facie evidence that an mRNA is destroyed by the RNAi pathway  
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Figure AII-4. Conservation of the four predicted Dicer LREs among vertebrate 
species. (A) Hs, Homo sapiens; Mm, Mus musculus, house mouse; Rn, Rattus norvegicus, 
rat; Cf, Canis familiaris, dog; Bt, Bos taurus, cow; Gg, Gallus gallus, chicken; Xt, 
Xenopus tropicalis, frog; Dr, Danio rerio, zebrafish; Fr, Fugu rubripes, Pufferfish. Dark 
blue denotes bases conserved in all vertebrates analyzed; the bar indicates the region 
matching the let-7 augmented seed region3. The corresponding amino acid is indicated 
for each Dicer codon. (B) Putative LREs in the Dicer mRNA coding region and their 
complementarity to let-7a. 
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Figure AII-5. Predicted let-7 target sites in human HMGA2 mRNA. (A) HMGA2 
LREs and their complementarity to let-7a. (B) Location of the seven LREs in the 3´ 
untranslated region of Homo sapiens (Hs), mouse (Mm), rat (Rn), dog (Cf), and chicken 
(Gg) HMGA2 mRNAs. (C) Conservation of bases in the HMGA2 3´ untranslated region 
among the five vertebrate species analyzed.  The position of the seven LREs is indicated. 
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(Soutschek et al., 2004). Although HMGA2 LRE 6 can mediate let-7–repression of 
reporter gene expression, we could not detect any stable 3´ cleavage product for this 
region of the HMGA2 mRNA in HeLa cells (Figure 8). In contrast, a stable 3´ cleavage 
product for the LRE 6 region of HMGA2 mRNA was readily detected when a control 
siRNA with complete complementarity to LRE 6 was introduced into the HeLa cells 
(Figure 8A). For the control siRNA, the cDNAs of these cleavage products were cloned 
and sequenced; the 5´ ends of 14 of 18 clones corresponded precisely to the scissile 
phosphate predicted for the siRNA with perfect complementarity to the HMGA2 LRE 6 
(Figure 8A). 
 Our data demonstrate that let-7 regulates both Dicer and HMGA2 expression in 
cultured human cells. To assess if let-7 controls these target mRNAs through the 
predicted Dicer and HMGA2 LREs, we constructed reporter vectors containing Dicer 
LRE 2 and 3, HMGA2 LRE 2, 3, 4, and 5, or HMGA2 LRE 6 and 7 inserted into the 3´ 
UTR of the Renilla reniformis (Rr) luciferase mRNA . Each reporter was tested for its 
ability to respond to let-7 in HeLa, NT2 and NIH3T3 cells. The expression of each of the 
three reporter constructs increased when the function of the endogenous let-7 RISC was 
inhibited in HeLa cells and NIH3T3 cells (Figure 6A). Conversely, introduction of the 
let-7a siRNA into NT2 cells repressed each of the three LRE-containing reporter 
plasmids (Figure 6B). Reporter regulation by let-7 was lost when mutations were 
introduced into the seed region of the Dicer and HMGA2 LREs (Figure 7).  
 In vitro RNAi provides a more sensitive method for detecting small RNA activity 
than cultured cell experiments (Haley and Zamore, 2004). Cleavage products are stable 
and continue to accumulate in RNAi reactions derived from Drosophila embryos for at  
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Figure AII-6. let-7-responsive elements (LREs) mediate Dicer and HMGA2 
repression by let-7. (A) LRE-containing Renilla luciferase reporter expression was 
increased in let-7-containing human HeLa or mouse NIH 3T3 cells when let-7 function 
was blocked with a let-7-specific, but not a control, 2´-O-methyl oligonucleotide. (B) In 
NT2 cells, LRE-containing reporter expression decreased upon introduction of let-7a as 
an siRNA, relative to introduction of a GFP-specific siRNA. Reporter expression was 
unaltered by the let-7-specific 2´-O-methyl oligonucleotide or the let-7a siRNA when the 
reporter lacked LREs (Figure S1). 
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Figure AII-7 
 
 
 
 
 
 
 
 
 
 
Figure AII-7. Mutations in the seed sequence abrogate let-7-directed repression of 
reporter constructs containing the Dicer or HMGA2 LREs. For each LRE, 
nucleotides 2–4 (CUC) were changed to GUG to reduce complementarity to the let-7 
seed and therefore to disrupt let-7 binding. 
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Figure AII-8. let-7 alters Dicer and HMGA2 mRNA steady-state levels without 
directing target mRNA cleavage. (A) 5´ RACE analysis of RNA harvested 72 h after 
NT2 cells were transfected with either a let-7a siRNA or an siRNA with perfect 
complementarity to HMGA2 LRE 6. The nested 5´ RACE PCR products were resolved 
on a 1.5% agarose gel. No product could be detected for the let-7a siRNA, although a 
discrete 3´ cleavage product was readily detected for the siRNA corresponding to LRE 6. 
The lower panel shows a digital over-exposure. Fourteen of 18 cloned 5´ RACE products 
corresponded precisely to the cleavage site predicted for the LRE 6 siRNA, diagnostic of 
siRNA-directed RNAi. (B) The ability of the let-7a siRNA to direct target cleavage was 
assessed in an in vitro reaction using Drosophila embryo lysate. Eight target RNAs were 
examined: a target containing a sequence fully complementary to let-7a, four targets 
corresponding to the four predicted Dicer LREs, and three targets corresponding to 
HMGA2 LRE1, 4, and 6. For each LRE-containing target RNA, a perfectly matched 
siRNA was used as a control demonstrating that the site can be targeted for cleavage by 
the RNAi pathway. None of the seven LRE-containing target RNAs were detectably 
cleaved in the presence of let-7a, after 24 h incubation. (C) The seven target RNAs were 
also analyzed in RNAi reactions using human HeLa cell S10 cytoplasmic extract. This 
extract contains functional, endogenous let-7-programmed RISC, as evidenced by the 
cleavage of the let-7-complementary target RNA in the absence of any exogenous 
siRNA. In contrast, the four Dicer and three HMGA2 LRE-containing target RNAs were 
only detectably cleaved in this assay when an siRNA with perfect complementarity to the 
LRE was included in the reaction. 
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least 24 h, allowing detection of target cleavage even for siRNAs complementary to as 
few as eleven target bases (Haley and Zamore, 2004). When tested in this assay, a let-7a 
siRNA failed to direct cleavage of target RNAs containing any of the four Dicer LREs or 
HMGA2 LREs 1, 4, or 6, although fully complementary siRNAs readily directed 
cleavage of the target RNAs at each of the seven tested LRE sites (Figure 8B). Similarly, 
S10 extract from cultured human HeLa cells, which contains endogenous let-7-
programmed RISC, did not direct cleavage at any of the seven tested LRE sites, although 
fully complementary siRNAs readily directed cleavage at the corresponding sites (Figure 
8C). Moreover, the endogenous let-7-programmed RISC present in the S10 extract 
cleaved a target RNA with complete complementarity to let-7 (Figure 8C). We conclude 
that let-7-directed repression of the Dicer and HMGA2 mRNAs occurs by a mechanism 
distinct from Argonaute2-catalyzed endonucleolytic cleavage. 
 In human cells, miRNAs bound to Ago2 can relocalize their mRNA targets from 
the cytosol to subcellular structures called P-bodies (Liu et al., 2005; Sen and Blau, 
2005). P-bodies contain both Dcp1 and Dcp2, enzymes that remove the characteristic 5´ 
cap of eukaryotic mRNA, and Xrn1, a 5´-to-3´ exonuclease that degrades uncapped 
mRNA. let-7-directed destruction of Dicer and HMGA2 mRNAs may reflect the active 
relocalization of these mRNAs by let-7 to the P-body. Alternatively, destabilization of 
Dicer and HMGA2 may be an indirect consequence of a block to translational 
initiation(Pillai et al., 2004; Pillai et al., 2005) or miRNA-promoted removal of the 
mRNA poly(A) tail (Giraldez et al., 2006; Wu et al., 2006). 
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mRNAs Down-Regulated by let-7 are Enriched in Conserved 3´ UTR Seed Matches 
Does let-7 generally regulate the stability of human mRNAs predicted to be its 
regulatory targets (Krek et al., 2005; Lewis et al., 2005), because they contain 
evolutionarily conserved complementarity between the let-7 seed and the mRNA? We 
compared the proportion of predicted let-7 targets among the set of mRNAs whose 
steady-state concentration was significantly reduced (p-value < 0.1) upon the introduction 
of the let-7a siRNA into NT2 cells to those mRNAs that were not. Of the mRNAs whose 
concentration declined significantly in the presence of let-7a, one-quarter (13 of 51) 
contain let-7 seed matches in the 3´ UTR that are conserved among four mammals (Lewis 
et al., 2005) (Supplementary Table 2). In contrast, less than four percent (221 of 6429) of 
mRNAs whose concentration was not significantly reduced contain such conserved seed 
matches. Thus, the set of mRNAs whose stability is reduced by let-7 is enriched more 
than seven-fold for conserved 7-nt let-7 seed complementarity. A similar enrichment was 
observed when we used either seed matches conserved among five vertebrates, which 
include both 8-nt open-reading frame matches and 6-nt 3´ UTR matches (> 6-fold 
enrichment) (Lewis et al., 2005) or when we used the 3´ UTR predictions of Krek et al. 
(Krek et al., 2005) (> 9-fold enrichment for conservation among 6 vertebrates or > 5-fold 
enrichment for conservation among 5 mammals). We conclude that a sizeable proportion 
of mRNAs proposed to contain evolutionarily conserved let-7-binding sites can, in fact, 
be regulated at the level of mRNA stability by let-7. However, not all proposed let-7 
targets were regulated at the mRNA level in our experiments. Expression of three 
members of the Ras proto-oncogene family were recently reported to be regulated by let-
7 (Johnson et al., 2005). In our experiments, the concentration of the mRNAs of each of 
these three Ras genes did not change significantly when let-7 was inhibited in HeLa cells 
nor when let-7a was introduced into NT2 cells, although all three were readily detected 
by the microarray (Supplementary Table 1, Unigene ID’s Hs.37003, Hs.505033, and 
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Hs.486502). This result suggests that stability of those three mRNAs is not regulated by 
let-7, although their translation may be let-7-regulated. 
 
let-7 represses Dicer mRNA expression in vivo 
Our finding that let-7 regulates Dicer mRNA levels in cultured human cells and 
that the four sites proposed to mediate this regulation are conserved among the nine 
vertebrates examined, suggest that let-7-directed regulation of Dicer mRNA expression is 
physiologically relevant. To test this idea in vivo, we blocked let-7 function in adult mice 
by intravenous administration of cholesterol-conjugated, phosphorothioate-modified 2´-
O-methyl oligonucleotides (Krutzfeldt et al., 2005). Three mice received 40 mg/kg daily 
for three days of a let-7a-complementary 2´-O-methyl oligonucleotide, and three received 
a control oligonucleotide; liver tissue was harvested on the fourth day and Dicer mRNA, 
relative to Actin mRNA, measured by qRT-PCR (Figure 9A). (As HMGA2 mRNA is not 
detectably produced in adult mouse somatic tissues (Zhou et al., 1996), we did not 
measure its expression in these experiments.) Relative to the control, intravenous 
administration of the let-7a-specific 2´-O-methyl oligonucleotide increased the steady-
state concentration of Dicer mRNA in liver tissue by a factor of 3.5 ± 0.5 (average ± 
standard deviation, n = 3; 0.001 < p < 0.004).  
In parallel, we examined the effect of the let-7-specific and control 2´-O-methyl 
oligonucleotides on let-7 expression, measured by Northern hybridization using a locked-
nucleic acid (LNA) probe complementary to let-7a. Control experiments with synthetic 
RNAs corresponding to the nine mouse let-7 paralogs demonstrated that the LNA probe 
detected let-7b, let-7c, let-7d, let-7e, and let-7f in addition to detecting let-7a; let-7g, let-
7i, or miR-98 were not efficiently detected (Figure 9B). let-7a, let-7b, and let-7c are all 
expressed in mouse liver (Lagos-Quintana et al., 2002). Intravenous administration of 
cholesterol-conjugated, phosphorothioate-modified 2´-O-methyl oligonucleotides 
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Figure AII-9. Intravenous administration of a let-7-specific, but not a control, 
antisense oligonucleotide increases the steady-state concentration of Dicer mRNA in 
liver. 2´-O-methyl antisense oligonucleotides contained two 5´ and four 3´ 
phosphorothioate modifications and were 3´ conjugated via a hydroxyprolinol linkage to 
cholesterol to facilitate uptake by liver cells (Krutzfeldt et al., 2005). Each of the six mice 
in the study received 40 mg/kg modified, conjugated 2´-O-methyl oligonucleotide daily 
on three successive days; liver tissue was harvested on the fourth day. (A) Dicer mRNA 
levels were measured by qRT-PCR in liver tissue. (B) The concentration of let-7, miR-
16, tRNAile, and pre-let-7 (Figure S2B) were measured in the same tissue by quantitative 
Northern blotting. (C) Quantitation of the data in (B). 
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Figure AII-9 
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Figure AII-10. pre-miRNAs Accumulate in Let-7 Treated Cells. NT2 cells were 
transfected with Let-7 siRNA or a GFP control siRNA at 72 hr interval for nine days. 
RNA was extracted and 20µg was analyzed by Northern blot using LNA probes for 
miRNAs as indicated. Relative abundances of pre-miRNAs and miRNAs were 
normalized to isoleucine tRNA as a loading control. Error bars represent standard 
deviation for three separate trials. 
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(Krutzfeldt et al., 2005) or 2´-O-methoxyethyl phosphorothioate oligonucleotides (Esau 
et al., 2006) has been reported to reduce accumulation of the complementary miRNA. We 
found that let-7 was partially depleted (~45% reduction) in the three mice that received 
the let-7-specific oligonucleotide, but not in the controls (Figure 9C), suggesting that the 
oligonucleotide inhibited let-7 function in part by reducing the steady-state concentration 
of let-7 and in part by binding let-7-programmed Argonaute-protein complexes and 
competing with binding to target mRNAs such as Dicer. 
 
let-7 can regulate miRNA biogenesis 
 We detected no change in the level of an endogenous miRNA, miR-16, in our let-
7 loss of function experiments in mice. Perhaps Dicer is abundant in many cell types and 
thus not rate limiting for miRNA production under normal circumstances. To test if let-7 
is capable of regulating miRNA biogenesis we sequentially transfected NT2 cells with 
let-7a or a control every 3 days for a total of  9 days. We then assessed miRNA and pre-
miRNA levels by northern blot. Although miRNA levels did not significantly change, 
pre-miRNAs increased 3-6 fold for each miRNA examined (miR-17-5p, miR-92, and 
miR-302b) suggesting that Dicer levels were reduced to a level that globally inhibits pre-
miRNA processing (Figure 10). Despite our prolonged treatment regimen miRNAs in 
RISC may be very stable, which may explain why we did not see a corresponding 
reduction in mature miRNAs.     
 
Discussion 
The finding that Dicer is regulated in human cells by let-7 reveals a feedback 
circuit controlling the RNA silencing pathway in vertebrates. The intracellular 
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concentration of Dicer, the RNase III enzyme that converts pre-miRNAs to mature 
miRNAs and long double-stranded RNA into siRNAs (Bernstein et al., 2001; Grishok et 
al., 2001; Hutvágner et al., 2001; Ketting et al., 2001), limits the production of let-7 
(Hutvágner et al., 2001) and likely miRNAs generally. We hypothesize that when let-7 
levels are high, Dicer levels fall, reducing the overall production of mature miRNAs. 
Conversely, when let-7 levels are low, Dicer levels would rise, leading to increased 
processing of pre-miRNA to mature miRNA. 
Feedback control of components of the RNA silencing pathway by miRNAs is not 
without precedent: in plants, both DCL1, the Dicer enzyme that excises miRNA from 
pre-miRNA, and the Argonaute protein AGO1 are regulated by miRNAs that target their 
mRNAs for cleavage (Vaucheret et al., 2004; Xie et al., 2003). As plant and animal 
miRNA genes are believed to have evolved separately (Allen et al., 2004; Bartel, 2004), 
it is remarkable that Dicer is the target of miRNA-mediated, feedback control in both 
kingdoms and underscores the importance of maintaining Dicer homeostasis in higher 
organisms. 
Materials and methods 
General methods 
Drosophila embryo lysate, in vitro RNAi reactions, and cap-labeling of target 
RNAs were as described (Haley et al., 2003). HeLa S10 was prepared as described 
(Dignam et al., 1983). For both Drosophila and HeLa reactions, the siRNA was 
incubated for 1 h at 25˚C (Drosophila) or 37˚C (HeLa) to assemble RISC, RISC 
assembly inactivated with 10 mM N-ethylmaleimide for 10 min on ice followed by 11 
mM DTT for 5 min on ice. Next, 0.02 g/l (f.c.) creatine kinase was added to restore 
the ATP-regenerating system, and then 0.25 nM, 32P-cap-radiolabeled target RNA was 
added and the incubation continued for 24 h. Cleavage products of RNAi reactions were 
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analyzed by electrophoresis on 8% denaturing acrylamide gels. Gels were dried, exposed 
to image plates, and then scanned with a FLA-5000 phosphorimager (Fuji, Tokyo, 
Japan). Images were analyzed using Image Gauge version 3.45 (Fuji). Data analysis was 
performed using Excel (Microsoft) and IgorPro 5.0 (Wavemetrics, Lake Oswego, OR). 
 
RNA, 2´-O-methyl, and DNA oligonucleotides 
Synthetic siRNA (Dharmacon, Lafayette, CO) were deprotected according to the 
manufacturer, annealed and used at 20 nM final concentration unless otherwise noted. 
siRNA sequences appear in Table S3. 2´-O-methyl oligonucleotides (IDT, Coralville, IA, 
or Dharmacon) were: 5´-Bio-CAU CAC GUA CGC GGA AUA CUU CGA AAU GUC 
C-3´ (complementary to the Pp-luc siRNA sense strand), 5´-Bio-UCU UCA CUA UAC 
AAC CUA CUA CCU CAA CCU U-3´ (complementary to let-7); 5´ Biotin was attached 
via a six-carbon spacer arm. For intravenous injection into mice, fully 2´-O-methyl-
modified oligonucleotides (Dharmacon) were: 5´-ApsApsC UAU ACA ACC UAC UAC 
psCpsUpsC psA-hydroxyprolinol-cholesterol-3´ (let-7-specific) and 5´-CpsGpsU ACG 
CGG AAU ACU UCG psApsApsA psU-hydroxypolinol-cholesterol-3´ (control), where 
‘ps’ indicates a phosphorothioate linkage. 
DNA oligonucleotides for synthesizing in vitro RNA targets containing individual 
Dicer or HMGA2 LRES were from IDT (Table S4). DNA oligonucleotides (Table S4) 
were used to PCR amplify templates for target RNA transcription using plasmid pGL-2 
(Promega) as a PCR template. RNA was transcribed from the PCR products using T7 
RNA polymerase as described (Haley et al., 2003). To generate reporter constructs to test 
the putative let-7-responsive elements from Dicer and HMGA2, DNA oligonucleotides 
were used for PCR with either Dicer or HMGA2 cDNA as template: HMGA2 LREs 2-5, 
5´-ATT CTA GAC TCT CCC TCT CTC TTT TCA TGT G-3´ and 5´-ATT CTA GAA 
CAA ATG AAT GCT GCA AGT AAC AAG-3´; HMGA2 LREs 6-7, 5´-ATT CTA 
GAG GAA GCA ATT GCT CAT GTT GGC-3´ and 5´-ATT CTA GAG TCT TAT GTA 
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GCT GCG ACC AAC-3´; Dicer LREs 2-3, 5´-ATT CTA GAC TCC TCT CTA GAA 
AAT CAT GAC C-3´ and 5´-ATT CTA GAC AAT AGA AGG GCT CTG CTC AG-3´. 
The PCR fragments were digested with Xba I, cloned into plasmid pRL-TK, and 
sequenced to confirm their identity. 
 
Construction of mutant let-7 responsive elements 
The seed sequence of each Dicer or HMGA2 LRE was altered by substituting 
GAG for nucleotides 2–4 of the wild-type let-7 seed sequence (CTC) using the Quick-
Change site-directed mutagenesis method (Stratagene, La Jolla, CA) using KOD 
polymerase (Novagen, San Diego, CA). All mutant sites were verified by sequencing. 
The primers used for mutagenesis were: Dicer LRE2, cgt gca acc aac tac gag ata ttc cat 
tca gaa and ttct gaa tgg aat atc tcg tag ttg gtt gca cg; Dicer LRE3, tgc taa caa atc tac gag 
aga tgg aag tcc tgt and aca gga ctt cca tct ctc gta gat ttg tta gca; HMGA2 LRE2, ctg aat 
acc act tac gag aaa tta agc ata tgt and aca tat gct taa ttt ctc gta agt ggt att cag; HMGA2 
LRE3, act act caa tac tac gag tga atg tta caa cga and tcg ttg taa cat tca ctc gta gta ttg agt 
agt; HMGA2 LRE4, cct cca agt ctg tac gag aaa tga att ctt taa and tta aag aat tca ttt ctc gta 
cag act tgg agg; HMGA2 LRE5, ctt gca aag acc tac gag cag act tca aaa gga and tcc ttt tga 
agt ctg ctc gta ggt ctt tgc aag; HMGA2 LRE6, aaa aca cac tac tac gag tta agt ccc agt ata 
and tat act ggg act taa ctc gta gta gtg tgt ttt; HMGA2 LRE7, taa gtc cca gta tac gag att ttt 
cat act gaa and ttc agt atg aaa aat ctc gta tac tgg gac tta. 
Cell culture and transfection 
HeLa, NT2, and NT2N cells (ATTC) were co-transfected with siRNA (Table S3), 
2´-O-methyl oligonucleotides, or plasmid DNA using Lipofectamine 2000 (Invitrogen, 
Carlsbad, CA) following the manufacturer’s instructions. NT2 cells were differentiated to 
NT2N cells by supplementing the culture medium with 0.01 nM retinoic acid for at least 
two weeks. pRL-TK-LIN28 and pRL-TK-M1 (Kiriakidou et al., 2004) Renilla luciferase 
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plasmids were used to monitor let-7 expression, and pGL-2 (Promega, Madison, WI) 
firefly luciferase plasmid was used as an internal control in transfection experiments. For 
figure 10 NT2 were split and transfected every third day at ~30% confluence using 20nM 
Let-7 or GFP siRNA and Dharmafect 4, according to the manufacturer’s instructions.  
Microarray analysis 
Microarray analysis was performed in triplicate using Affymetrix Human 
Genome Array U133A (Affymetrix, Santa Clara, CA). RNA from HeLa and NT2 cells 
was isolated with TRIZOL (Invitrogen). 5 g total RNA was used for cDNA synthesis 
using the GeneChip Expression 3´-Amplification One-Cycle cDNA synthesis kit 
(Affymetrix). cRNA was synthesized and labeled with the GeneChip Expression 3´-
Amplification IVT labeling kit (Affymetrix), then purified and fragmented with the 
GeneChip Sample Cleanup Module (Affymetrix). Raw data were extracted using 
Affymetrix GCOS software. The .cel files were imported into the S-plus Array Analyzer 
module (version 2.0) and the data normalized using the RMA (Robust Multichip 
Average) method based on quantiles . Differential expression testing was performed 
using the Local Pooled Error Test (LPE) (Jain et al., 2003). Genes which were 
differentially expressed were filtered based on the Benjamini Hochberg method 
(Benjamini and Hochberg, 1995) of testing significance (FDR ≤ 0.05) and empirical fold-
change (≥ 2-fold). The complete set of gene expression data can be viewed on the NCBI 
gene expression omnibus web site (http://www.ncbi.nlm.nih.gob/geo/, accession number 
GSE 2918). 
Quantitative PCR analysis 
0.5-1 g RNA was primed with oligo(dT) and reverse transcribed with 
Superscript II (Invitrogen). Quantitative PCR reactions were performed in triplicate with 
0.5 M gene specific primers using the Quantitect SYBR Green PCR reaction mix 
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(Qiagen) in a DNA Engine Opticon2 (MJ Research). Analysis was performed using 
Opticon Monitor (MJ Research), Excel (Microsoft), and IgorPro 5.0 (Wavemetrics). 
Relative steady-state mRNA levels were determined from the threshold cycle for 
amplification by the 2-∆∆CT method (Livak and Schmittgen, 2001). PCR primers for 
human cells were: GAPDH, 5´-GAA GGT GAA GGT CGG AGT-3´ and 5´-GAA GAT 
GGT GAT GGG ATT TC-3´; Dicer , 5´-CAG AAC GTT GCT CAG CGA GTC-3´ and 
5´-GGT TGC ACG GGT ATT TCC TG-3´; HMGA2, 5´-GAA GAC CCA AAG GCA 
GCA AA-3´ and 5´-CGG CAG ACT CTT GTG AGG ATG-3´. For mouse mRNA, PCR 
primers were: Actin, 5´-ATG CCA ACA CAG TGC TGT CTG G-3´ and 5´-TGC TTG 
CTG ATC CAC ATC TGC T-3´; Dicer , 5´-GCA GGC TTT TTA CAC ACG CCT-3´ 
and 5´-GGG TCT TCA TAA AGG TGC TT-3´ (Sago et al., 2004). 
 
3´ cleavage product analysis by RACE 
5´ RACE was carried out as described (Llave et al., 2002) for HMGA2 LRE 6 
using the HMGA2 reverse transcriptase primer (above) and a reverse PCR primer, 5´-
CAA GCA AGC GAT TCA AAG TAC AAT C-3´, and a nested 3´ PCR primer, 5´-GTT 
AGA AGA CAC TCA AAG GAA CAG-3´. 
 
Western blot analysis 
Proteins were separated on 4-20% gradient SDS-PAGE gels, blotted to 
Immobilon-P membrane (Millipore) using semi-dry electro-blot (Bio-Rad), and probed 
with antibodies: α-Dicer rabbit polyclonal antibody (Billy et al., 2001) (Figure 3A) 
diluted 1:1000 followed by HRP-conjugated mouse anti-rabbit secondary antibody 
(Pierce) or α -Dicer monoclonal antibody (Clonegene, Hartford, CT) (Figure 3B) diluted 
1:500 followed by HRP-conjugated sheep anti-mouse secondary antibody (GE 
Healthcare, Piscataway, NJ); α -HMGA2 antibody (Tessari et al., 2003) diluted 1:1000 
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followed by HRP-conjugated rabbit secondary antibody (Cell Signaling Technology, 
Danvers, MA) and visualized with SuperSignal West Dura kit (Pierce, Rockford, IL) 
using an LAS 5000 imager (Fuji). 
 
Acknowledgements  
We thank Witold Filipowicz for anti-human Dicer antibody, Guidalberto Manfioletti for 
anti-human HMGA2 antibody, Zissimos Mourelatos for the pRL-TK-LIN28 and pRL-
TK-M1 plasmids, members of the Zamore lab for advice, suggestions, and comments on 
the manuscript, and Dianne Schwarz for providing S10 extract. PDZ is a W.M. Keck 
Foundation Young Scholar in Medical Research; G.H. is a Wellcome Trust CD Fellow. 
This work was supported in part by grants from the National Institutes of Health to PDZ 
(GM62862 and GM65236) and from the Wellcome Trust to GH (076624/Z/05/Z), a 
Charles A. King Trust fellowship to GH, an EMBO long-term fellowship (ALTF 910-
2004) to HS, and a DOE fellowship to BL.  
 
Supporting Information 
 
 
 
 
 
 
 
 223
Figure AII-S1. Validation of the let-7-responsive reporter, the let-7-specific 2´-O-
methyl antisense oligonucleotide, and the let-7a siRNA. (A) A Renilla luciferase 
reporter bearing a single let-7-responsive element (LRE) from human Lin-28 mRNA 
(Kiriakidou et al., 2004) was repressed in human HeLa cells and in differentiated NT2N 
cells, demonstrating that the let-7 expressed in these two cell lines functions in RNA 
silencing. In contrast, the LRE-containing reporter was not repressed in NT2 cells, which 
lack detectable let-7. A reporter bearing a mutated LRE (mLRE) (Kiriakidou et al., 2004) 
was not repressed in any of the cell lines. (B) In HeLa cells, a let-7-specific 2´-O-methyl 
antisense oligonucleotide blocked repression of the LRE-containing reporter, increasing 
its expression relative to both the expression of the mutant LRE-containing reporter 
(mLRE) and the control 2´-O-methyl oligonucleotide specific for a firefly luciferase 
siRNA. (C) In NT2 cells, a let-7a siRNA repressed expression of the LRE-containing 
reporter, but not the mutant LRE-containing reporter (mLRE); an siRNA specific for 
firefly luciferase had no detectable effect on reporter expression. In (A) the level of 
normalized Renilla luciferase expression of the mLRE reporter in NT2 cells was set to 1; 
in (B) and (C) the level of expression of the mLRE reporter in the presence of the control 
2´-O-methyl oligonucleotide or siRNA was set to 1. 
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Figure AII-S1 
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Figure AII-S2 
 
 
 
Figure AII-S2. (A) A lock-nucleic acid (LNA) oligonucleotide probe can distinguish 
among some, but not all, of the vertebrate let-7 paralogs. Synthetic RNA 
corresponding to each of the nine let-7 paralogs was detected by Northern analysis using 
a 5´-32P-radiolabeled LNA probe corresponding to the perfect reverse complement of let-
7a. (B) The same LNA probe was used to detect pre-let-7 in liver tissue from the 
experiment in Figure 9. 
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Table AII-S1. Microarray data and analysis. (A) ‘Inhibition of let-7 in HeLa’ and (B) 
‘let-7 siRNA in NT2’ report raw data for gene expression with a control 2´-O-methyl 
antisense oligonucleotide (‘control’) versus a let-7-specific 2´-O-methyl oligonucleotide 
(‘experimental’) and with a control siRNA (‘control’) or a let-7a siRNA (‘experimental’), 
respectively. Each worksheet gives the value for the three independent replicates, the 
average value for all trials, , as well as identifying information and functional annotation 
for each gene. P-values for the change in expression between experiment and control 
(‘Adj. p-value’) were adjusted using the local-pooled-error test (Jain et al., 2003). (C) 
‘NT2 experiment vs. miRNA predictions’ summarizes the predicted regulatory 
relationships between each gene on the microarray and human miRNAs, as previously 
reported (Lewis et al., 2005). miRNA predictions are from either Lewis et al. 
Supplemental Table 2 (columns F, G, H, I, J and K) for microRNA binding sites 
conserved among five vertebrates (5 v) and from Lewis et al. Supplemental Table 3 
(columns L, M, N, O, P and Q) for microRNA binding sites conserved among four 
mammals (4 m) (Lewis et al., 2005). Columns J and P indicate whether the corresponding 
gene is a predicted microRNA target, according to Lewis et al.'s supplemental tables 2 
and 3, respectively; an asterisk indicates that the mRNA for this gene contains at least 
one predicted microRNA binding site, either in its ORF or in its 3´UTR. Columns K and 
Q indicate whether let-7 is predicted to regulate the corresponding gene; ‘Y’ indicates 
that at least one let-7 binding site was predicted for the mRNA of the gene, and ‘N’ 
means that no let-7 binding site was predicted. (D) ‘Up-reg. non-let-7 targets (5 v)’ and 
‘Up-reg. non-let-7 targets (4)’ summarize the predictions of Lewis et al. (Lewis et al., 
2005) for genes which were significantly (adj. p-value < 0.1) up-regulated following let-7 
siRNA transfection into NT2 cells. Only genes not predicted to be regulated by let-7 are 
included.    (Too large to include) 
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Table AII-S2. Comparison of mRNAs down-regulated upon the introduction of a let-7a 
siRNA into NT2 cells with previously published predictions of let-7 target mRNAs based 
on the presence of evolutionarily conserved complementarity between the mRNA and the 
let-7 seed sequence.  (Too large to include) 
 
Table AII-S3. siRNAs used in this study. 
 
Table AII-S4. DNA oligonucleotides used for PCR to produce templates for 
transcription of the eight target RNAs used in Figure 4. 
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LMA and Tb were placed into a food-restriction
paradigm under DD conditions, we found that
they maintained the rhythm that had been en-
trained by light (high-amplitude, free-running pe-
riod of ~23.7 hours) and never showed an increase
in LMA or Tb in anticipation of the food presen-
tation (fig. S3). Hence, although a BMAL1-based
clock is necessary to support food entrainment,
restoration of clock function in the SCN alone is
not able to rescue this behavior.
To test the hypothesis that the BMAL1-based
clock induced in the DMH during restricted
feeding might drive circadian entrainment, we
performed stereotaxic bilateral delivery of AAV-
BMAL1 (the same construct and vector as used
in the SCN) into the DMH of Bmal1−/− mice.
Mice who sustained bilateral DMH injections of
theAAV-BMAL1did not demonstrate entrainment
to a 12:12 LD cycle or free-running rhythms of Tb
or LMA in DD (Fig. 3A). By contrast, under
conditions of food restriction in DD, they ex-
hibited a clear anticipatory increase in Tb and
LMA before food presentation (Fig. 2C and Fig.
3B). Each individual mouse showed very little
day-to-day variation in the timing of the increase
in Tb and LMAunder DD (i.e., the phase angle of
entrainment was stable). Finally, the increase in
Tb and LMA before the predicted period of food
presentation persisted during a 24-hour fast at the
end of restricted feeding (arrow in Fig. 3B), dem-
onstrating the circadian nature of the response.
In both our study and the study byMieda et al.
(8), clock gene expression in the DMHwas largely
restricted to cells in the compact part of the nu-
cleus, which consists of small, closely packed
neurons that are highly reminiscent of the SCN
itself. These neurons appear mainly to have local
connections with the adjacent output zones of the
DMH (23), suggesting that the timing signal
from the compact part of the DMHmay impinge
upon the same output neurons in the remainder of
the DMH as are used to control light-entrained
rhythms directed by the SCN. This relationship
may explain how the DMH clock is able to
override the SCN clock input during conditions
of food entrainment in an intact animal. It is un-
likely that feedback from the DMH alters activity
in the SCN in any major way, because the SCN
remains phase-locked to the LD cycle for many
weeks during food entrainment (as long as the
animals are not also hypocaloric). These obser-
vations also raise the interesting possibility that
the DMH may form the neuroanatomic basis of
the so-called methamphetamine-sensitive circa-
dian oscillator (MASCO), which also operates
independent of the SCN and does not entrain to
light [for a review, see (24)].
Our data indicate that there is an inducible
clock in the DMH that can override the SCN and
drive circadian rhythms when the animal is faced
with limited food availability. Thus, under re-
stricted feeding conditions, the DMH clock can
assume an executive role in the temporal regula-
tion of behavioral state. For a small mammal,
finding food on a daily basis is a critical mission.
Even a few days of starvation, a common threat in
natural environments, may result in death. Hence,
it is adaptive for animals to have a secondary
“master clock” that can allow the animal to switch
its behavioral patterns rapidly after a period of
starvation to maximize the opportunity of finding
food sources at the same time on following days.
In an intact animal, peripheral oscillators in
many tissues in the body, including the stomach
and liver, as well as elsewhere in the brain, may
contribute to food entrainment of circadian
rhythms (25, 26). Consequently, it has been dif-
ficult to dissect this system by using lesions of
individual components of the pathway (3, 9, 10).
However, by starting with a genetically arrhyth-
mic mouse and using focal genetic rescue in
the brain, we have identified the SCN molecular
clock as sufficient for light but not food entrain-
ment of Tb and LMA rhythms in mice, and the
DMH as sufficient for food but not light entrain-
ment of circadian rhythms of Tb and LMA. These
results demonstrate the power of viral-based gene
replacement in the central nervous system to
dissect complex neural functions.
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Endogenous siRNAs Derived
from Transposons and mRNAs in
Drosophila Somatic Cells
Megha Ghildiyal,1* Hervé Seitz,1* Michael D. Horwich,1 Chengjian Li,1 Tingting Du,1
Soohyun Lee,2 Jia Xu,3 Ellen L.W. Kittler,4 Maria L. Zapp,4 Zhiping Weng,5 Phillip D. Zamore1†
Small interfering RNAs (siRNAs) direct RNA interference (RNAi) in eukaryotes. In flies, somatic cells
produce siRNAs from exogenous double-stranded RNA (dsRNA) as a defense against viral infection.
We identified endogenous siRNAs (endo-siRNAs), 21 nucleotides in length, that correspond to
transposons and heterochromatic sequences in the somatic cells of Drosophila melanogaster. We
also detected endo-siRNAs complementary to messenger RNAs (mRNAs); these siRNAs
disproportionately mapped to the complementary regions of overlapping mRNAs predicted to
form double-stranded RNA in vivo. Normal accumulation of somatic endo-siRNAs requires
the siRNA-generating ribonuclease Dicer-2 and the RNAi effector protein Argonaute2 (Ago2). We
propose that endo-siRNAs generated by the fly RNAi pathway silence selfish genetic elements in
the soma, much as Piwi-interacting RNAs do in the germ line.
Three RNA-silencing pathways have beenidentified in flies and mammals: RNAinterference (RNAi), guided by small in-
terfering RNAs (siRNAs) derived from exogenous
double-stranded RNA (dsRNA); the microRNA
(miRNA) pathway, in which endogenous small
RNAs repress partially complementary mRNAs;
and the Piwi-interacting RNA (piRNA) pathway,
whose small RNAs repress transposons in the germ
line (1–3) and can activate transcription in hetero-
chromatin (4).
Endogenous siRNAs (endo-siRNAs) silence
retrotransposons in plants (5, 6), and siRNAs
corresponding to the L1 retrotransposon have
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been detected in cultured mammalian cells (7).
Genetic and molecular evidence suggests that
in addition to suppressing viral infection, the
RNAi pathway silences selfish genetic elements
in the fly soma: Mutations in the RNAi gene
rm62 (8) suppress mutations caused by retroele-
ment insertion (9); depletion of the Argonaute
proteins Ago1 or Ago2 increases transposon
expression in cultured Drosophila Schneider 2
(S2) cells (10); small RNAs have been detected
in Drosophila Kc cells for the 1360 transposon
(11) and are produced during transgene silencing
in flies (12); and siRNAs have been proposed to
repress germline expression of suffix, a short
interspersed nuclear element (SINE) (13).
The defining properties ofDrosophila siRNAs
are their production from long dsRNA by Dicer-2
(Dcr-2), which generates 5′-monophosphate ter-
mini; their loading into Argonaute2 (Ago2); and
theirAgo2-dependent, 3′-terminal, 2′-O-methylation
by the methyltransferase Hen1 (14–16), unlike
most miRNAs (17). In vivo (Fig. 1A, rightmost
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University of Massachusetts Medical School, Worcester, MA
01605, USA. 2Program in Bioinformatics, Boston Univer-
sity, Boston, MA 02215, USA. 3Department of Biomedical
Engineering, Boston University, Boston, MA 02215, USA.
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Fig. 1. High-throughput
pyrosequencing revealed
3′-terminally modified
21-nt RNAs in the fly
soma. (A) Length and se-
quence composition of the
small RNA sequences from
a library of total small RNA
from the heads of flies
expressing an inverted re-
peat (IR) silencing thewhite
gene and for a parallel
library enriched for RNAs
modified at their 3′ ends.
(B) Similar analysis for
small RNA sequences
from Drosophila S2 cells.
For data labeled “without
miRNAs,” pre-miRNA–
matching sequences were
removed computationally.
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panel) and in vitro (18), nearly all siRNAs
produced by Dcr-2 from exogenous dsRNA are
21 nucleotides (nt) in length.
We characterized the somatic small RNA
content of S2 cells (19) and of heads expressing
an RNA hairpin silencing the white gene by
RNAi (20). To identify endo-siRNA candidates,
we analyzed two types of RNA libraries. For total
18- to 29-nt RNA libraries, 89% (S2 cells) and
96% (heads) mapped to annotated miRNA loci.
In contrast, libraries enriched for small RNAs
bearing a 3′-terminal, 2′-O-methyl modification
(21) were depleted of miRNAs: Only 19% (S2
cells) and 49% (heads) of reads and 2.4% (S2
cells; 58,681 reads; 12,036 sequences) and 12%
(heads; 22,685 reads; 2929 sequences) of unique
sequences mapped to miRNA loci.
Figure 1 shows the length distribution and
sequence composition of the four libraries. The
total RNA samples were predominantly miRNAs,
a bias reflected in their modal length (22 nt)
and pronounced tendency to begin with uracil.
Exclusion of miRNAs revealed a class of small
RNAs with a narrow length distribution and no
tendency to begin with uracil. Except for an
unusual cluster of X-chromosome small RNAs
(fig. S1) and a miRNA-like sequence with an
unusual putative precursor on chromosome 2
(fig. S2), few of these small RNAs are likely to
correspond to novel miRNAs: None lie in the
arms of hairpins predicted to be as thermo-
dynamically stable as most pre-miRNAs (i.e.,
< –15 kcal/mol).
After excluding known miRNAs, 64% (heads)
(Fig. 1A) and 78% (S2 cells) (Fig. 1B) of se-
quences in the libraries enriched for 3′-terminally
modified small RNAs—that is, those likely to
be Ago2-associated—were 21 nt long. For fly
heads, 37% (8404 reads) derived from the white
dsRNA hairpin. The abundance of these exo-
siRNAs can be estimated by comparing them
to the number of reads for individual miRNAs in
the total small RNA library, where 1.6% (660
antisense and 491 sense reads) were 21-nt oligo-
mers (21-mers) and matched the white sequences
in the dsRNA-expressing transgene. The collec-
tive abundance of all white exo-siRNAs was less
than the individual abundance of the 10 most
abundant miRNAs in this sample; the median
abundance of any one exo-siRNA species was
two reads. The white–inverted repeat (IR) trans-
gene phenocopies a nearly null mutation inwhite,
yet the sequence of the most abundant exo-siRNA
was read just 37 times.
In heads, the sequence composition of the
21-nt, 3′-terminally modified small RNAs close-
ly resembled that of exo-siRNAs, which tended
to begin and end with cytosine. In heads and S2
cells, the 21-mers lacked the sequence features of
piRNAs, which either begin with uracil (Aub-
and Piwi-bound) or contain an adenine at po-
sition 10 (Ago3-bound) and are 23 to 29 nt long
(1, 2). These data suggest that the 21-nt small
RNAs are somatic endo-siRNAs.
In S2 cells, endo-siRNAs mapped largely to
transposons (86%); in fly heads, they mapped
about equally to transposons, intergenic and
unannotated sequences, and mRNAs. The
finding that 41% of endo-siRNAs mapped to
mRNAs without mapping to transposons sug-
gests that endo-siRNAs may regulate mRNA
Fig. 2. Endo-siRNAs correspond to transposons. (A) Distribution of annotations for the genomic matches of
endo-siRNA sequences. Bars total more than 100% because some siRNAs match both LTR and non-LTR
retrotransposons or match bothmRNA and transposons. (B) Transposon-derived siRNAs withmore than 50 21-nt
reads mapped about equally to sense and antisense orientations. (C) Alignment of endo-siRNA sequences to
Drosophila transposons. The abundance of each sequence is shown as a percentage of all transposon-matching
siRNA sequences. LTR, long terminal repeat; TIR, terminal inverted repeat. Here and in subsequent figures, data
from high-throughput pyrosequencing and sequencing-by-synthesis were pooled for wild-type heads.
Table 1. Endo-siRNAs preferentially map to overlapping, complementary mRNAs.
Sample Enrichment
Enrichment after
randomization Z score P
Mean SD
Fly heads 10.9 1.0 0.38 26.1 7.9 × 10−151
S2 cells 12.3 1.1 0.42 27.0 5.2 × 10−161
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expression. Endo-siRNAs mapping to mRNAs
were likelier by a factor of >10 than expected by
chance (5.22 × 10−161 < P < 8 × 10−151) to derive
from genomic regions annotated to produce over-
lapping, complementary transcripts (Table 1 and
table S1). These data suggest that such over-
lapping, complementary transcripts anneal in
vivo to form dsRNA that is diced into endo-
siRNAs. We note that among the mRNAs for
which we detected complementary 21-mers was
ago2 itself.
Endo-siRNAs mapped to all three large chro-
mosomes (figs. S3 to S5). siRNAs corresponding
to the three transposon types in Drosophila were
detected, but long terminal repeat (LTR) retro-
transposons, the dominant class of selfish genetic
elements in flies, were overrepresented even after
accounting for their abundance in the genome
(Fig. 2A and table S2). Unlike piRNAs, which
are disproportionately antisense to transpos-
ons, but like siRNAs derived from exogenous
dsRNA, about equal numbers of sense and anti-
sense transposon-matching endo-siRNAs were
detected (Fig. 2B and fig. S6) (1–3, 22). Like
piRNAs, endo-siRNAs map to large genomic
clusters (table S3). Of 172 endo-siRNA clusters
in S2 cells, four coincided with previously iden-
tified piRNA clusters (cluster 1, at 42A of chro-
mosome 2R; clusters 7 and 10 in unassembled
genomic sequence; and cluster 15 in the chro-
mosome 3L heterochromatin). In heads, we de-
tected 17 clusters; five corresponded to clusters
found in S2 cells, but only one was shared with
the germline piRNAs: the flamenco locus, con-
sistent with recent genetic evidence that a Piwi-
independent but flamenco-dependent pathway
represses the Idefix and ZAM transposons in the
soma (23). That both endo-siRNAs and piRNAs
can arise from the same region suggests either
that a single transcript can be a substrate for
both piRNA and siRNA production or that dis-
tinct classes of transcripts arise from a single
locus. The abundance and distribution of endo-
siRNAs across the sequences of individual
transposon species reflected the natural history
of when the elements entered the fly genome, but
not their mechanism of transposition (Fig. 2C)
(24).
Statistically significant reductions in siRNA
abundance were observed in dcr-2L811fsX null
mutant heads relative to heads from heterozygous
siblings for 38 transposons (fig. S7 and table S4).
Normalized for sequencing depth, sequencing
results from homozygous dcr-2 mutant heads
yielded fewer 21-mers overall (by a factor of 3.1)
and fewer 21-mers corresponding to transposons
(by a factor of 6.3) than did their heterozygous
siblings (P < 2.2 × 10−16; c2 test). In contrast,
overall miRNA abundance—normalized to se-
quencing depth—was essentially unchanged be-
tween dcr-2 heterozygotes and homozygotes
(fig. S7 and table S5). These data suggest that
endo-siRNAs are produced by Dcr-2, but we do
not yet know why some endo-siRNAs persist in
dcr-2L811fsX mutants.
Fig. 3. Transposon silencing requires Dcr-2 and Ago2, but not Dcr-1. (A and B) The change in mRNA
expression (mean ± SD, N = 3) for each transposon between dcr-2L811fsX (A) or ago2414 (B)
heterozygous and homozygous heads was measured by quantitative reverse transcription polymerase
chain reaction. The data were corrected for differences in transposon copy number between the paired
genotypes. (C) The change in transposon expression (mean ± SD, N = 3) in S2 cells was measured for
the indicated RNAi depletion relative to a control dsRNA.
Fig. 4. The composition of somatic small RNAs is altered in the absence of Ago2. (A and B) Size
distribution (A) and sequence composition (B) of sequences from a library of total 18- to 29-nt RNA
from the heads of ago2 null mutant flies or a library enriched for 3′-terminally modified RNAs.
Reads matching pre-miRNA sequences were removed. (C) Distribution of annotations for the
genomic matches of small RNA sequences from the two ago2 libraries.
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Transposon expression in the soma reflects
both the silencing of transposons—potentially by
either or both posttranscriptional and transcrip-
tional mechanisms—and the tissue specificity of
transposon promoters. Drosophila somatic cells
may contain siRNAs targeting transposons that
would not be highly expressed even in the
absence of those siRNAs, because the promoters
of those transposons are not active in some or all
somatic tissues or because they are repressed by
additional mechanisms. We analyzed the expres-
sion of a panel of transposons in heads from ago2
and dcr-2 mutants and in S2 cells depleted of
Dcr-1, Dcr-2, or Ago2 by RNAi (Fig. 3 and fig.
S8). We found that the steady-state abundance of
RNA from the LTR retrotransposons 297 and
412 increased in heads from dcr-2L811fsX null mu-
tants (Fig. 3A). Similarly, the steady-state abun-
dance of RNA from the LTR retrotransposons 297,
412, mdg1, and roo, the non-LTR retrotransposon
F-element, and the SINE-like element INE-1
increased in ago2414 mutant heads (Fig. 3B).
In S2 cells, RNA expression from the LTR
retrotransposons 297, 1731, mdg1, blood, and
gypsy and from the DNA transposon S-element
all increased significantly (0.00001 < P < 0.002)
when Dcr-2 was depleted or when both Dcr-2
andDcr-1were depleted, but notwhenDcr-1 alone
was depleted (Fig. 3C). Similarly, ago2(RNAi) in
S2 cells desilenced transposons, including nine
LTR and non-LTR retrotransposons and the DNA
transposon S-element (fig. S8).
Is Ago2 required for the production or
accumulation of endo-siRNAs? We sequenced
18- to 29-nt small RNAs from ago2414 homozy-
gous fly heads and from the same small RNA
sample treated to enrich for 3′-terminallymodified
RNAs. After computationally removing miRNAs,
the sequences from the untreated library con-
tained a prominent 21-nt peak (Fig. 4A) that pre-
dominantly began with uracil (Fig. 4B), much
like miRNAs and unlike siRNAs in wild-type
heads, which often began with cytosine (Fig. 1A).
Perhaps in the absence of Ago2, only a sub-
population of endo-siRNAs that can bind Ago1
accumulates. The small RNAs from the ago2414
library enriched for 3′-terminally modified se-
quences were predominantly 24 to 27 nt long
and often began with uracil—a length distribution
and sequence bias characteristic of piRNAs,
which, like siRNAs, are 2′-O-methylated at their
3′ ends. Both the 21-nt small RNAs and the
piRNA-like RNAs in the ago2 mutant heads
mapped to transposons, unannotated hetero-
chromatic and unassembled sequences, but the
piRNA-like sequences mapped to mRNAs far
less frequently than did either the 21-mers or wild-
type endo-siRNAs (Fig. 4C). How these piRNA-
like small RNAs are generated and whether they
contribute to transposon silencing in the fly soma
remain unknown.
Note added in proof: The loci described
here in figs. S1 and S2 correspond to endo-
siRNA–generating hairpins recently identified
in (25–27).
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Resource Partitioning and Sympatric
Differentiation Among Closely
Related Bacterioplankton
Dana E. Hunt,1* Lawrence A. David,2* Dirk Gevers,1,3,4 Sarah P. Preheim,1
Eric J. Alm,1,5† Martin F. Polz1†
Identifying ecologically differentiated populations within complex microbial communities remains
challenging, yet is critical for interpreting the evolution and ecology of microbes in the wild. Here we
describe spatial and temporal resource partitioning among Vibrionaceae strains coexisting in coastal
bacterioplankton. A quantitative model (AdaptML) establishes the evolutionary history of ecological
differentiation, thus revealing populations specific for seasons and life-styles (combinations of free-living,
particle, or zooplankton associations). These ecological population boundaries frequently occur at deep
phylogenetic levels (consistent with named species); however, recent and perhaps ongoing adaptive
radiation is evident in Vibrio splendidus, which comprises numerous ecologically distinct populations at
different levels of phylogenetic differentiation. Thus, environmental specialization may be an important
correlate or even trigger of speciation among sympatric microbes.
Microbes dominate biomass and controlbiogeochemical cycling in the ocean,but we know little about the mecha-
nisms and dynamics of their functional differen-
tiation in the environment. Culture-independent
analysis typically reveals vast microbial diversity,
and although some taxa and gene families are
differentially distributed among environments
(1, 2), it is not clear to what extent coexisting
genotypic diversity can be divided into function-
ally cohesive populations (1, 3). First, we lack
broad surveys of nonpathogenic free-living bacte-
ria that establish robust associations of individual
strains with spatiotemporal conditions (4, 5); sec-
ond, it remains controversial what level of genetic
diversification reflects ecological differentiation.
Phylogenetic clusters have been proposed to cor-
respond to ecological populations that arise by
neutral diversification after niche-specific selec-
tive sweeps (6). Clusters are indeed observed
among closely related isolates (e.g., when ex-
amined by multilocus sequence analysis) (7) and
in culture-independent analyses of coastal bacterio-
plankton (8). Yet recent theoretical studies suggest
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